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Introduction: Banked cultured Langerhans cell (LC) free allogeneic
kératinocytes, could be a readily available resource for the treatment of burns. 
The key questions that have not been resolved regarding the natural history of 
allotransplanted cultured kératinocytes, are when, how and why they are 
eliminated. Previous work at the Blond Mclndoe Centre in a Large White pig 
model has demonstrated the survival of allotransplanted kératinocytes at 
three weeks in a “chimeric" context (transplanting mixtures of autologous and 
allogeneic kératinocytes). The cultured cells were labelled by retroviral gene 
transfer to introduce a lacZnIs histochemically detectable marker. This work 
however, involved grafting onto de-epidermalised dermis that was shown to 
be capable of regenerating an epidermis without the aid of transplanted 
kératinocytes. Additionally, the keratinocyte labelling efficiency was low. The 
purpose of this study was to investigate the fate of cultured allogeneic 
transplanted kératinocytes, when they are the only source of epidermal tissue 
in a wound incapable of epidermal regeneration. To accomplish this, the aim 
was to develop a more efficient means of porcine keratinocyte labelling with 
the lacZnIs marker and to immunohistochemically characterise the cellular 
infiltrate with regard to allogeneic split skin graft rejection and compare this 
with the immune cell infiltrate associated with lacZnIs labelled LC-free cultured 
allogeneic kératinocytes grafted onto Integra ^  (a non-regenerative dermal 
template).
Methods: The Large White pig was used in view of the similarity of its skin 
architecture to humans. Retroviral gene transduction of cultured porcine 
kératinocytes was conducted with a MFGIacZnIs construct in the PT67
amphotropic packaging cell line. Leucocyte phenotypes infiltrating porcine 
skin were characterised immunohistochemically using a panel of monoclonal 
antibodies specific to porcine antigens: CD1, CD3, CD4, CD5, CD6, CDS, 
CD25, CD45, SWC3, SWC6, SLA DP, SLA DP, SLA DR and IgXLC with ABC 
staining. Porcine jejunum was employed as a positive control. LC depletion 
with Anti-MHC H and complement was monitored using flow cytometry. 
MFGIacZnIs labelled LC-depleted cultured kératinocytes sheets and 
keratinocyte-dermal composites were auto and allografted onto Integra™and 
onto deep fascia respectively. LacZnIs /Fgalactosidase expression was 
detected using X-Gal staining of tissue biopsies at different time points up to 
21 days following grafting and a reduced panel of monoclonal antibodies 
(omitting CDS, SLA DP and SLA DQ) was used to immunophenotype the 
infiltrate at these time points.
Results: The new PT67 producer line succeeded in achieving close to 100% 
of keratinocyte transduction with the MFG lacZ construct following three 
passages in a cell culture system containing irradiated retroviral producer 
cells and 3T3 fibroblasts as feeder cells. Stability was demonstrated with no 
apparent reduction in lacZ nis expression by porcine kératinocytes following a 
further seven passages on irradiated 3T3 fibroblasts. A reduction was 
demonstrated however, both in the number and size of colonies formed by 
kératinocytes following transduction. LCs were shown to be successfully 
eliminated from disaggregated epidermal cells using antibody and 
complement. We also demonstrated that overnight incubation results In up 
regulation of MHO class II antigen and increases the efficiency of LC 
elimination. As with retrovirally transduced kératinocytes a reduction was
demonstrated however, both in the number and size of colonies formed by 
kératinocytes that had undergone treatment with antibody and complement. 
The differential distribution of leucocyte phenotypes as determined by the 
panel of antibodies within normal porcine skin was shown for the first time. 
The cell phenotypes examined were CD1 (mainly dendritic cell), pan 
leucocyte determinant CD45, pan T-cell determinants CD3, CD5 and CD6 as 
well as CD4 and CD8, MHC class II determinants SLA DP DQ and DR, SM/C3 
(found on cells of myeloid extraction including macrophages and 
granulocytes), SIVC6 (null cell population), immunoglobulin light chain (B cell) 
and CD25 (IL-2 receptor). CD 1-positive cells were found mainly in the 
epidermis. The remainder were concentrated in different proportions within 
the papillary dermis and around hair follicles. Counts of all determinants 
except for CD1 (and SWC6) were considerably raised in split skin graft 
undergoing rejection. With regard to cultured allogeneic kératinocytes, 
results suggest that they are rejected after 18 to 21 days when grafted onto 
biointegrated Integra™. Keratinocyte dermal composite grafts surviving at 
three weeks, however showed no sign of rejection. This difference in survival 
may be related to the 'proinflammatory nature of Integra™ alluded to by 
others. Any inference relating to the afore mentioned results must be 
however, tempered with caution as a high percentage of grafts were lost due 
to problems relating to the wound chamber. The staining pattern with regard 
to cultured kératinocytes grafted onto Integra™ suggests infiltration by 
dendritic cells by day 7. The infiltrate at the time of graft loss was comprised 
mostly of T-cells (SLA DR staining suggests many are activated) with CD4 
and CD8 phenotypes present in equal number. With regard to the
keratinocyte dermal composites, although host dendritic cells were seen to 
have infiltrated the graft bed by day 14, the character of infiltrate did not 
suggest rejection at any of the time points.
Conclusions: This study has succeeded in characterising the differential 
immunoinfiltrate invading LC-free cultured allogeneic as opposed to 
autologous cultured porcine kératinocytes. The residence of the autologous 
and allogeneic cells was demonstrated unequivocally using retroviral gene 
marking. Due to problems relating to the wound chamber model a high 
percentage of grafts were lost. This has meant that results can only be 
suggestive and that it is very difficult to draw meaningful conclusions. The 
immune rejection of kératinocytes grafted onto Integra™ was however not of 
great vigour and was not evident with respect to the composite grafts at 21 
days. This is consistent with a promising potential for LC-free cultured 
allogeneic skin products in the treatment of burn injuries.
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Introduction
The host response to allogeneic keratinocyte transplantation
29
1.1 Early burn wound resurfacing
Intact skin serves as a barrier preventing microbial invasion as well as fluid 
and nutrient loss. Destruction of skin due to thermal insult results in loss of 
this barrier capability. The degree to which this may impact on survival has 
been shown to be related to the amount of body surface area (BSA) burnt 
(Bull, 1971). Wounds that are greater than 20% BSA pose a significant threat 
due to fluid loss and potential infection and do best with early excision and 
resurfacing (Burke et al., 1974).
Earlier resurfacing of wounds also helps limit systemic inflammatory and 
catabolic responses (Press, 1997).
1.2 Split skin grafts
Autologous split thickness skin grafts remain the gold standard for resurfacing 
burns. In an injury more extensive than 30% BSA however, limitations in 
available skin graft donor area often necessitate multiple operations. Dermis 
does not regenerate. Repeat harvesting from the same donor area results in 
progressive dermal thinning and may result in poor healing and scarring 
(Place et al., 1997). There is also the additional burden of blood loss that 
occurs with skin harvest and the act of harvesting a graft creates a new 
wound, which further adds to the metabolic burden.
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1.3 Cultured epithelium
In 1975 Rheinwald and Green succeeded in producing sheets of cultured 
human kératinocytes using a 3T3 murine fibroblast feeder layer and a growth 
factor-enriched medium (Rheinwald and Green, 1975). The introduction in 
1979 of an enzyme (Dispase™) that selectively disrupted bonds between 
kératinocytes and glass or substrate plastic, but not intercellular bonds, 
allowed the sheets to be lifted out and used as grafts (Green et al., 1979). 
Since then there have been a number of reports detailing the use of cultured 
autologous epithelium as sheet grafts in burns with mixed success (Hefton et 
al., 1983; Madden et al., 1986; Thivolet et al., 1986; Pandya et al., 1998). In 
spite of advances in culture technology it still takes between 3 to 6 weeks to 
produce confluent keratinocyte sheets ready for grafting, thus limiting their 
usefulness.
1.4 Allogeneic keratinocyte transplantation
Allogeneic keratinocyte transplantation (AKT) (Hammond et al., 1987; Brain et 
al., 1989) refers to the grafting of cultured kératinocytes between genetically 
different members of the same species. Kératinocytes may be cultured and 
cryopreserved in great numbers. 'Banked' allogeneic kératinocytes could thus 
be used to provide sufficient confluent sheets for immediate use as an 
elective procedure.
AKT may in addition to the provision of epithelial cover in burns, be useful in a
variety of clinical settings. AKT may be of benefit in the promotion of healing
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within chronic leg ulceration (Leigh et al., 1987), skin graft donor sites, 
wounds created by removal of congenital giant naevi and in chronic fragile 
skin conditions such as epidermolysis bullosa (Hill et al., 1992). Genetically 
modified allogeneic kératinocytes may also be used to deliver gene therapy 
(Sevan et al., 1999).
A number of difficulties have been encountered with cultured sheet grafts that 
potentially compromise their take as well as long term survival of the graft. 
Fragility of cultured keratinocyte sheets (making them difficult to handle and 
easily damaged) is a technical problem common to both autologous and 
allogeneic grafts. Additionally, optimal health and vascularity of the bed is 
required to ensure graft take.
Viral transmission such as with HIV by infected allogeneic kératinocytes is a 
potential problem for the recipient of allogeneic (or xenogeneic) kératinocytes 
(Clarke, 1987);(Rappersberger et al., 1988; Chesebro et al., 1990; Pirnay et 
al., 1997; Kim et al., 1992; Ramarli et al., 1995). Reports regarding the 
transmission of new variant CJD through transplantation of allogeneic 
kératinocytes or any other transplanted organ are yet to emerge.
The majority of reports indicate that transplanted cultured allogeneic 
epithelium are eventually lost (Aubock et al., 1988; Burt et al., 1989; Brain et 
al., 1989), although there have been isolated reports of their long term 
survival (Otto et al., 1995). Aside from the aforementioned potential technical 
obstacles, which may be surmountable, rejection remains a paramount 
consideration.
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1.5 Rejection of allogeneic skin grafts
Acute rejection of allogeneic skin graft refers to the destruction of transplanted 
skin that occurs following a period of transplant acceptance. It was 
characterised in detail by Medawar and Gibson (Gibson and Medawar, 1943). 
Following early experience with second set skin allograft reactions in human 
burns they concluded that an active acquired or specific immune process 
caused graft rejection after an initial period of take (Gibson and Medawar, 
1943). Medawar observed the survival of autologous skin surrounded by 
allograft undergoing rejection (Medawar, 1944), reinforcing the view that 
rejection is cell-specific. He further concluded that antigen-antibody 
interactions were responsible for graft destruction rather than direct 
lymphocyte involvement (Medawar, 1944; Medawar, 1945).
In the late 1940’s and early 1950’s evidence began to accumulate (particularly 
with regard to tumour antigens) suggesting that lymphocytes were intimately 
involved with and mainly responsible (in acute rejection) for killing allogeneic 
cells (Snell, 1957).
Within the last two to three decades advances in three principle areas have 
contributed to the current understanding of the rejection process. The first 
concerns work in the field of dendritic cells. Work in this field contributed to 
understanding how the rejection process is initiated. The second involves the 
development of monoclonal antibodies. Early work using cytotoxicity assays 
(Kisielow et al., 1975), helped to delineate T from B cells and discover certain 
T-cell subsets. The advent of hybridoma technique in the development of
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monoclonal antibodies (Kohler and Milstein, 1975) in the mid 1970s, facilitated 
subsequent identification of discrete T and B cell phenotypes. This also 
enabled the study of rejection occurring following T-cell depletion by prior 
administration of particular monoclonal antibodies (Tinois et al., 1989). 
Development of mutant mouse strains expressing discrete structural 
mutations in products of the major histocompatibility complex (MHC)
comprised the third principle area. This allowed for study of rejection across
specific histocompatibility barriers (Rosenberg et al., 1991).
1.5.1 Sensitisation phase of acute rejection
Acute rejection of transplanted allogeneic split skin grafts is initiated following 
the migration of mature Langerhans cells (LC) to regional nodes where they 
fulfil their role as APCs. The LC present both class I (expressed normally by 
kératinocytes) and class II (expressed by LCs but not normally by 
kératinocytes) MHC antigens (Romani and Schuler, 1992; Rosenberg and 
Singer, 1992).
1.5.2 Langerhans cells
LC (see Figure 1.1) first described by Paul Langerhans in 1868 were originally 
thought to be a cell type of the nervous system (Romani and Schuler, 1992). 
They then were regarded as worn out melanocytes and only after the 
demonstration by electron microscopy of a specific cytoplasmic organelle, the 
Birbeck granule, did they assume an identity as a distincT-cell type. In the 
70’s MHC II molecules as well as Fc and complement receptors were
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demonstrated on the cell surface confirming their nature as 
immunocompetenT-cells (Romani and Schuler, 1992). Although direct 
evidence is still lacking it now seems most probable that the LC lineage is 
myeloid and might be derived from precursors found in bone marrow 
(Steinman, 1991). In vitro studies established that LCs mature into potent 
immunostimulatory dendritic cells (Schuler and Steinman, 1985). In this state 
they lose the ability to further take up antigen. Cell expression of MHC II and 
MHC I complexes in which the antigen is presented increases dramatically 
with maturation (Witmer-Pack et al., 1988; Banchereau and Steinman, 1998). 
Figure 1.1:
Schematic diagram illustrating features of dendritic cells (adapted from 
Steinman et al., 1995).
ARC specialised for T-cell-
mediated immunitv
Lack CD3, 14, 16, 19
High levels of antigen presenting 
molecules: MHC I and II. CD 1 ,
Low FcRs and C3Rs, weak 
phagocytosis, nonadherent
High levels of accessory 
molecules: iCAMs. LFAs, B7s
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These LCs have been shown to be powerful stimulators of T-cell proliferation 
(Schuler and Steinman, 1985; Banchereau and Steinman, 1998). In vivo the 
life cycle of LCs is thought to originate in the bone marrow (Romani and 
Schuler, 1992). Within the epidermis antigen may be phagocytosed and 
processed, following which the LC will commence the process of maturation 
by migration to a regional node. The regional node is thought to be their ‘final 
resting ground’ where the LC mature into dendritic cells where they may 
present antigen to naïve T-cells (Knight and Stagg, 1993; Steinman et al., 
1995).
Interaction between the T-cell CD (cluster of differentiation) 28 and the ARC 
B7 costimulatory molecule (as well as that between the T-cell receptor (TCR) 
and major histocompatibility molecules) is thought to be necessary for 
effective T-cell alloactivation (Abraham et al., 1992); (Allison, 1994). Other 
cells besides dendritic cells (DCs) are capable of presenting antigen but in 
spite of this are unable to alloactivate naïve Th cells. These cells tend to lack 
the necessary CD28 ligands (Nickoloff et al., 1995).
Although certain other cells such as macrophages and B cells may be 
capable of stimulating proliferation of memory T-cells once they themselves 
are activated, by far the most potent stimulator of naïve T-cells are DCs 
(Knight and Stagg, 1993; Janeway and Bottomly, 1994). Kératinocytes 
although not capable of antigen processing, can be induced to express both 
MHC II molecules as well as the CD28 ligand B7-3 (Nickoloff et al., 1995). 
The significance of this is not yet clear.
Within skin there are now thought to be three pools of dendritic cells. One 
pool, represented by LCs, is contained within the epidermis. A further pool
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exists within the dermis. These differ from LCs in their cell surface expression 
as well as a lack of Birbeck granules. In culture however, they behave like 
dendritic cells in terms of their shape and motility, cell surface phenotype and 
potent T-cell stimulating activity. The third pool exists within afferent lymph 
and are thought to be shorter lived and have a higher turn over than the 
epidermal LCs (Steinman et al., 1995). In comparison to epidermal LCs the 
immune surveillance function of afferent and dermal dendritic cell pools are 
not as well defined.
Following primary allografting of skin there are two principal ways in which 
naïve T-cells become activated. The ‘direct’ pathway is defined as the 
processing, migration to a regional node maturation and presentation of 
alloantigen by a graft derived ARC. The classical or ‘indirect’ pathway is the 
phenomenon whereby host LCs migrate into the graft, process antigen and 
then migrate back out to regional lymph nodes to alloactivate naïve T-cells 
(Schuurman, 1994). Although the direct pathway is thought to be important to 
the initiation of the acute rejection process in sensitising the host to graft 
antigens the indirect pathway may have a role to play with regard to driving 
the destruction of transplanted tissue once underway (Benichou, 1999). Naïve 
T-cells distribute preferentially from blood to lymphoid tissues via the high 
endothelial venules (Knight and Stagg, 1993). This is consistent with much of 
the evidence to date which supports central (i.e. within a regional draining 
node) presentation as essential for the initiation of acute rejection (Barker and 
Billingham, 1967; Tilney and Gowans, 1970; Rosenberg and Singer, 1992). 
Memory T-cells are distributed to non-lymphoid tissues (Knight and Stagg, 
1993) and consequently may be open to activation at these sites (in
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secondary immune responses or late rejection) by indirect means (host 
derived APCs) (Benichou, 1999).
1.5.3 T-cells
Following activation by primed APCs phenotypically distinct T helper (Th) cells 
functionally differentiated by their cytokine expression profile may be 
demonstrated (see Figure 1.2). ThO cells (cytokine profile: IL-2, IL-4 IFNy, 
lymphotoxin) may be induced to differentiate into Thi cells (cytokine profile: 
IL-2, IFNy, lymphotoxin) specialising in cell-mediated immunity, by exogenous 
IL-12 or into Th2 cells (cytokine profile: IL-4, IL-5, IL-6, IL-10) specialising in 
humoral immunity, by exogenous IL-4 (Nickerson et al., 1994).
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Figure 1.2: Schematic diagram illustrating the Th1/Th2 paradigm (adapted 
from Nickerson et al., 1994).
IL-2 “1 Cell -  mediated 
IFNy J Immunity
Thi
IL-12ARC
Naïve
T-cell ThOpoO
IL-2
IL-4
Co-stimuli
Th2
IL-4 Humoral 
IFNy J Immunity
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IL-2 is required for a further complex interaction to occur between resting 
cytotoxic T lymphocytes (CTL) and APCs transforming them into mature CTL 
cells (Rosenberg and Singer, 1992).
The sensitisation phase initiated by APCs encompasses therefore Th cell 
activation as well as the generation of CTL cells.
Th and resting CTL cells tend to differ with respect to their CD4/CD8 
phenotypes and hence their receptor specificities. Th cells express CD4; an 
accessory molecule involved in the recognition of processed foreign antigen 
presented within the MHC II molecule cleft (Barclay et al., 1997). CD8 is a co­
receptor with MHC I restricted T-cell receptors and is associated with resting 
CTL function (Barclay et al., 1997). Although the above is the general rule, 
there is a population of T-cells, of varying proportion depending on species, 
that express dual CD4/CD8 antigens and appear able to assume both T 
helper and cytotoxic functions (Rosenberg and Singer, 1992).
1.5.4 B cells
B cells are no longer thought to play the dominant role in acute skin graft 
rejection (Rosenberg and Singer, 1992). It is now thought that during acute 
rejection, antibody activity is principally targeted at endothelial MHC II 
antigens (Mason and Morris, 1986).
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1.5.5 Effector phase
The effector phase is characterised by a (principally) cell-mediated response 
involving CD8-expressing CTL cells (Rosenberg and Singer, 1988) 
(Rosenberg and Singer, 1992).
CTL induced cell death is allogeneic cell-specific (Chandler and Passaro, 
1993), sparing neighbouring non-allogeneic cells. Acute rejection also results 
in a degree of non-specific damage to non-allogeneic neighbouring cells. This 
is thought to be caused by infiltrating inflammatory cells such as activated 
macrophages which may be mediated by inflammatory cytokines secreted by 
activated Th or CTL cells (Chandler and Passaro, 1993; Rosenberg and 
Singer, 1992). The extent of bystander tissue damage relates directly to the 
degree of associated inflammation (Doody et al., 1994; Rosenberg and 
Singer, 1992). The way in which the rejection response is initiated may be 
important to the degree of inflammation. Were the mechanism for direct 
presentation to be bypassed and indirect presentation to proceed gradually 
and late and in addition to be targeted only at MHC I antigens, the 
accompanying inflammatory response may be much dampened. Damage to 
neighbouring autologous tissue may thus be reduced.
1.6 Rejection of cultured keratinocyte allografts
There have been conflicting reports concerning the behaviour of LCs in vitro 
when disaggregated epidermal cells are co-cultured. Certain investigators 
failed to demonstrate the presence of LCs (Hefton et al., 1984; Morhenn et
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al., 1982; Thivolet et al., 1986); in addition the cultured grafts appeared to 
survive transplantation. Others demonstrated the presence of LCs in human 
epidermal cell culture at three weeks (Demidem et al., 1986). It has since 
become apparent that LCs in culture can alter phenotype considerably 
depending on culture conditions (Teunissen et al., 1990; Witmer-Pack et al., 
1988; Schuler and Steinman, 1985; Romani and Schuler, 1992) which may 
partly explain the above.
Initial reports in the 80 s failed to demonstrate an overt immune response 
mounted against cultured epidermal allografts (Thivolet et al., 1986; Hefton et 
al., 1983; Madden et al., 1986; Gielen et al., 1987). The models used 
however, were human partial thickness wounds of uncontrolled depth, such 
as tangentially excised partial thickness burns (Thivolet et al., 1986; Madden 
et al., 1986) or chronic ulcers (Hefton et al., 1983; Gielen et al., 1987)), which 
may well have contained residual regenerative epithelial elements.
Several investigators have been unable to demonstrate residual donor 
kératinocytes in the healed wound. This despite the absence of an overt 
rejection response and have therefore suggested that allogeneic donor cells 
undergo replacement by host epithelial elements (Gielen et al., 1987; Burt et 
al., 1989); (Brain et al., 1989); (van der Merwe et al., 1990); (Zhao et al., 
1992) (Phillips et al., 1993). This is consistent with the notion of spontaneous 
cell death or cell-specific targeting by CTL cells with minimal accompanying 
inflammatory destruction of neighbouring elements.
Others (Aubock et al., 1988) have however demonstrated abrupt rejection of 
cultured epidermal allografts with a 14.5 day (mean) survival time.
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All the above studies concentrated on chronic ulcers or burns in humans. In 
the late 1980's and early 90's increasing use was made of animal models to 
study rejection of allogeneic elements in a detailed and controlled manner 
(Fabre and Cullen, 1989; Doody et al., 1994; Carver et al., 1991; Suzuki et al., 
1995; Rouabhia, 1996; Rouabhia et al., 1995).
Fabre working with inbred rats demonstrated that acute rejection of cultured 
keratinocyte allografts does not appear to be associated with antibody 
production (Fabre and Cullen, 1989). Rejection however, was delayed only 
by a few days when compared with split thickness allografts (supporting 
Aubock’s earlier work (Aubock et al., 1988)). Carver et al., (1991) similarly 
reported only a brief delay in rejection of cultured allogeneic epithelial grafts in 
a pig model.
1.7 Chimeric grafts
The chimera in classical Greek mythology was a beast with the head of a lion, 
the body of a goat and tail of a serpent (Allen, 1990). The term has been 
adopted to represent tissues, organs or whole animals engineered to contain 
elements of differing parentage. The effect on autologous elements that a 
potential immune response mounted against foreign elements might have can 
thus be observed. Within the last few years attention has focused on the 
design of chimeras of cultured keratinocyte sheets consisting of syngeneic 
and allogeneic keratinocyte elements of varying proportions (Rouabhia et al., 
1995; Suzuki et al., 1995). Using inbred mouse strains one group reported 
replacement of allogeneic kératinocytes by 30 days post grafting (Rouabhia et
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al., 1995). In comparison to control allogeneic grafts only a weak immune 
response was mounted against the chimeric graft. A further group using 
similar inbred mouse strains looked at chimeric grafts with a syngeneic to 
allogeneic ratio of: 1:15 and demonstrated similar success (Suzuki et al., 
1995). The study ended at 14 days post grafting. Both studies showed 
complete replacement of autologous by syngeneic kératinocytes at the study 
end point. In a further study Rouahbia looked at chimeras consisting of 
cultured xenogeneic (human) and syngeneic kératinocytes. Results were 
similar to those in the previous experiment, with the chimeric grafts surviving 
at 30 days almost as well as the isograft with similar ultrastructural 
characteristics (Rouabhia, 1996). These results suggest (at least in the 
particular inbred mouse populations studied), a highly selective or cell-specific 
rejection response sparing syngeneic elements.
1.8 Porcine model
The domestic pig has been used to study wound healing for at least 4 
decades (Winter, 1962). Porcine skin resembles human skin more closely 
than other common small laboratory animals. The epidermis and dermis are 
of similar thickness and there is a distinct dermal papillary layer (see 
Figure1.3). Both man and pig rely on subdermal fat rather than fur for 
insulation. Its epidermal appendages consist of hair follicles, sebaceous and 
apocrine glands. One way in which the pig differs from humans is in its lack of 
eccrine sweat glands (Winter, 1972) as it does not regulate body heat with 
surface sweating.
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Figure 1.3: Porcine Skin
Photomicrograph (X40) H&E stained, formalin fixed cryostat sections. 
PD = papillary dermis; RD = reticular dermis; HF = hair follicle
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Porcine kératinocytes may be cultured with relative ease to produce sheet 
grafts (Sevan et al., 1997). Resultant sheets show similar ultrastructural 
characteristics to human cultured epithelial sheets (Sevan et al., 1997); 
(Kangesu et al., 1993). The creation of wounds that extend down to muscle 
fascia, reduces the possibility of re-epithelialisation by residual host 
keratinocyte elements. Take of autologous cultured sheets has been 
demonstrated on a wound bed prepared with the non-regenerative dermal 
template Integra™ (Grant and Martin, 1998). In this model a 4cm diameter 
disc of Integra^ "'  ^was stitched to the wound bed and left to take for 10 days 
prior to receiving the cultured epidermal sheet. The graft was encompassed 
within an open cylindrical PTFE chamber as described by Kangesu and 
colleagues in 1993. The graft was covered by non occlusive saline-soaked 
gauze dressing facilitating easy access to the wound bed as well as reducing 
contamination by host kératinocytes from the peripheral wound edge. 
Although Integra™ has in the past been investigated with respect to 
autologous cultured epithelium in the porcine model (Grant and Martin, 1998), 
there are no reports of its use in conjunction with cultured allogeneic 
epithelium. Integra™, a dermal substitute consisting of bovine collagen and 
chondroitin-6-sulfate and an epidermal layer of synthetic polysiloxane polymer 
(Silastic) is known to encourage a mild inflammatory response (Stern et al., 
1990). This presence of inflammatory cells at the time of allografting may 
prejudice graft take.
Swine have been used as a model for allotransplantation for more than three 
decades (Caine et al., 1969). The similarities in physiology and immunology 
have lead researchers to experiment with kidney, liver, heart, pancreas and
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small bowel transplantation (Kenmochi et al., 1994). Their size, laboratory 
adaptability and breeding characteristics are further advantages. Serious 
consideration has in recent years been accorded the pig as a potential 
xenograft donor with regard to a variety of organs (Sachs, 1994). There has 
been intensive work in the last decade in the production of porcine-specific 
monoclonal antibodies (Saalmuller et al., 1998a), which has made it possible 
for in depth phenotyping of cells of the porcine immune system to be carried 
out.
1.9 Cell labelling
Various attempts have been made in the past to label cultured cell 
populations in order to track their fate after grafting. Methods used with regard 
to the human model are varied. Typing of ABO antigens as expressed by 
epidermal cells in the upper Malpighian layers has been attempted (Thivolet 
et al., 1986). Others have looked at MHC class I expression by human 
kératinocytes (Gielen et al., 1987), or Y chromosome detection (male to 
female recipient) (Burt et al., 1989; Brain et al., 1989), and DNA fingerprinting 
(van der Merwe et al., 1990). In the pig model neither blood group nor MHC 
class I characterisation of kératinocytes is established as yet. Female Large 
White pigs adapt more easily to the animal house and laboratory environment 
and are easier to handle. We have therefore used them in preference to 
males and so could not consider looking at Y chromosome detection. We 
were interested in a method that allowed monitoring of autologous (as well as
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allogeneic) kératinocyte sheet grafts which therefore precluded the use of 
DNA fingerprinting.
Using retroviral transduction techniques the reporter gene MFG lacZnIs 
coding for the marker enzyme p-galactosidase has been successfully 
introduced into porcine kératinocytes (Bevan et al., 1997; Ng et al., 1996a; Ng 
et al., 1996b; Ng et al., 1997a). The nuclear localised p-galactosidase enzyme 
causes the nucleus to turn blue when fixed and then incubated with X-Gal or 
magenta when incubated with M-Gal.
1.10 Thesis objectives
This thesis sets out to examine the effector immune response to allogeneic 
kératinocytes within the Large White pig model (see Figure 1.4).
My objectives were:
1. To establish a means of tracking kératinocytes in vivo. Work therefore 
concentrated initially on the development of a labelling technique 
employing retroviral vectors of nuclear localised genes. It was then 
important to ascertain whether the method was intrinsically damaging to 
kératinocytes.
2. To attempt to ensure that grafted cells were free of LCs. As discussed 
above, investigators had previously determined that the LC phenotype In 
vitro contrasts strongly with that in vivo maturation (Teunissen et al., 1990; 
Witmer-Pack et al., 1988; Schuler and Steinman, 1985; Romani and 
Schuler, 1992). Little is known about the behaviour of LCs in the type of 
medium we use to culture porcine kératinocytes which is designed to
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prevent early differentiation. Most researchers (excluding (Demidem et al., 
1986)) have had difficulty detecting LCs (Hefton et al., 1984; Morhenn et 
al., 1982; Thivolet et al., 1986). It was decided therefore to proceed down 
the road of direct elimination. Here too It was felt important to examine 
whether the eliminatory process (antibody complement lysis) was 
detrimental to keratinocyte replication.
3. Examine the leucocyte population within normal Large White pig skin 
using a range of porcine-specific monoclonal antibodies. The few 
monoclonal antibodies that had been tested thus far were used to 
determine the immune cellular population within porcine jejunum. The 
majority of those now available had however, not previously been tested 
with respect to porcine skin. Having assembled a panel of recently 
developed monoclonal antibodies I sought first to examine the distribution 
of CD-specific cells within normal porcine skin and jejunum. Here we were 
seeking to establish a baseline for future investigations.
4. Evaluate leucocyte-infiltrating allogeneic split skin grafts undergoing 
rejection (the classical skin transplant model). Here too, the aim was to 
examine the population for comparison with later investigation.
5. Immunophenotype the response to cultured allogeneic kératinocytes 
grafted onto Integra™.
6. Establish a ‘living skin equivalent’ (keratinocyte dermal composite) and 
then examine the immune response following allografting using 
immunophenotyping techniques.
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The long term fate of grafted cultured allogeneic kératinocytes remains 
uncertain. The host immune response to AKT has thus far not been well 
characterised.
As outlined above there are a variety of clinical settings in which AKT may be 
useful. Through elucidating the host response to AKT it is hoped that it will 
one day be possible to devise techniques that allow maximally effective use of 
AKT thus helping to minimise patient morbidity.
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Fiaure1.4: Flow diagram illustrating general outline of thesis
Phase 1 Establishing cell tracking and ceii cuiture parameters
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Chapter 2
Materials & Methods
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2.1 MATERIALS
2.1.1 Cell culture
2.1.1.1 Gel! Lines
3T3 Swiss Mouse fibroblasts were obtained from the Imperial Cancer 
Research Fund, London.
The ecotropic retroviral producer cell line TELCeB which produces the MFG 
lacZ nis retroviral vector (Ferry et al., 1991) (see Figure 2.1) was obtained 
from D. Winton & S. McCutcheon, Cambridge.
Figure 2.1: Schematic diagram of MFG vector construct,
MFG recombinant retrovirus encoding lacZ. Moloney murine leukaemia virus 
(MoMuLV) long terminal repeat sequences are used to generate both a full 
length viral RNA (for encapsidation into virus particles) and a subgenomic 
mRNA, which is responsible for expression of inserted sequences. No 
selectable marker exists in the vector (adapted from (Dranoff et al., 1993)).
BamNco
SASD
lacZLTR LTR
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The retroviral packaging cell line GP+EnvAm12 (Markowitz et al., 1988) was 
obtained from Genetix Pharmaceuticals, New Jersey USA.
The amphotropic retroviral packaging cell line PT67 was obtained from 
Clontech, California 94303-4230, USA.
Porcine kératinocytes were freshly obtained following disaggregation of partial 
thickness skin harvested from Large White pigs.
2.1.1.2 Cell culture media and supplements
MATERIAL SUPPLIER
Duibecco's Modified Eagle's Medium DMEM 
(Glucose 1g per 1)
GIBCO BRL, Life 
Technologies, Paisley
Duibecco's Modified Eagle's Medium DMEM 
with Glutamax™ (Glucose 1g per 1)
Duibecco's Modified Eagle's Medium DMEM 
with Glutamax™ and Glucose 4.5g per 1
GIBCO BRL, Life 
Technologies, Paisley
Calcium-free Opti-MEM®1
Calcium-free Opti-MEM®1 with Glutamax™
Hank's balanced salt solution (HBSS) Sigma-Aldrich Co. Ltd., Poole, 
Dorset.
Fetal Calf Serum (FCS) Batch No. 72189 Imperial Laboratories Ltd, 
West Portway, Andover, 
Hant’s, England
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Penicillin/streptomycin 5000units per ml per 
5000|ug per ml
GIBCO BRL, Life 
Technologies, Paisley
Gentamicin 50 mg per ml
Amphotericin B 250pg per ml
L-Glutamine 200mM
Calcium Chloride 0.1 M
Ciprofloxacin 2 mg per ml BAYER AG, Levrkusen, 
Germany
NUTMIX F12 (HAM with Glutamax™) GIBCO BRL, Life 
Technologies, Paisley
Recombinant human epidermal growth factor Sigma-Aldrich Co. Ltd., Poole, 
Dorset.Hydrocortisone
Cholera toxin
Actrapid® (recombinant human insulin) Novo Nordisk Pharmaceutical 
Ltd, Crawley, West Sussex
Triiodothyronine (T3) Sigma-Aldrich Co. Ltd., Poole, 
Dorset.Adenine
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2.1.1.3 Culture materials (miscellaneous)
MATERIAL SUPPLIER
25 cm  ^ filter capped tissue culture 
flasks
Greiner Labortechnik Ltd, Dursley, 
Gloucestershire
75 cm  ^ filter capped tissue culture 
flasks
Petri dishes tissue culture grade 
100mm X 20mm
Petri dishes 60mm X 15mm Corning Glass Works, Corning, NY 
14831
Universal flasks (20ml) Becton Dickinson Labware, Becton 
Dickinson Labware Europe,Falcon® conical flasks (50ml)
24 well tissue culture plates
6 well tissue culture plates
Syringes 1ml, 2ml, 5ml, 10ml, 20ml
Rat tail collagen type 1 Sigma-Aldrich Co. Ltd., Poole, Dorset.
Trypsin (0.25%) Difco Laboratories, Detroit Michigan
Trypsin/EDTA (0.05%/0.02%) GIBCO BRL, Life Technologies, 
Paisley
Dispase® II Boehringer Mannheim, Lewes, Sussex
Tegapore® 3M Health Care, St.Paul, MN USA
Stainless steel grids used in the culture of composites were constructed in- 
house with stainless steel mesh of 106|im pore size obtained from
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Glenammer Engineering, Glenammer, Dalrymple, Ayrshire, Scotland. A 
'Mitutoyo' dial thickness gauge used to gauge the thickness of de- 
epidermalised dermis was obtained from Alan G Smith Ltd, Gravesend, Kent 
(see Figure 2.2).
All inverted phase contrast microscopy was carried out using an Olympus 
CK2 microscope.
Figure 2.2: Mitutoyo™ dial thickness gauge used to gauge the thickness of
de-epidermalised dermis.
2.1.2 Retroviral transduction
Cell lines used in these studies have been outlined above. The polyanion, 
Polybrene™ (Hexadimethrine Bromide), which promotes retroviral 
transduction (Jiang et al., 1991) was obtained (as Sequabrene) from Sigma- 
Aldrich Co. Ltd., Poole, Dorset. Acrodisk® PF syringe filters (0.2pm, 0.4pm 
and 0.2/0.8pm) were obtained from Gelman Sciences, Ann Arbor, Ml, USA. 
Chemicals used in the staining of MFG lacZ nIs transduced cells were:
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Magnesium chloride, obtained from FSA laboratory supplies, 
Loughborough, Leicestershire; potassium ferricyanide and potassium 
ferrocyanide obtained from Sigma-Aldrich Co. Ltd., Poole, Dorset.
X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galactoside), the substrate for the 
lacZ expressed enzyme p-galactosidase, was obtained from GIBCO BRL, 
Life Technologies, Paisley.
In preparation for flow cytometry, saponin (used in the permeablisation of p- 
galactosidase expressing cells prior to labelling) was obtained from Sigma- 
Aldrich Co. Ltd., Poole, Dorset, as was the sheep anti - mouse FITC 
secondary reagent. The primary monoclonal antibody to p-galactosidase was 
obtained from Boehringer Mannheim, Lewes, Sussex.
Alamar Blue™ an indicator dye used in the determination of cell proliferation 
was obtained from Serotec, Kidlington, Oxford, UK. The change in colour 
(from blue to red) on reduction was monitored using an Anthos 2001 
pi ate reader (serviced by Labtech International, Ringmer, East Sussex).
Flow cytometry was undertaken under the supervision of Mrs. J. Sargent, 
senior scientist. Dept, of Haematology Research, Pembury Hospital, 
Pembury, Kent.
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2.1.2 Langerhans cell elimination
The monoclonal antibody (moAB) used against the SLA DR epitope was an 
lgG2a isotype (mouse anti-pig) derived from the cell line MS A3 obtained from 
VMRD Inc., Pullman WA 99163, USA. The secondary reagent sheep anti­
mouse FITC was obtained from Sigma-Aldrich Co. Ltd., Poole, Dorset, 
England. Lyophilised sheep serum was obtained from ICN Biomedicals, Inc., 
Aurora, Ohio. Isotype control moAB was gifted by Dr WC Davis, WSU 
Monoclonal Antibody Centre, Veterinary Microbiology and Pathology, 
Washington State University, Pullman WA 99164.
Low-Tox®-M rabbit complement {Cedarlane) was obtained from VH BIO Ltd, 
Gosforth, Newcastle upon Tyne, who also donated samples of Low-Tox®-M, 
Low-Tox® guinea pig and baby rabbit complement. Goat serum was obtained 
from Sigma-Aldrich Co. Ltd., Poole, Dorset, England. Sodium azide was 
obtained from BDH laboratory supplies, Poole, Dorset, England 
Peripheral blood lymphocytes for use as positive controls were obtained from 
whole blood harvested from experimental pigs at termination. Both Lympho- 
paque™ and Lymphoprep™ (similar products) were used in density gradient 
separation. Lympho-paque™ density gradient separation medium, (Density: 
1.086 +/- 0.002g per ml, batch no. 807697), was supplied by Nyegaard & Co., 
Oslo, Norway. Lymphoprep™ (density 1.077 +/- 0.001 g per ml, batch no. 
808743) was supplied by NYCOMED AS, Diagnostica, Oslo, Norway. 
Although the expiry dates were 07 1993 and 08 1993 respectively neither 
appeared to show signs of deterioration, and functioned as expected.
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The following isotype control antibodies were donated by Dr MJ Hamilton 
WSU Monoclonal Antibody Centre:
Cell Line Isotype
ColiS69A IgGI
ColiS205D1 lgG2a
ColiS169A lgG2b
2.1.3 Histochemistry and Immunohistochemistry
2.1.4.1 Histochemistry
Paraformaldehyde and glutaraldehyde used as fixatives, as well as 
haematoxylin, eosin and DPX mountant were obtained from BDH laboratory 
supplies, Poole, Dorset, England. To facilitate cryostat sectioning OCT 
compound was used, obtained from Tissue-Tek, Miles Inc, Elkhart, IN, USA.
2.1.4.2 Immunohistochemistry
Primarv Antibodies: (porcine-specific unless otherwise stated)
Monoclonal Antibody 
Specificity
Cell Line / 
Clone
Isotype Source
CDIa (human) NA1/34-
HLK
lgG2a Serotec, Kidlington, Oxford, UK
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GDI 76-7-4 lgG2a VMRD, Inc., Pullman, WA, USA
CD2 PG168A lgG3 VMRD, Inc., Pullman, WA, USA 
(Gift)
GD2 MSA4 lgG2a Dr. J.K. Lunney, Beltsville, USA
CD3 8E6 IgGI VMRD, Inc., Pullman, WA, USA
CD3 FY1H2 lgG1 Dr. H. Yang, Pirbright, UK
CD4 PT90A lgG2a VMRD, Inc., Pullman, WA, USA
CD4a b38c6 IgGI Labor B. Glatthaar, Reutlingen, 
Germany
CD4 STH 293 IgGI Dr. M. Shimizu, Ibaraki, Japan
CDS PG114A IgGI VMRD, Inc., Pullman, WA, USA 
(Gift)
CD6 PG90A IgGI VMRD, Inc., Pullman, WA, USA 
(Gift)
CD8 PT81B lgG2b VMRD, Inc., Pullman, WA, USA
CD25 PGBL25A IgGI VMRD, Inc., Pullman, WA, USA 
(Gift)
CD25 231 3B2 IgGI Serotec, Kidlington, Oxford, UK
CD45 K252.1E4 IgGI Serotec, Kidlington, Oxford, UK
SLADR MSA3 lgG2a VMRD, Inc., Pullman, WA, USA
SLADR TH14B lgG2a VMRD, Inc., Pullman, WA, USA
SLADP H42A lgG2a VMRD, Inc., Pullman, WA, USA
SLADQ TH81A5 lgG2a VMRD, Inc., Pullman, WA, USA
\gXlC K139.3E1 lgG2a Serotec, Kidlington, Oxford, UK
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SWC3 74-22-15 IgGI VMRD, Inc., Pullman, WA, USA
SWC6 MAC320 IgG Serotec, Kidlington, Oxford, UK
Cytokeratin 14 
(human)
LL001 IgG 1. Leigh, Dept. Exp. Dermat. The 
Royal London Hospital (Gift)
Cytokeratin 10 
(human)
LHP2 IgG 1. Leigh, Dept. Exp. Dermat. The 
Royal London Hospital (Gift)
Cytokeratin 6 (human) LHK6 IgG 1. Leigh, Dept. Exp. Dermat. The 
Royal London Hospital (Gift)
Collagen VII (human) LH7.2 IgG 1. Leigh, Dept. Exp. Dermat. The 
Royal London Hospital (Gift)
Collagen IV (human) PHM12 IgGI Serotec, Kidlington, Oxford, UK
Laminin (human) Rabbitahuman
polyclonal
Serotec, Kidlington, Oxford, UK
Secondary reagents:
For single immunofluorescent labelling, fluorescein isothiocyanate (FITC) 
conjugated sheep anti-mouse or FITC-conjugated goat anti-rat was obtained 
from Dako Ltd, High Wycombe, Buckinghamshire England. Cy3 conjugated 
goat anti-mouse was obtained from Amersham Life Science Ltd., Little 
Chalfont, Buckinghamshire, England.
For dual and triple immunofluorescent labelling igG2b-specific FITC- 
conjugated goat anti-mouse, IgGI and lgG2a-specific phycoerythrin 
conjugated goat anti-mouse secondary reagents were obtained from Serotec, 
Kidlington, Oxford, UK. Biotin conjugated goat anti-mouse with IgGI, lgG2a or 
lgG2b specificities were also obtained from Serotec, Kidlington, Oxford, UK.
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FITC-conjugated to avidin, texas red conjugated to avid in and FITC- 
conjugated to avidin as well as biotinylated anti-avidin D were obtained from 
Vector Laboratories, Peterborough, East Anglia. Lyophilised normal sheep 
serum was obtained from ICN Biomedicals, Inc., Aurora, Ohio. Normal goat 
and horse serum were obtained from Sigma-Aldrich Co. Ltd., Poole, Dorset. 
Propidium iodide (1mg per ml) fluorescent nuclear stain was supplied by 
Molecular Probes, Oregon, USA.
For immunoperoxidase staining using the nickel-enhanced avidin-biotin 
complex (ABC) method, biotinylated horse anti-mouse IgG and the avidin- 
biotin complex were obtained from Vector Laboratories, Peterborough, East 
Anglia. Hydrogen peroxide (30% w/v) was obtained from BDH laboratory 
supplies, Poole Dorset. Diaminobenzidine (DAB), glucose oxidase, a-D(+)- 
glucose and normal horse serum were obtained from Sigma-Aldrich Co. Ltd., 
Poole, Dorset.
Porcine jejunum used as a positive control for many of the antibodies was 
obtained from a freshly terminated experimental animal. 2-methyl-butane 
(isopentane) used to control the freezing rate of the jejunum was obtained 
from Sigma-Aldrich Co. Ltd., Poole, Dorset, England. Fine quartz sand (- 
50+70 mesh) used to construct a sand bath was also obtained from Sigma- 
Aldrich Co. Ltd., Pooie, Dorset.
Both brightfield and fluorescent microscopy were performed using an 
Olympus BH2 microscope.
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2.1.6 Animal work
2.1.5.1 Animal source and housing
Animal experiments were performed under a Home Office personal licence, 
No. PIL60/6453, under project licence PPL70/4100.
14 outbred female Large White pigs aged 6-7 weeks and weighing 20-25 kgs 
were obtained from Bury Farm, Edgware, Middlesex, and from the Royal 
Veterinary College, Pond Street. Pigs were fed on ‘super grade pig pellets' (a 
weaning diet suitable for pigs up to 6 months of age) obtained from J&W Atlee 
Ltd, Parsonage Mills, Dorking, Surrey England. The delousing agent 
ivermectin (Ivomec®), was supplied by MSD-AGVET, Division of Merck Sharp 
and Dome Ltd. Hoddieston, Hertfordshire, England.
2.1.5.2 Anaesthesia and perioperative care
Drug Source
Ketamine (Vetalar®) Parke-Davies Veterinary Ltd, Pontypool, Gwent
Xylazine (Rompun®) Bayer UK Ltd, St. Edmunds, Suffolk
Halothane (Fluothane®) Zeneca Ltd, Macclesfield, Cheshire
Nitrous Oxide BOC Ltd, Guilford, Surrey
Oxygen BOC Ltd, Guilford, Surrey
Buprenorphine (Temgesic®) Reckitt & Colman Products Ltd, Hull
Lignocaine gel (2%) Biorex Laboratories Ltd, London
Amoxycillin/Clavulanic acid for Smith Kline Beecham Animal Health, Surrey
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injection (Synulox®)
Phenobarbitone (Expirai®) Civa Ltd, Watford, Hertfordshire
2.1.5.3 Wound chambers and protective jackets
Wound chambers were constructed from polytetrafluoroethylene (PTFE) by 
the Bioengineering Department at the Northwick Park Institute for Medical 
Research (see Figure 2.3). The chambers were protected by jackets made 
from thermoplastic Spectrum ® and secured with Velcro® straps (see Figure 
2.4). These were obtained from Promedics Ltd, Blackburn. Medium density 
furniture foam used to line the jackets and foam adhesive was obtained from 
Southern Foam, Crawley, Sussex.
Figure 2.3: Polytetrafluoroethylene (PTFE) wound chamber constructed by
the Bioengineering Department at the Nothwick Park Institute for 
Biomedical Research
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Figure 2.4: Thermoplastic Spectrum® jackets secured with Velcro® straps 
protect the chambers. Medium density furniture foam secured with foam 
adhesive was used to line the jackets.
2.1.5.4 Theatre Consumables
Consumables Source
Silver nitrate in aqueous solution 
(0.25%)
Eastbourne District General Hospital, 
Eastbourne, England
Chlorhexidine (4%) surgical scrub 
(Hydrex®)
DePuy Healthcare Ltd, Leeds, England
Chlorhexidine 0.5% in spirit
10% povidone iodine in aqueous 
solution (Betadine®)
Seton Healthcare, Oldham, Lancashire, 
England
Fucidin ointment (2% fusidic acid) Leo Laboratories, Buckinghamshire, 
England
Sterile normal saline Steripak Ltd, Runcorn, Cheshire,
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(sodium chloride Ph. Eur. 0.9% w/v) England
Liquid paraffin The Pharmacy, Northwick Park Hospital, 
Harrow, England
Synthetic wool bandage (Velband®) Johnson & Johnson, Ascot, Berkshire, England
Silicone coated dressings (N-A 
Ultra®)
Paraffin gauze (Jelonet®) Smith & Nephew, Chessington, Surrey
Adhesive bandage (Elastoplast®)
2/0 silk sutures Ethicon Ltd, Edinburgh
5/0 Proline sutures
The Zimmer® pressurised air powered dermatome was purchased from 
Zimmer, Dover, Ohio, USA.
Integra™ artificial skin was obtained from Integra Life Sciences Corporation, 
Plainsboro, New Jersey, USA.
2.1 METHODS
2.2.1 Cell culture
All cells were cultured in a standard manner. A Jouan class II tissue culture 
hood was used at all times. Cells were grown in a LEEC incubator kept at a 
constant 37°C, 98% relative humidity and 10% CO2 concentration. Cells were 
generally subcultured just prior to confluence.
2.2.1.1 3T3 Swiss mouse fibroblasts
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The medium used for culturing 3T3 fibroblasts consisted of the following:
Ingredient Volume
DMEM (1g per 1 glucose) with Glutamax™ 500ml
Penicillin/Streptomycin 10ml (100 units per ml/100 pg per ml)
FCS 56ml (10% of total volume)
Prior to the availability of DMEM containing Glutamax™ (the dipeptide L- 
alanyl-L-glutamine which is substituted on a molar equivalent basis for L- 
glutamine), L-glutamine (200mM per ml, thawed from frozen stock) was 
added to give a final concentration (5ml in 500ml) of 2mM.
Cells were culture in 75cm^ tissue culture flasks in which 10ml of culture 
medium was sufficient. Medium was changed every 2-3 days. To subculture a 
confluent flask, culture medium was aspirated using a sterile pasteur pipette. 
5ml of HBSS was added, the flask gently agitated and the HBSS then 
aspirated. 3ml of trypsin/EDTA (0.05%/0.02%) was added and the flask gently 
agitated and then placed in the incubator. The flask was checked at 5 minute 
intervals. Following detachment of the cells 5ml of culture medium is inserted. 
All 10ml were then withdrawn and placed in a universal container. The 
universal was then spun for 5 minutes at 1200-1500rpm (approximately 250- 
300g) in a Jouan C312 centrifuge. Supernatant was then aspirated leaving a 
small volume covering the residual pellet. Medium was added and with 
repeated cycles of aspiration and then release, the cells were resuspended 
and could be subdivided into flasks containing fresh medium. Cells from one 
confluent flask were usefully subdivided in up to 6 further flasks and were
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subcultured between 15 and 20 passages before infection or significant 
morphological change necessitated their discarding.
2.2.1.2 Large White pig kératinocytes
Under anaesthetic a 5cm wide and 10cm long strip of partial thickness skin 
was harvested from the paravertebral region. The Zimmer™ dermatome was 
set at 12 to ensure a partial skin thickness of approximately 200pm (as 
determined with the Mitutoyo dial gauge). The harvested skin was placed in a 
45ml conical tube containing 35ml of transport medium, wrapped in parafilm 
and placed on ice for transportation to the laboratory. Transport medium 
contained the foliowing:
Ingredient Volume
DMEM (1g per 1 glucose) with Glutamax™ 500ml
Penicillin/Streptomycin 600 units per ml/600 pg per ml 60ml
FCS 28ml (5% of total volume)
Gentamicin 250 pg per ml 2.5ml
Prior to the availability of DMEM containing Glutamax™, L-glutamine (200mM 
per ml, thawed from frozen stock) was added to give a final concentration 
(5ml in 500ml) of 2mM.
In the laboratory the harvested skin was washed 4 times in HBSS. It was then 
placed in 35ml of trypsin (0.25%, Difco Laboratories) containing 
penicillin/streptomycin (100 units per ml/100 pg per ml) and amphotericin B
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(1.25 pg per ml) for 2 hours in a water bath set at 37°C. At the end of 2 hours 
the epidermis was carefully separated from the dermis and minced finely. The 
minced epidermis was then placed back into the trypsin solution and shaken 
to further disaggregate the cells. The solution was then passed through a 
stainless steel sieve (pore size ~ 100pm), then transferred to a conical tube 
and a further 10-15 ml of 3T3 growth medium added. Following centrifugation 
the pellet was resuspended in porcine keratinocyte growth medium the 
ingredients of which were:
Ingredient Volume
Calcium-free Opti-MEM®1 500ml
Penicillin/Streptomycin 10ml (100 units per ml/100 jug per ml)
0.1 M Calcium Chloride 0.75m\ (final concentration 0.5mM)
FCS 5ml (1% of total volume)
Prior to the availability of DMEM containing Glutamax™, L-glutamine (200mM 
per ml, thawed from frozen stock) was added to give a final concentration 
(5ml in 500ml) of 2mM. The final [Ca^ ]^ is adjusted to 0.5mM by the addition 
of 0.1 M GaCL.
0.1ml of resuspended kératinocytes were mixed with 0.1ml 1% trypan blue 
and the viable cells then counted using a haemocytometer. 4X10® viable 
keratinocyte per 75cm^ tissue culture flask (5.3X1 O'* per cm^) were then plated 
out into a prepared flask.
Flasks were prepared for keratinocyte culture by collagen coating and plating 
with 2X10® (per 75cm^ tissue culture flask) irradiated 3T3 cells. Collagen
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coating was performed by treating each flask with 7 ml of rat-tail collagen type 
1 (50 pg per ml dissolved in 0.02M acetic acid) at room temperature for 2 
hours. The flasks were then dried for one hour in the hood and then rinsed in 
HBSS before use. Collagen stock was made by dissolving 5 mg rat tail 
collagen type 1 in 20 ml of 0.1 M acetic acid which was then diluted to lOOmIs 
with culture grade H2 O. The solution was sterilised with 10 mis chloroform
and stored overnight in the fridge. The chloroform was aspirated on the
following day with a sterile glass pipette. The collagen stock was 
subsequently stored at 4 °C.
Irradiated 3T3 cells were prepared up to a day before keratinocyte plating by
Irradiating with 6,000 rad (from a shielded ^^^Cs source) and were plated at a 
density of 2X10® per 75cm^ flask in the keratinocyte growth medium. As
outlined in Chapter 3 the number of irradiated 3T3 fibroblasts were
correspondingly reduced if irradiated PT67 retroviral producer cells are used 
as feeder cells (but no alteration in medium was necessary).
An evaluation was made of both keratinocyte sheets and composites grown in 
a modified medium described by Green (Green et al., 1979) and compared to 
the keratinocyte growth medium described above (see Chapter 6). The 
ingredients of this modified medium included:
Ingredient Volume (ml)
DMEM (glucose 1 g per 1) with Glutamax™ 63
Hams F12 22
FCS 10 (10%)
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Insulin Actrapid® 0.143 (5 jug per ml)
Epidermal growth factor (in DMEM with 10% FCS) 1 (10 ng per ml)
Hydrocortisone (in DMEM) 1 (0.4 jug per ml)
Cholera toxin (in DMEM with 10% FCS 1 (10'^ ^M)
Triiodothyronine (T3 10'“M) 0.1 (2Xia^^M)
Adenine (1.8X10'^M) 0.1 (1.8X10-^ M)
Penicillin/streptomycin 2ml (100 units per ml/100 jug per ml)
2.2.1.3 TELCeB, GP+EnvAm12 and PT67 cell lines
These lines were cultured in a similar fashion to Swiss 3T3 fibroblasts. The 
TELCeB and PT67 cell lines required DMEM with a glucose concentration of 
4.5g per I. The PT67 clone that was selected out for use in transduction 
experiments required 15-20ml of medium (per 75cm^ tissue culture flask) for 
optimum growth.
2.2.1.3.1 Determination of TELCeB as ecotropic or amphotropic producer
2.2.1.3.1.1 TELCeB transduction of 3T3 cells
TELCeB cells were cultured in 75cm^ flasks until just confluent. The 
supernatant was removed and filtered. 1.6X10® 3T3 cells in 0.5 ml were plated 
out in duplicate in 6 well plates to which were added the following dilutions of 
TELCeB supernatant, 3T3 culture medium. 8 pg per ml of polybrene was also 
added to each well.
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Amounts inserted into wells in duplicate (ml)
TELCeB supernatant 1.5 0.15 0.015
3T3 culture medium 1.35 0.485
After 24 hours the medium was changed. After 4 days of culture plates were 
fixed and stained with X-Gal.
The experiment was repeated with 10® 3T3 cells in 0.5 ml per plate and the 
following supernatant and culture medium concentrations:
Amounts inserted into wells in duplicate (ml)
TELCeB supernatant 1.5 0.15 0.015
3T3 culture medium — 2.35 1.485
2.2.1.3.1.2 TELCeB transduction of porcine kératinocytes
TELCeB cells were cultured in 75cm^ flasks until just confluent. The 
supernatant was removed and filtered through a 0.02pm Acrodisk^^ filter. 
2X10® irradiated 3T3 cells in 0.5 ml and 3.05X10® porcine kératinocytes were 
plated out in duplicate in 5X 6 well plates to which were added the following 
dilutions of TELCeB supernatant and porcine keratinocyte culture medium.
Amounts inserted into wells in 
duplicate (ml)
TELCeB supernatant 1.0 0.1 0.01
Porcine keratinocyte culture medium 1.0 1.9 1.99
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To each of the five 6 well plates the following concentration of polybrene was 
added.
6 well plate number A B C D E
Polybrene (pg per ml) 0 2 4 8 12
The medium was changed after 24 hours and cultured for a further 3 days 
before staining.
2.2.1.3.2 3T3 transduction with GP+Env Am i2 producer cell line
From a just confluent (with GP+Env Am i2 ‘producer’ cells) 75cm^ flask 
supernatant was extracted and filtered (0.02pm A cro d isk™  filter). 5 ml was 
diluted 1:2 in 3T3 growth medium and inserted into a flask containing 3T3 
cells plated the previous day (2X10® cells into the 75cm^ flask). The medium 
was changed after 24 hours and fixed and stained with X-Gal after 3 days of 
culture.
2.2.1.3.3 Porcine keratinocyte transduction with GP+Env Am12 producer 
cell line
Approximately 2X10® irradiated GP+Env Am i2 cells were plated out per 
75cm^ flask which then received 2X10® P4 porcine kératinocytes. A control 
flask containing irradiated 3T3 cells and keratinocyte at equivalent numbers 
was set up In parallel. The medium was changed every 2-3 days and after a 
week of culture both flasks were fixed and stained with X-Gal.
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2.2.1.4 Cryopreservation of cells
Following trypsinisation as described above, cells were spun down, counted 
with a haemocytometer. Up to 5x10® cells were then resuspended in 1ml of 
DMEM (1g per I glucose) with Glutamax™ and 2% penicillin/streptomycin (100 
units per ml / 100 pg per ml), 20% FCS and 10% dimethyl sulphoxide 
(DMSO). The cells were frozen at -70°C for 24 hours in insulated containers 
and then kept in liquid nitrogen for long term storage. Vials of cells were 
defrosted by rapid thawing in a 37°C water bath, resuspended in 10ml of 3T3 
culture medium spun down in order to pellet the cells and the medium drawn 
off. The pellet of cells was resuspended in culture medium appropriate to the 
cells and centrifuged a second time prior to resuspension and plating out.
2.2.2 Keratinocyte sheet grafts
Following confluence, kératinocytes were cultured for a further five days to 
allow a second layer to form thus enhancing the mechanical integrity of the 
sheet. A fine balanced was maintained between culturing long enough to 
allow for a degree of mechanical integrity and over long resulting in 
keratinocyte differentiation and loss of viability.
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2.2.3 Preparation of sheets for grafting
6-8 hours prior to grafting, the sheets were detached, stored in keratinocyte 
culture medium and transported from laboratory to operating theatre. In order 
to detach the sheets medium was aspirated from the flask and 3ml of 
Dispase® (2mg per ml in DMEM) inserted. The flask was gently agitated and 
incubated for 30 minutes. When the sheet began to detach the Dispase® was 
washed off with HBSS and the sheet gently encouraged to further detach and 
rolled a little way towards the flask centre with a sterile glass rod. Sterile 
backing material Tegapore® (fashioned to form a disc of 3.0cm diameter) was 
laid down in the centre of the flask. Using a pair of sterile fine forceps the 
redundant edges of the keratinocyte sheet were lifted centripedally onto the 
backing material. The sheet and backing material were then placed in a well in 
a 6 well plate into which 1ml of keratinocyte growth medium was placed. 6 
well plates were wrapped in cling film in readiness for transportation from 
laboratory to operating theatre.
2.2.4 Assessment of feeder cell transduction potential
In experiments involving retroviral transduction of kératinocytes intended for 
use as sheet grafts, the feeder cell population contained retroviral producer 
cells until the last passage when the feeder cells were entirely composed of 
irradiated 3T3 fibroblasT-cells. To make doubly certain that no retroviral 
producer cells were included in the sheet graft, supernatant was harvested 
and tested on 3T3 fibroblasT-cells. 10® 3T3 fibroblasT-cells per well were
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plated out in triplicate in 6 well plates one day prior to the detachment of 
keratinocyte sheet grafts. On the following day supernatant was added to the 
medium in a series of dilutions ranging from 0.5 to 10-3 with 8pg per ml 
polybrene added. After 48 hours the medium was changed and after a further 
24-48 hours the plates were stained with X-Gal. The results were consistently 
negative.
2.2.5 Composites
2.2.5.1 Preparation of dermis
Strips of partial thickness skin 5X10cm were harvested using the Zimmer 
dermatome at settings ranging from 8 to 18. The skin was placed in a 50 ml 
conical tube containing 35ml of ‘composite’ transport medium wrapped in 
parafilm and transported back to the laboratory.
The composite transport medium contained:
Ingredient Volume
HBSS 500ml
Penicillin/streptomycin 600 units per ml/600 pg per ml 60ml
Gentamicin 250 pg per ml 2.5ml
The skin was subsequently washed 4 times with HBSS and then cut into 
sections of -  6X5cm (larger than Is actually necessary to allow for contraction 
(Ralston et al., 1997)). These were then placed into separate 100mm X 20mm
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pétri dishes and incubated for 96 hours (medium was changed at 48 hours) at 
37°C in 1M NaCI containing antibiotics. The antibiotic cocktail consisted of 
amphotericin B 2.5p per ml (1/100 dilution from stock), penicillin/streptomycin 
lOOiu per ml or lOOpg per ml (1/50 dilution), ciprofloxacin lOpg per ml (1/200 
dilution) and gentamicin lOOpg per ml (1/50 dilution). The epidermis was then 
easily separated from the dermis and lifted off. Before the epidermis had been 
entirely lifted off a central stitch (6.0 proline) was placed with the knot 
overlying the papillary dermis. The dermis was then placed In fresh 100mm X 
20mm petri dishes containing distilled water and antibiotics (as above) at 
37°C for a further 10-12 days.
2.2.5.2 Preparation of keratinocyte -  dermal composites
Following preparation of dermal sheets as above the distilled water was 
replaced with HBSS and the sheets incubated for one hour at 37°C. The 
sheets were then washed twice more with HBSS before being gently 
transferred to 60mm X 15mm petri dishes. The dermis was laid flat with the 
papillary surface uppermost, covering most of the surface area of the dish, 
surface tension between dermis and dish plastic helping to keep the dermis 
flat against the plastic. Kératinocytes were seeded in 2 ml of keratinocyte 
culture medium at densities of 1.38X10® per cm ,^ 4X10® per cm^ and 1.38X10® 
per cm  ^for in-vitro studies (see Chapter 6), and -1.38X10® per cm^ when 
culturing composites to be used as grafts. One day later the composites were 
gently transferred onto stainless steel grids in 100mm X 20mm petri dishes 
and 25 ml of keratinocyte culture medium added to cover the composites. The
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composites were cultured for a further seven days with medium changes 
every 2 days. As with keratinocyte sheet grafts, sterile backing material 
Tegapore® (fashioned to form a disc of 3.5cm approximate diameter) was laid 
down in the centre of the composite. Using a pair of sterile fine forceps the 
redundant edges of the composite were lifted centripedally onto the backing 
material. The composite and backing material were placed in a well in a 6 well 
plate into which 1ml of keratinocyte growth medium were placed. 6 well plates 
were then wrapped in cling film in readiness for transportation from laboratory 
to operating theatre.
2.2.6 Determination of cellular metabolism using Alamar Blue™ 
indicator dye method
Alamar Blue™ (obtained as a kit from Serotec, Kidlington, Oxford, UK) is an 
oxidation-reduction indicator dye that both fluoresces and changes colour 
(from blue to red) in response to chemical reduction of growth medium 
resulting from cellular metabolic activity. The reagent is water-soluble and 
non-toxic to cells. Alamar Blue™ was added to test cultures during the log 
phase growth stage, in an amount equal to 10% of the culture volume. Cells 
were returned to the incubator for 4 hours. 400pl from each test flask was 
added to each of 3 wells in a 96 well plate. Using the Anthos 2001 platereader 
absorbance was measured at a wavelength of 570nm. Background 
absorbance was measured at 600nm and subtracted.
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2.2.7 Antibody compiement pre-treatment (complement lysis)
Epidermal cells (suspended in porcine keratinocyte growth medium) were 
aliquoted into universals at a concentration of 10  ^cells per ml and incubated 
on ice with 400pl per 10  ^ cells MS A3 or ColiS205D1 (porcine SLA DR- 
specificity, lgG2a isotype, lgG2a isotype control respectively) at a dilution of 
1/100. After 45 minutes filter-sterilised complement was added at a final 
dilution of 1/10 and incubated for a further 45 minutes on ice. Cells were then 
washed twice and counted.
2.2.8 Flow cytometry
Flow cytometry involves the measurement of specific parameters of a single 
particle flowing past a point. In this study the particles concerned were single 
cells which were either epidermal cells, peripheral blood lymphocytes or 
retroviral producer cells (PT67 cell line).
2.2.8.1 Preparation of single cell suspensions
The first stage in preparation for flow cytometry is to generate a single cell 
suspension. Cultured kératinocytes (1®^ to 3""^  passage) and PT67 retroviral 
producer cells were trypsinised (trypsin/EDTA (0.05%/0.02%) as for 
subculture. Following centrifugation the supernatant was discarded, the pellet 
resuspended in PBS with 0.01% sodium azide and 0.2% fetal calf serum and 
counted using a haemocytometer. Freshly disaggregated epidermal cells
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(either immediately, following antibody-complement pretreatment or following 
overnight incubation) were similarly suspended in keratinocyte growth 
medium and counted and then centrifuged (this process repeated twice). 
Following final counts, cells were suspended in PBS with 0.01% sodium azide 
and 0.2% fetal calf serum at a concentration of 5X10® cells per ml.
2.2.8.1.1 Lymphocytes
Peripheral blood lymphocytes were used as positive controls throughout 
experiments looking at SLA DR expression in epidermal cells, as the 
expected proportion of SLA DR-positive lymphocytes is between 10 and 20% 
(personal communication Dr K Haverson, Dept, of Clinical Veterinary 
Immunology, University of Bristol).
Blood taken from experimental pigs at termination was stored in CPD bags 
(350ml capacity bags containing a citrate phosphate dextrose solution, 
obtained from the blood bank at Queen Victoria Hospital, East Grinstead, UK) 
at room temperature for up to 3 days prior to use. 20ml aliquots of blood were 
diluted with a further 10ml of HBSS. The dilute blood was then underlayed 
with 10ml of lymphopaque or lymphoprep and centrifuged at room 
temperature at 700g (~2000rpm) for 45 minutes. The interface layer was 
carefully removed and resuspended in HBSS. The suspension was then 
washed twice in HBSS with centrifugation at 400g (-1600 rpm) for 5 minutes 
at room temperature. The pellets were then resuspended and used 
immediately or cryopreserved in liquid nitrogen for later use. Following
81
washes and counts, cells were suspended in PBS with 0.01% sodium azide 
and 0.2% fetal calf serum at a concentration of 10® cells per ml.
2.2.8.2 Indirect labelling for SLA DR
200 111 of keratinocyte cell suspension or lOOpI of lymphocyte suspension 
were placed in 1.5ml Eppendorf® vials. Test and control vials were matched in 
duplicate or triplicate. Three types of control were generally used. These were 
peripheral blood lymphocytes as a positive control, substitution of the primary 
antibody with isotype control (ColiS205D1, lgG2a isotype) and labelling with 
the secondary reagent alone was a further negative control. 40pl (half this 
amount for the lymphocyte suspensions) of MS A3 (porcine SLA DR- 
specificity, lgG2a isotype) or ColiS205D1 at a dilution of 1/100 was added. 
The vials were gently agitated and incubated for 30 minutes at 4°C. Cells 
were then washed twice with PBS with 0.01% sodium azide and 0.2% FCS by 
microcentrifugation for 2 minutes at 1200g (4000rpm). 200pl (lOOpI for 
lymphocyte suspensions) of sheep anti-mouse FITC diluted 1/100 was added 
and the vials gently agitated and incubated for a further 30 minutes in the dark 
at 4°C. Cells were then washed twice with PBS with 0.01% sodium azide and 
0.2% FCS by microcentrifugation for 2 minutes at 1200g (4000rpm). In later 
studies, cells were first incubated for 2 minutes with propidium iodide (Img 
per ml) at a dilution of 1/100 after the first wash. After the second wash cells 
were resuspended in 0.5ml PBS with 0.01% sodium azide and 0.2% FCS and 
kept at 4'"C. Cells underwent flow cytometry within 12 hours of labelling.
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2.2.8.3 Staining for p-gaiactosidase expression
Following a protocol described recently (Mouawad et al., 1997) PT67 
retroviral producer cells were first fixed as single cell suspensions in 
acetone/PBS (65:35) at 20°C for 10 minutes. Subsequent processing was 
similar to that for SLA DR detection with the following differences. The primary 
antibody (test and control) was diluted 1/20 in PBS containing 0.1% of 
saponin (a detergent whose function is to permeablise the cell and nuclear 
membrane). Cells were incubated for 45 minutes at each stage on ice and 
were processed as described earlier (2.2.13.2) with the omission of propidium 
iodide.
2.2.8.4 Data access
The software used to access and statistically represent data was WinMDI 
(windows multiple document interface) version 2.8, freely available from Dr J 
Trotter at http://facs.scripps.edu/.
2.2.8.5 Gating
A light scatter dot plot of forward scatter (FS) versus side scatter (SS) was 
used to gate out debris and clumps (see Figure 2.5 (a)). Gating was cruder 
early on in the study but as processing improved it was possible to gate in an 
increasingly refined manner.
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Statistics (calculated by the WinMDI® software) allow relative quantification of 
events within specified gates. A second cytogram is created in the form of a 
dot plot looking at gated events with LFL1, a filter allowing measurement of 
green fluorescence, as the X axis against LFL2 or LFL3 (filters for red 
fluorescence) along the Y axis (see Figure 2.5 (b). This protocol was followed 
in spite of the fact that a second indirect label was not used. This allowed for 
easier identification of subgroups both in terms of relative quantification as 
well as density of expression (geometric mean fluorescence). A histogram of 
log fluorescence may alternatively be plotted looking at gated events only and 
markers set between log 10 and log 1000 (see Figure 2.5 (c)). The geometric 
mean of gated events lying between these markers may then be calculated.
In later studies propidium iodide was incorporated which enabled gating out of 
dead cells using the LFL3 filter (see Figure 2.6).
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Figure 2.5: Flow cytometry gating
Dotplot 2.5 (a) is a light scatter plot of the test sample consisting of freshly 
trypsinised porcine epidermal cells. Clumps and debris were (crudely) gated 
out. Dotplots 2.5 (b) are plots of R3 gated events (from dotplot 2.5 (a)) sorted 
by filters LFL1 and LFL2. The LFL1 filter was poorly compensated. A gate R2 
was then placed around a clear group of cells seen only in the test sample. 
The histogram 2.5 (c) shows the events delineated in R2 (b) plotted against 
log fluorescence of FITC (LFL1). The histogram shows the isotype control 
labelled sample in solid red with the SLA DR labelled cells in black line.
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Figure 2.6: Gating with the addition of propidium iodide (using LFL3)
The light scatter plot (SS vs FS) illustrates the plotting of region 1 crudely 
excluding debris (coloured green) and clumps. The following two dot plots 
illustrate test and control samples with FITC (LFL1) plotted against propidium 
iodide (LFL3). The dead cells (densely stained with propidium iodide) are 
gated (coloured blue). Region 4 (R4) displays a group of cells brightly 
fluorescing green (FITC labelled), albeit poorly compensated, that appears 
only with test sample and not with the control. The WinMDI® software was 
used to calculate the proportion of cells in R4 expressed as a percentage of 
cells in region 1 (R1 ) having excluded dead cells (R3). The last dot plot 
illustrates back gating and shows the light scatter characteristics of the group 
of cells of interest (R4).
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2.2.9 Histochemistry
All sections were cut in the cryostat to a thickness of 15f4,m. Slides were left to 
dry at ambient room temperature for at least two hours prior to fixing and 
staining. Prior to staining with haematoxylin and eosin slides were fixed for 30 
minutes in 4% paraformaldehyde on ice. Slides were then immersed twice in 
phosphate buffered saline (PBS) for periods of five minutes. Slides were then 
covered with haematoxylin for between 20-30 seconds (less time is required 
at higher cellular densities) before rinsing in tap water. The slides were then 
left in running tap water for 8-10 minutes. They were then covered in eosin for 
6 minutes, rinsed and dehydrated by immersion in ascending concentrations 
of IMS (30, 70 and finally 100%) for 1 minute at a time, before a final 
immersion in xylene for at least 1 minute. Slides were then mounted in DPX, 
covered with a coverslip and left on a rack to dry.
2.2.10 Immunohistochemistry
2.2.10.1 Immunoperoxidase staining by the Avidin Biotin Complex (ABC)
Method
15|^m sections were cut with the cryostat at -18°C. 2-3 sections were placed 
on each vector-bonded slide depending on the size of section. Slides were 
kept in the cryostat for up to a week in a -40°C freezer until ready for drying, 
fixation and staining.
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Slides were dried for an hour using a small fan, which delivered cool air at a 
fairly constant pressure. The fan was placed 12 inches away from the slide 
rack which was situated in almost upright position at an angle of 
approximately 30“ to the vertical. A hydrophobic pen (DAKO Ltd, High 
Wycombe, Buckinghamshire) was used to isolate sections on the slide. 
Recommendations were received for fixation of the membrane antigens from 
a number of sources. One source advised pure ethanol on ice (Dr WC Davis 
Washington State University) another advised pure acetone on ice for most 
with heat fixation for detection of the CD4 epitope (Dr K Haverson, Dept, of 
Clinical Veterinary Immunology, University of Bristol). A comparison was 
made between the different fixation methods and it appeared that ice cold 
ethanol for 20 minutes was better than ice cold acetone for fixation of most 
epitopes. Ice cold acetone for 20 minutes was preferred for fixation of CD2, 
CD3 and IgÀLC antigens. CD4 was best fixed with heat. This was achieved 
with the construction of sand bath consisting of a shallow pyrex dish filled with 
fine quartz sand to a depth of 1cm. This was placed on a hot plate, which was 
set to the lowest setting, and the bath was allowed over several hours to 
equilibrate to a temperature of 60°C. Slides were placed with care directly on 
to the sand for 30 minutes.
Following fixation slides were immersed in PBS twice for 3-5 minutes at a 
time.
The slides are then immersed in 0.05% hydrogen peroxide for 30 minutes (to 
inactivate endogenous peroxidase). Following 2X5 minute washes in PBS, 
nonspecific binding sites were then blocked by incubation with 5% normal 
horse serum for 30 minutes. The sections to be labelled with the monoclonal
89
antibody MAC320 (SWC6 specificity) were incubated with 7.5% goat serum 
rather than horse serum (as the primary antibody is of rat origin and the 
second layer antibody therefore biotinylated goat anti-rat). The serum was 
then drained off and primary antibody directly applied (50pl per section). 
Primary antibodies were diluted in PBS. The dilutions are listed in Table 2.1.
Table 2.1: Primary monoclonal antibodies used in immunophenotyping.
Monoclonal Antibody Specificity Cell Line / Clone Dilution (ABC)
CD1 76-7-4 1/50
CD2 MSA4 1/2
CD3 FY1H2 1/5
CD4 STH 293 1/5
CD5 PG114A 1/30
CD6 PG90A 1/50
CD8 PT81B 1/250
CD25 231.3B2 1/3
CD45 K252.1E4 1/3-1/5
SLADR MSA3 1/250
SLADR TH14B 1/50
SLADP H42A 1/50
SLADQ TH81A5 1/50
lgA.LC K139.3E1 1/2
SWC3 74-22-15 1/100
SWC6 MAC320 1/3
Most of the monoclonal antibodies sourced have only recently become 
available (Saalmuller et al., 1998b) and used mainly in cell labelling for flow 
cytometry. Antibodies were therefore tested by staining jejunal sections at
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dilutions ranging from 1/50 to 1/1500 for antibodies produced as mouse 
ascites fluid (those antibodies purchased from VMRD), and neat to 1/5 for 
those monoclonal antibodies grown in a cell culture system. The antibodies 
listed in Table 2.2 were found not to be optimally effective with ABC and 
alternatives found to stain consistently well were therefore used.
Table 2.2: Primary monoclonal antibodies that on testing (with ABC and
immunofluorescence) did not prove efficient at immunohistochemical labelling.
Monoclonal 
Antibody Specificity
Cell Line / Clone
CD2 PG168A
CD3 8E6
CD4 PT90A
CD4a b38c6
CD25 PGBL25A
The CD4 antigen was best displayed with immunofluorescent staining rather 
than with ABC.
Following incubation at 4“C overnight, the primary antibody was washed off 
by 2X5 minute immersions in PBS. The second layer antibody was 
biotinylated horse anti-mouse IgG diluted 1/100 in PBS (except for sections 
labelled with MAC320 (SWC6 specificity) which is of rat origin and the second 
layer antibody was therefore biotinylated goat anti-rat IgG diluted 1/100 in 
PBS). Following incubation with the biotinylated second layer antibody for one 
hour, the sections were washed by 2X5 minutes immersions in PBS and then
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incubated at room temperature for a further hour with avidin-biotin complex. 
During this time the DAB (diaminobenzidine) developing solution was made 
up. This was prepared in the following way. 125mg of DAB was dissolved in 
5ml of distilled water. This was filtered and added to 300ml of 0.1M sodium 
acetate into which 7.35g of ammonium nickel sulphate and 600mg of a  D- 
glucose had been dissolved. This quantity of solution is sufficient for one rack 
of slides.
Slides were further washed in PBS (2X5 minutes immersions) and then 
equilibrated in 0.1M sodium acetate buffer at pH 6 by 2X5 minutes 
immersions. The DAB developing solution was activated immediately prior to 
the immersion of the slides by the addition of 6mg of glucose oxidase to the 
solution. Slides were immersed and their development monitored. After 3-4 
minutes the degree of staining was checked under the light microscope. A fine 
balance was sought between over staining (poorly specific) and under 
staining (poorly sensitive). When staining was judged to be optimal, usually 
taking between 4.5 and 5 minutes, slides were removed and washed in 0.1 M 
sodium acetate (2X5 minutes) and then PBS (2X5 minutes). They were then 
dehydrated by immersion in ascending concentrations of IMS (30, 70 and 
finally 100%) for 3 minute at a time, before a final Immersion in xylene for at 
least 1 minute. Slides were then mounted in DPX mountant, covered with a 
coverslip and left on a rack to dry.
During staining room temperature was maintained at a temperature of 
between 18 and 21 “C.
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2.2.10.2 Indirect labelling with a single fluorochrome
Slides were air dried and sections isolated with a hydrophobic pen as before. 
Following fixation (acetone, ethanol or heat), nonspecific binding sites were 
blocked by incubation for 30 minutes with 10% serum (sheep or goat to match 
the origin of the secondary reagent). The serum was then drained off and 50 
pi of primary antibody applied (see Table 2.3 for dilutions) and the sections 
incubated overnight at 4“C.
Table 2.3: Primary monoclonal antibodies used in indirect
immunofluorescent single or dual labelling.
In dual labelling of sections the two primary monoclonal antibodies were of 
different isotype so as two allow for isotype-specific secondary labels attached 
to different fluorochromes.
Monoclonal Antibodies Isotype Concentration
CD45 IgGI 1/5
CD3 (8E6) IgGI 1/10-1/15
GDI lgG2a 1/15
SLA DR (MSA 3) lgG2a 1/40-1/50
CD8 lgG2b 1/40
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On the following day slides were washed by 2X Sminute immersions in PBS. 
The secondary antibody (sheep anti-mouse FITC or goat anti-mouse Cy3) 
was applied at a dilution of 1/100 and the sections incubated for 1 hour within 
a humid chamber in the dark. The slides were then washed by 2X 5min. 
immersions in PBS. They were then mounted in glycerine mountant and 
stored at 4“C.
2.2.10.3 Indirect dual fluorochrome labelling
The primary steps for fixation and section isolation were as described earlier 
for indirect single fluorochrome labelling. Following incubation for 30 minutes 
with 10% goat serum as described above, the serum was drained off sections 
and cocktails of two primary monoclonal antibodies of differing isotype (50 pi 
per section, see Table 2.3 for dilutions) were applied. The sections were 
incubated at 4°C overnight. On the following morning they were washed twice 
in PBS. Secondary dual fluorochrome labelling was subsequently achieved in 
one of several ways (see Tables 2.4a and 2.4b). One method involved 
combining two different fluorochrome-labelled isotype-specific secondary 
antibodies. FITC of lgG2b specificity in combination with Phycoerythrin (PE) 
of IgGI or lgG2a specificity was used for this method. These are combined in 
a cocktail with staining steps as for single fluorochrome labelling. The intensity 
of the IgGI isotype-specific PE label was seen to diminish within hours of 
staining (not shown). A more effective way to achieve dual labelling was to 
secondarily label using biotin with IgGI or lgG2a isotype-specificity. This was 
followed up with a cocktail consisting of Texas red -  avidin (or
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aminomethylcoumarin (AMCA) - avidin) and !gG2b-specific FITC (see Table 
2.4b for steps). The Texas red or AMCA staining may be enhanced by 
additional steps of isotype-specific biotin followed by a cocktail consisting of 
Texas red -  avidin (or AMCA - avidin) and lgG2b-specific FITC, (see Table 
2.4b for description of steps). This however generally gave an overly intense 
Texas red or AMCA stain with reduced sharpness.
Unless stated otherwise sections were incubated at each stage following 
primary labelling, for 1 hour at room temperature within a humid chamber in 
the dark. Between each step slides were washed by 2 X 5 minute immersions 
in PBS. Following completion of staining slides were mounted in glycerine 
mountant and stored at 4“C.
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Table 2.4: Steps in dual fluorochrome labelling
Dual fluorochrome labelling was achieved following initial labelling with 
monoclonal antibodies of differing isotype following which, secondary labelling 
may either be achieved through the use of different fluorochromes attached to 
isotype-specific secondary antibodies (a), or by combining an isotype-specific 
fluorochrome-labelled secondary antibody with an isotype-specific biotin 
labelled secondary antibody (b).
(a)
Stage I Sections are incubated overnight at 4“C with a cocktail of primary 
antibody isotype 1 (eg CD3 IgGI) and primary antibody isotype 2 (eg 
CD8 lgG2b).
Stage II Slides are washed X3 in PBS then secondarily labelled with PE anti­
isotype 1 (1/10) and FITC -  anti-isotype 2 (1/20)and incubated for 1 
hour at room temperature.
(b)
Stage 1 Sections are incubated overnight at 4°C with a cocktail of primary 
antibody isotype 1 (eg CD3 IgGI) and primary antibody isotype 2 
(eg CD8 lgG2b).
Stage II The slides are washed X3 in PBS then labelled with either PE anti­
isotype 1 (1/10) or FITC anti-isotype 1 (1/20).
Stage III After 30 minutes incubation (at room temperature) biotin anti-isotype 
2 (1/100) is added and incubated (at room temperature) for a further 
30 minutes and then washed X2 in PBS.
Stage IV Sections are then further labelled with either a cocktail of PE anti­
isotype 1 (1/10) and FITC avidin(1/100) anti-isotype 2 or AMCA 
avidin(1/33) anti-isotype 2 or a cocktail of FITC anti-isotype 1 (1/20) 
and Texas Red (1/100) anti-isotype 2 or AMCA avidin (1/33) anti­
isotype 2 and incubated for 45 minutes at room temperature
Optional futher steps
Stage V Sections are washed X2 in PBS then biotinylated anti-avidin 1/100 is 
added and incubated at room temperature for 30 minutes
Stage VI Sections are washed X2 in PBS and stage IV is then repeated
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2.2.10.4 Triple fluorochrome labelling
The primary steps for fixation and section isolation were as described earlier 
for indirect single fluorochrome labelling. Slides were incubated for 30 minutes 
with 10% goat serum as described above. The serum was then drained off 
sections and 50 pi per section of cocktails of three monoclonal antibodies 
each with different isotype-specificities (see Table 2.3 for dilutions) were 
applied. This was followed by a cocktail of lgG2b-specific FITC with lgG2a or 
IgGI-specific PE with the addition of an lgG2a or IgGI-specific biotin 
(specificity of biotin being different to that of PE). A further step involved 
labelling with AMCA -  avidin (see Table 2.5 for description of steps). The 
incorporation of an additional multiplication step as with 2.2.10.3 was found to 
be counterproductive with either over intense or more often loss of intensity of 
AMCA staining. In discussion with the manufacturers it was thought that 
stearic hindrance and distortion might account for the effects seen.
Sections were incubated at each stage (following primary labelling) for 1 hour 
at room temperature within a humid chamber in the dark. Between each step 
slides were washed by 2 X 5min. immersions in PBS. Following completion of 
staining slides were then mounted in glycerine mountant and stored at 4“C.
97
Table 2.5: Steps in triple fluorochrome labelling
Stage 1 Sections are incubated overnight at 4°C with a cocktail of primary 
antibody isotype 1 (eg CDS IgGI), primary antibody isotype 2 (eg 
CDS IgG2b) and primary antibody isotype 3 (eg SLA DR lgG2a)
Stage II The slides are washed X3 in PBS then labelled with PE anti­
isotype 1 (1/10) and FITC -  anti-isotype 2 (1/20)
Stage III After 30 minutes incubation (at room temperature) biotin anti­
isotype 3 (1/100) is added and incubated (at room temperature) 
for a further 30 minutes and then washed X2 in PBS
Stage IV Sections are then further labelled with a cocktail of PE anti­
isotype 1 (1/10), FITC anti-isotype 2 (1/20) and AMCA avidin 
(anti-biotin) (1/33) and incubated for 45 minutes at room 
temperature
Optional futher steps
Stage V Sections are washed X2 in PBS, biotinylated anti-avidin 1/100 is 
then added and incubated at room temperature for 30 minutes
Stage VI Sections are washed X2 in PBS and stage IV is then repeated
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2.2.10.5 Wet preparations of immunofluorescent labelled lymphocytes
Lymphocytes were prepared in the manner described in 2.2.8.11. 200pl of 
lymphocyte suspension was placed in each Eppendorf® vial. 40pl of primary 
antibody (see Table 2.6 for antibodies and dilutions) was added. The vials 
were gently agitated and incubated for 30 minutes at 4°C. Cells were then 
washed with PBS with 0.01% sodium azide and 0.2% PCS by 
microcentrifugation for 2 minutes at 1200g (4000rpm). Cells were then 
incubated for 2 minutes with propidium iodide at a dilution of 1/100. They were 
then washed again with PBS with 0.01% sodium azide and 0.2% PCS by 
microcentrifugation for 2 minutes at 1200g (4000rpm). 200pl (lOOpI for 
lymphocyte suspensions) of sheep anti-mouse PITC diluted 1/100 was then 
added and vials gently agitated and incubated for a further 30 minutes in the 
dark at 4°C. Cells were then washed twice with PBS with 0.01% sodium azide 
and 0.2% PCS by microcentrifugation for 2 minutes at 1200g (4000rpm). 
Following resuspension in PBS with 0.01% sodium azide, two drops of 20 pi 
were placed at either end of a slide and a coverslip gently placed over the 
slide. Sides were stored at 4°C in the dark. Photomicrographs were taken 
within 24 hours of staining.
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Table 2.6: Primary MoAB dilutions in wet preparations of labelled cell
suspensions
Antibodies Diiutions
GDI 1/50
CD2 1/2
CD3 1/3
CD4 172
CDS 1/50
CD6 3/50
CDS 1/10
\gXLC 1/2
CD25 1/2
CD45 1/50
SLA DR 
(MSA3)
1/50
SLA DP 
(H42A)
1/50
SLADQ
(TH81A5)
1/50
SLA DR 
(TH14B)
1/50
SWC6 Neat
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2.2.11 X-Gal staining
2.2.11.1 Cultured cells
Medium was aspirated and the flask washed in 3 times with PBS. The cells 
were then fixed with 7ml (for a 75cm^ tissue culture flask) of 2% formaldehyde 
and 0.02% gluteralehyde in PBS for five minutes. The flask was then rinsed 3 
times with PBS and then incubated in X-Gal solution for two hours at 37°C. 
The X-Gal solution consists of 5mM potassium ferricyanide, 5mM potassium 
ferrocyanide, 2mM magnesium chloride and 0.05% X-Gal (5-bromo-4-chloro- 
3-indolyl-beta-D-galactoside). Following two hours the X-Gal solution was 
aspirated and the flask rinsed 3 times with PBS. Finally 5mI of filtered PBS 
containing 0.01% sodium azide was placed in the flask which was then stored 
at 4°C.
2.2.11.2 Wound blocks
Following sectioning of the harvested wounds (see Section 2.2.22 and Figure 
2.5), blocks were placed in 2% formaldehyde in PBS for 48 hours. Following 
this the formaldehyde solution was removed and the blocks washed and then 
incubated for a further two days in sucrose solution (containing 150g sucrose 
and 0.1% sodium azide in PBS) with a medium change every day. The blocks 
were then rinsed twice in PBS and covered with X-Gal solution and incubated 
as with cultured cells. Following incubation the blocks were rinsed and stored 
as with cultured cells.
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2.2.11.3 Wound sections
Following drying and fixing (as for H&E) slides were immersed for five minutes 
twice in PBS and then covered in X-Gal solution and incubated for two hours 
at 37°C. Following incubation, slides were immersed for five minutes twice in 
PBS and then stained with haematoxylin and eosin.
2.2.12 Rhodamine B staining
To enabie identification of colonies in the studies looking at colony forming 
efficiency, 6 well plates were stained with X-Gal as described above. 
Following this 1ml of 1% rhodamine B solution was placed in each well and 
left at room temperature for 3 minutes. The wells were then twice rinsed 
carefully with distilled water.
2.2.13 image analysis
In the studies looking at colony forming efficiency, 6 well plates were stained 
with X-Gal and rhodamine B as described above. Images were then digitally 
recorded using a Seescan CCD (Charged Couple Device) computerised 
camera imaging system and analysed using Image Pro Plus® software with 
respect to number and size of colonies. Identical settings were used in all 
cases.
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2.2.14 Statistics
All statistical analysis was carried out using the computer software package 
Sigmastat® (Jandel Scientific Software, Jandel Gmbh, Erkrath, Germany).
2.2.15 Animal work
On arrival animals were marked with indelible ink according to litter source, 
and additionally were numbered with an ear tag under the first anaesthetic. 
They were housed together in a single large pen for 5-7 days prior to surgery 
to facilitate their acclimatisation. Following surgery the pigs were housed in 
separate pens (see Figure 2.7).
Figure 2.7: Large White pig returned to pen following a dressing change
following which thermoplastic Spectrum® jackets were applied.
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2.2.15.1 Anaesthesia, analgesia and euthanasia
As all procedures were performed under general anesthetic (see Figure 2.8), 
the pigs were not fed on the morning of surgery. Premedication consisted of 
an intramuscular injection of ketamine (Vetalar®) and xylazine (Rompun®) at 5 
mg per kg and 1 mg per kg respectively. The inhalational anesthetic (once the 
pigs were sufficiently drowsy) consisted of 2-5% halothane (Fluothane®) and 
a 50:50 mix of nitrous oxide and oxygen administered at a rate of 3-51 per 
min.
Figure 2.8: Large White pig under general anaesthetic in preparation for
chamber implantation
Postoperative analgesia consisted of topical lignocaine gel BP 2% w/v to 
donor sites and a subcutaneous injection of 4pg per kg buprenorphine 
(Temgesic®).
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Antibiotic prophylaxis employed at each procedure consisted of an 
intramuscular injection of 350mg amoxycillin/87.5mg clavulanic acid 
(Synulox®) given perioperatively.
The pigs were killed following the final procedure with an intravenous or 
intracardiac injection of pentobarbitone (Expirol®) 25mg per kg.
2.2.15 Tissue harvesting
2.2.15.1 Harvesting Skin
The pig was anaesthetised and laid in a prone position on the operating table. 
The pig’s paravertebral region was washed with dilute chlorhexidine (4%) 
surgical scrub (Hydrex®). Hair in the paravertebral region was then clipped 
short and the skin shaved. The paravertebral region was then further cleaned 
with chlorhexidine 0.5% in spirit. Liquid paraffin was used to grease the skin 
and the blade within the Zimmer dermatome (on setting no. 12) which was 
then used to harvest the skin. The donor site was dressed in vaseline 
impregnated gauze (Paranet®) and treated with topical lignocaine gel BP 2% 
w/v. The site was then further dressed with gauze and circumferentialiy with 
Elastoplast®. For assessment of dermal thickness (see Chapter 6), the setting 
on the dermatome varied between 8 and 18. Following de-epidermalisatron 
dermal thickness was assessed with the dial gauge. The harvested skin was 
placed directly into transport medium, wrapped In parafilm and placed on ice.
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2.2.15.2 Harvesting Blood
Blood was harvested from experimental animals just prior to termination. 
Under general anaesthetic, with the pig tying supine on the table, the needle 
attached to a CPD (citrate phosphate dextrose) blood collection bag was 
inserted directly Into the pigs heart. This was achieved with the needle 
inserted into the chest in the mid axillary line at just above a line parallel with 
heart apex and directed towards the heart. Blood then flowed directly into the 
bag under gravity. This was kept at room temperature until processing.
2.2.15.3 Harvesting Jejunum
Following termination of an experimental animal, a midline laparotomy incision 
was performed to enter the abdominal cavity. The duodenojejunal flexure was 
located and jejunum traced for 30cm. The distal 20cm of this length of 
jejunum was extracted and washed. The extracted jejunum was then divided 
into 3cm lengths. One end of each length was then tied around the neck of a 
disposable plastic Pasteur pipette and then everted around the bulb of the 
pipette (such that the previously luminal villi were now exteriorised). The bulb 
was then placed in a foil boat containing OCT compound and the pipette cut 
off at the neck. The foil boat was frozen in isopentane in the vapour phase of 
liquid nitrogen.
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2.2.17 Wound preparation
The pig was anaesthetised and laid in a prone position on the operating table. 
Each flank and paravertebral region was then cleaned with chlorhexidine (4%) 
surgical scrub and then meticulously shaved with electric clippers and a fresh 
razor. The flanks were then scrubbed with chlorhexidine 0.5% in spirit and the 
pig draped with sterile drapes. Three 4cm diameter circles were marked out 
on each flank. Two were situated in a paravertebral position and the third was 
situated beneath and between the other two (see Figure 2.9). The circles 
were then excised down to deep fascia with meticulous haemostasis and with 
removal of all fat overlying the deep fascia. 2 cm of undermining at the level of 
deep fascia was then undertaken circumferentialiy to facilitate chamber 
implantation.
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Figure 2.9: Diagram showing the placement of wounds on the pig's flank
adopted as standard throughout this study. Two were placed in a 
paravertebral position and a further one situated beneath and between them. 
These three were mirrored on the on the opposite flank (wound numbering 
system as shown).
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2.2.18 Grafting Integra™
Prior to the induction of anaesthesia, Integra™ artificial skin was removed in a 
sterile fashion from its foil container and placed in a sterile basin. It was then 
successively rinsed (in order to remove traces of isopropanol) in two changes 
of at least one litre of normal saline per change. 4.5 cm diameter circles of 
Integra™ cut using a sterile paper template (of PTFE chamber base) were 
placed in a basin containing sterile saline in preparation for implantation.
With wounds prepared as above, the Integra™ discs were stitched in place 
using a circumferential running stitch of 5.0 proline (Ethicon). Chambers were 
then implanted and the Integra™ dressed with a 4cm diameter disc of N-A 
Ultra® and 0.25% silver nitrate soaked gauze. The thermoplastic Spectrum® 
jackets were applied and secured with Velcro® straps (see Figure 10). 
Dressings were changed thereafter every 3-4 days for the ensuing 10 days, 
during which time the Integra™ was biointegrating (Grant et al., 1998).
2.2.19 Chamber implantation
In order to facilitate chamber implantation 1 -  2 cm incisions were made 
through skin, down to deep fascia at the upper and lower poles of each 
circular wound. This method rather than a longer incision made at either of the 
poles was adopted to reduce the extent of incised tissue and subsequent 
scarring. Sterile chambers were then implanted, the 2cm-phalange extending 
beneath the undermined area and secured (as well as incisions closed) with 
2.0 silk through preprepared holes at the upper and lower poles of the
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chamber. Only the upper and lower poles of the chamber were stitched In 
place (rather than four quadrants) in an effort to minimise tracking of 
pathogens along the braided silk stitch.
2.2.20 Grafting keratinocyte sheets
10 days after grafting of Integra™ the silicone top layer was easily separated 
off the underlying biointegrated bed. Keratinocyte sheets were detached and 
processed as described earlier (2.2.3 and 2.2.4). Using sterile technique each 
graft was in turn lifted out of the 6 well plate and placed on the biointegrated 
lntegra™-neodermal bed. The wound was then dressed in a 4cm diameter 
disc of N-A Ultra® and normal saline-soaked gauze. The thermoplastic 
Spectrum® jackets were applied and secured with Velcro® straps. Dressing 
changes were generally undertaken every three or four days.
On one occasion the dressing change took place after a 5 day interval and all 
three pigs involved were found to have wound infections and surrounding 
cellulitis. These settled down after several days following intramuscular 
injection of 350mg amoxycillin/87.5mg clavulanic acid (Synulox®).
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2.2.21 Grafting composites
Composites were processed as described earlier (see Section 2.2.5), and 
transported to the laboratory. Using sterile technique each graft was In turn 
lifted out of a 6 well plate and placed on the newly prepared fascial bed. 
Composites were secured circumferentialiy with acrylic glue and a 5ml vial 
was sufficient for 3 wounds. Dressing of wounds (including timing) were 
performed as for sheet grafts.
2.2.22 Processing of harvested grafts
Immediately following termination of animals on predetermined days grafts 
were harvested by excising the entire wound down to muscle. These were 
then washed in saline, photographed, wrapped in saline-soaked gauze and 
placed in a labelled petri dish. The dishes were then wrapped in cling film and 
then placed in a polystyrene box containing an ice slurry, in preparation for 
transportation to the laboratory (reaching the laboratory 2-3 hours later).
In the laboratory harvested wounds were divided as per Figure 2.10 (a) or 
Figure 2.10 (b). Blocks were immersed longitudinally (side on) in OCT 
compound in labelled foil boats and held In the vapour phase of liquid nitrogen 
until the OCT compound was completely opaque. Foil was then removed and 
the block inserted in a labelled compartment box and then placed in a -40°C 
freezer compartment.
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Figure 2.10: Schematic representation of harvested wound processing. 
Circular harvested wounds were carefully pinned to a board, the pins marking 
out the grid patterns shown in (a) or (b). The edges were squared off (as 
shown in (a)) to facilitate easier processing. The wounds were then sectioned 
as shown and labelled accordingly. Only the wounds pertaining to 
experimentation with cultured composite grafts (chapter 8) were sectioned as 
shown in (b). The protocol was altered to facilitate analysis of the wound 
centre and edges.
(a)
B1 B2
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(b)
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Chapter 3
Development of a PT67 MFG lacZnIs amphotropic retroviral
producer cell line
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3.1 Introduction
In order to evaluate the short, medium and long term biological efficacy of 
transplanted allogeneic components, the source of kératinocytes within a 
regenerated epithelium following allografting must be determined. This may 
be investigated by various means.
There are two principle approaches:
(a) Analysis of kératinocytes for an intrinsic differentiating feature. Examples 
of this include: detection of ABO antigens (Thivolet et al., 1986; Mauduit et 
al., 1987; Zhao et al., 1992), molecules of the major histocompatibility 
complex (Gielen et al., 1987) and chromosomal differences in cases of 
cross gender grafting (Brain et al., 1989; Burt et al., 1989). Detection of Y 
chromosomes by gross DNA hybridisation or polymerase chain reaction 
(PCR) techniques that involve disruption of tissue architecture makes it 
then difficult for further analysis of immune or other events occurring in 
relation to the keratinocyte under consideration. Other techniques such as 
in situ DNA hybridisation or the use of monoclonal antibodies with 
immunohistochemistry can be highly sensitive, and would preserve tissue 
architecture. They cannot however, be used to track the fate of autologous 
grafted cells.
(b) Labelling kératinocytes with a marker. Ideally, identification of marked 
kératinocytes should not necessitate tissue disaggregation thus allowing
for further analysis of tissue in the vicinity of the cells under analysis.
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Using an in vitro marking technique, autologous as well allogeneic grafted 
cells may be tracked subsequent to grafting.
Ideally the marker should be stable over the required number of cell divisions, 
easily detectable, non-toxic to host or neighbouring cells and incapable of 
contaminating non labelled cells.
Labelling can be achieved by the use of radioactive probes (such as ^^®iodine 
and ®^chromium) or fluorescent probes (such as fluorescein, rhodamine 
isothiocyanate, bisbenzimide and PKH26) that colour either membrane or 
nuclear material. A variety of problems have been associated with the above. 
The radioactive probes have been used in lymphocyte tracking; however 
toxicity, internal radiation effects, poor uptake and rapid elution (Horan et al., 
1990) render them unsuitable for anything but short term in vivo work. 
Disadvantages associated with the fluorescent probes include rapid escape 
with some, during the first 5 hours of tracking (Olszewski., 1987). With others, 
a dilution of intensity of labelling with each cell division and a tendency with 
some dyes to leach out and contaminate neighbouring (previously unlabelled) 
cells (Mosahebi et al., 1999), make them unsuitable for in vivo transplantation 
in which the probed cells are expected to undergo a series of cell divisions.
To overcome many of the deficiencies of radioactive and fluorescent probes, 
increasing use has been made of labelling by the insertion of a marker gene. 
The marker typically codes for an enzyme that on incubation with a suitable 
substrate results in identifiable colour staining. The gene having been isolated
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in plasmid form is appropriately packaged in preparation for cell entry and 
then host DNA integration.
There are a variety of methods for insertion of a gene into a mammalian cell. 
These include physical and chemical gene transfer techniques, which give 
predominantly transient gene expression and the use of viruses. Retroviruses 
have highly efficient mechanisms for genome integration and consequently 
gene expression tends to be more stable.
The E. coli p-galactosidase lacZ gene has been used extensively with 
respect to keratinocyte tracking (Garlick et al., 1991; Jiang et al., 1991; 
Setoguchi et al., 1994; Stockschlader et al., 1994; Jensen et al., 1994; Ng et 
al., 1997).
The lacZnIs marker gene has been modified, as the name implies, by the 
insertion of a nuclear localisation signal (nis) to ensure that the product coded 
for is nuclear localised (Ferry et al., 1991). This helps differentiate between 
endogenous expression and that due to gene marking, because endogenous 
p-galactosidase can sometimes be seen in the cytoplasm (but not the 
nucleus) of control tissues. The encoded (3-galactosidase enzyme gives rise 
to dense nuclear localised blue staining on incubation with the substrate X- 
Gal and magenta when incubated with M-Gal.
Retroviral transduction is achieved using a replication incompetent retroviral 
particle containing only the marker gene of interest and the packaging signal 
Y"". The particle itself does not contain the gag (core structural proteins), pol 
(reverse transcriptase) and env (coat glycoproteins) genes and is therefore 
replication incompetent. The envelope coating the genetic material needs to
116
be amphotropic in order to transduce cells of a different species. Markers that 
are currently available aren't always packaged within envelopes that can enter 
the particular species for which they are required. Hence they need to be 
tested and may need to be further packaged by a packaging cell line that 
provides a glycoprotein coat capable of entering the target species.
There are two principle ways of targeT-cell transduction. One using 
supernatant taken from retroviral producer cells, the other, rendering producer 
cells replication incompetent and using them as feeder cells. There are 
advantages and disadvantages with both methods.
Supernatant transduction involves using the medium harvested from a viable 
retroviral producer cell culture and utilised directly or indirectly for 
transduction. Direct usage of the supernatant involves culturing the recipienT- 
cells in the presence of supernatant. Indirect usage of the supernatant 
involves the use either of resuspended retroviral particles following 
ultracentrifugation of the supernatant or the use of dialysis techniques. For 
direct supernatant transduction to be most effective, the viral titre within the 
supernatant needs to be minimally diluted. Kératinocytes are susceptible 
however, to small changes in medium constituents. In particular they tend to 
differentiate (losing the ability for further cell division) with rising calcium 
concentration. For optimal keratinocyte culture the biochemical make up of 
supernatant from retroviral producer cells therefore needs to be similar to 
keratinocyte growth medium. This requirement may conflict with the nutritional 
needs of retroviral producer which may be very different to those of 
kératinocytes. Poor ability of retroviral producer cells to thrive in keratinocyte
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culture medium makes their culture in this medium and subsequent 
successful direct supernatant transduction more difficult.
Using retroviral producer cells as feeder cells for kératinocytes will get round 
the problems delineated with respect to direct supernatant transduction. 
Producer cells (such as PT67), rendered replication incompetent by irradiation 
survive in keratinocyte culture medium for between 2 and 5 days producing 
retroviral particles.
Retroviral producer cells may package particles in an envelope that is 
ecotropic (capable of entering cells pertaining only to the producer species) or 
amphotropic (will enter cells in a variety of species). A producer line that 
packages retroviral particles in an ecotropic envelope may be used to 
transduce an amphotropic packaging cell line transforming it into an 
amphotropic producer cell line.
Production efficiency by retroviral producer cells may drop with repeated cell 
division as the retroviral producer cell line population becomes increasingly 
heterogeneous. There are two principle means of restoring efficiency. The first 
is to use selective media that favour cells with the marker gene linked to a 
sequence whose expression allows for selection within the selective medium. 
The second is to plate ouT-cells at low density and to pick a series of 
colonies, grow them up and test in order to detect the most efficient clones.
With respect to their efficacy as feeder cells for kératinocytes, producer cells
may differ from 3T3 cells (Swiss mouse fibroblasts -  the traditional feeder cell
line as used by Rheinwald and Green (Rheinwald and Green, 1975)) in
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several respects which may serve to limit their performance. Irradiated 
producer cells may be more limited both quantitatively and qualitatively in 
terms of their cytokine output as well as a markedly reduced survival in 
comparison to 3T3 cells. This may effect porcine keratinocyte phenotype, 
clonal expansion, colony forming efficiency and keratinocyte intercellular 
dynamics in a detrimental manner.
Mammalian cell expression of genes inserted by transduction, may be 
transient if translation alone of retroviral RNA has occurred without reverse 
transcription and incorporation into host DNA. Expression may not remain 
stable even following successful marker gene transduction through 
successive cell divisions and may disappear altogether (Fenjves, 1994) or be 
seen to vary with cell phenotype (Altmann and Trachsel, 1993). Prior to the 
use of labelled cells in vivo, it was useful therefore to examine the in vitro 
behaviour of transduced kératinocytes.
The aims of this study included the following:
• To establish a retroviral producer line capable of efficient porcine 
keratinocyte transduction
• To determine the effect of irradiated PT67 feeder cells on porcine 
keratinocyte colony forming efficiency
• To determine the stability of expression of lacZnIs transduced porcine 
kératinocytes in vitro
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To examine the nature of porcine keratinocyte lacZnIs expression in 
relation to confluence in culture
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3.2 Results
3.2.1 Cloning TELCeB:
Retroviral producer lines in use by the laboratory were of very low titre and 
hence poorly transduction efficient. The first objective was therefore, to clone 
the retroviral producer line TELCeB (Cosset et al., 1995) in an effort to 
increase it’s efficiency, and to verify if it could transduce porcine 
kératinocytes. The TELCeB cell line is derived from the human cell line TE671 
(Takeuchi et al., 1994) infected with the MFGIacZnis retroviral vector (see
Figure 3.1), (forming TEL) and transfected with CeB. CeB is a Moloney
murine leukaemia (MoMLV) viral gag-pol expression plasmid derived from 
pCRIP (Takeuchi et al., 1994; Cosset et al., 1995) (see Figure 3.2).
Figure 3.1: Schematic diagram of MFG vector construct
MFG recombinant retrovirus encoding lacZ. Moloney murine leukaemia virus 
(MoMuLV) long terminal repeat sequences are used to generate both a full 
length viral RNA (for encapsidation Into virus particles) and a subgenomic 
mRNA, which is responsible for expression of inserted sequences. No 
selectable marker exists in the vector (adapted from Dranoff et al., 1993).
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Figure 3.2: Schematic diagram of CeB construct
Initiation ( v  ) and termination ( ▼ ) codons are shown. The thick dotted line 
shows MoMuLV derived sequences (adapted from Cosset et al., 1995).
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The cell line was grown up from frozen state to subconfluence, then plated out 
in 6cm tissue culture grade petri dishes in concentrations of 100, 300, 500 
and 1000 cells per dish. On the l f ^  day healthy looking colonies had grown 
up in dishes plated with 300 and 500 cells. A dish plated with 500 cells was 
stained with X-Gal (see Figure 3.3). There was marked heterogeneity of p- 
galactosidase expression with 80% of cells staining blue in most colonies, a 
few colonies showing approximately 95% blue staining cells and some 
showing 30-40% staining.
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Figure 3.3: X-gal staining of TELCeB cells
A 9cm diameter Petri dish plated with 500 TELCeB cells was stained after 11 
days. The image (X20 objective) shows cells within a colony displaying the 
nuclear localised blue staining. The colony photographed shows a high 
proportion (approximately 95%) of cells with nuclear localised p-galactosidase 
expression.
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Disks of filter paper (0.75mm diameter) soaked in Trypsin/EDTA 
(0.05%/0.02%) and sterilised by irradiation with 66,000 rads/hour for 18hours, 
were used to transfer numbered colonies (from a petri dish plated initially with 
300 cells) to a 24 well plate.
On the following day the paper disks were removed. Microscopic examination 
revealed homogenous looking colonies. When most colonies became just 
confluent, 80% of the cells were trypsinised and transferred to corresponding 
6 well plates. The 24 well plate was stained with X-Gal 4 days later (see 
Figure 3.4) Judged according to percentage of cells showing blue nuclear 
staining and density of nuclear staining, the best colonies were nos. 
5,11,15,18,22 and 24. These colonies were transferred from 6 well plates to 
25cm^ flasks. When just confluent the cells were transferred to 75cm^ flasks.
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Figure 3.4: X-gal staining of TELCeB clones grown up in 24 well plate
The 24 well plate containing TELCeB clones was fixed and X-Gal stained. 5 
of the wells did not have any cells, 4 of the wells were difficult to interpret in 
that cells were seen only on the periphery of the well. Of the remaining 15 
wells, 2 displayed close to 100% of cells staining blue, 3 had approximately 
95% staining one of which did not appear to have as dense nuclear staining 
as the rest, 1 well had 90-95%, 4 had approximately 90% staining, two of 
which did not appear to have as dense nuclear staining as the rest, 3 had 
80%, one had 60% and the remaining well displayed only 40% of cells 
staining blue. The images (X I00) show the most prolifically and intensely 
staining clones from well no. 5 (a); well no. 11 (b); well no. 15 (c); well no. 18 
(d): well no. 22 (e); well no. 24 (f);).
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3.2.2 Determination of TELCeB as ecotropic or amphotropic producer
There was uncertainty as to the capacity of TELCeB to transduce both 3T3 
cells and porcine kératinocytes. 2 consecutive attempts at 3T3 transduction 
(see Chapter 2 for method) were carried out with supernatant from clones 
from well numbers 5, 11, 15, 18, 22 and 24 in order to determine which of 
these was superior. These were determined (and confirmed by an 
independent assessor) to be from wells 11 and 24 (see Table 3.1 and Figure 
3.5).
Table 3.1: X-Gal staining results following transduction of 3T3 Cells in 6-
well plates by selected colonies
Flask
number
Neat supernatant
% transduction
1/10 supernatant
% transduction
1/100 supernatant
% transduction
Study 2^  ^Study 1^ Study 2^ d
study
1^  ^Study 2^  ^Study
3T3 (control) 0 0 0 0 0 0
5 50 40 '-10 2 -1 <1
5 (duplicate) 40 15 1
11 unreliable 30-40 -5% 4-5 unreliable unreliable
15 5 5 <1 <1 <1 unreliable
18 40 10-15 4 <1 <0.5 <1
19 10 10-15 3 <1 <1 <1
22 20-30 10 10 2 - <1
24 30 40-50 5-10 <5 1 <1
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Figure 3.5: X-Gal stained 3T3 cells
Following supernatant transduction of 3T3s in 6-well plates by TELCeB 
clones flasks were stained with X-Gal to enable comparison between clones. 
The best clones (see Table 3.1) were from well numbers 11 and 24, 
photomicrographs (X200) (a) and (b) with approximately 30% and 40% 3T3 
cell nuclei staining blue respectively.
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Attempts were then made to transduce porcine kératinocytes (see Chapter 2 
for method) in 6 well plates with 0, 2, 4, 8, or 12 pg per ml of polybrene in 
each of the plates. Staining with X-Gal demonstrated a complete lack of 
keratinocyte transduction at any of the polybrene concentrations by the 
TELCeB lines (see Figure 3.6).
This experiment demonstrated that this TELCeB construct was not producing 
amphotropically packaged retrovirus.
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Figure 3.6: X-gal stained kératinocytes
Photomicrograph (X200) of X-gal stained keratinocyte and TELCeB clone 11 
feeder cells. The TELCeB cells stain blue as expected; however the 
kératinocytes show a complete lack of MFGIacZ expression, indicating a lack 
of transduction and ecotropicity of the TELCeB produced envelope protein.
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3.2.3 Transduction of GP+EnvAm12 (amphotropic packaging cell line) 
with MFGIacZnIs
TELCeB although a good ecotropic producer of MFGIacZnIs was not able to 
package retroviral particles in envelopes capable of entering porcine 
kératinocytes. An attempt was made therefore, to use TELCeB in order to 
transduce the amphotropic packaging cell line GP+Env Am 12 (Markowitz et 
al., 1988), hoping to covert it to an amphotropic producer cell line capable of 
transducing porcine kératinocytes.
GP+EnvAm12 is a clone isolated from an NIH/3T3 derived cell line containing 
the MoMLV gag and pol genes and transfected with the H070A amphotropic 
env gene (Markowitz et al., 1988).
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Flasks containing the packaging cell line GP+Env Am 12 at 30-40% 
confluence were exposed on consecutive days to medium with a 50% 
concentration of supernatant from ‘just confluent' TELCeB (clone number 11) 
cultures. 1 flask received growth medium alone, as a control. When the 
GP+Env Am 12 flasks reached 80-90% confluence, an attempt was made to 
transduce 3T3 cells and P4 porcine kératinocytes (P4 denotes cells that have 
undergone 4 passages, with PO referring to cells straight off the pig and P1 to 
cells that have undergone 1 passage). The method used for transducing 3T3 
cells was by direct supernatant transduction and for transducing P4 
kératinocytes utilised the GP+Env Am 12 cells as feeder cells (see Chapter 2 
for method).
Four days later both test and control kératinocytes were plated once more 
onto irradiated 3T3 cells. 3 days later the kératinocytes, 3T3s and a separate 
flask of transduced GP+Env Ami 2 cells were stained with X-Gal. 
Approximately 80% of the GP+EnvAm12 cells transduced expressed the lacZ 
gene (see Figure 3.7). There was no detectable expression of p- 
galactosidase by the target kératinocytes or 3T3 cells (with X-Gal staining). A 
colleague working in tandem with the same line experienced similarly 
negative results. Others, including workers at this laboratory have in the past 
been moderately successful with GP+EnvAm12 (Markowitz et al., 1988; Ng 
et al., 1997a; Mathor et al., 1996). The line that had previously been found to 
work in our laboratory had become infected and the newly ordered cells we 
subsequently used turned out to be greatly inferior.
128
Figure 3.7: X-gal stained GP+EnvAm12 cells
Photomicrograph (X200) of GP+EnvAm12 cells stained with X-gal. The cells 
had undergone transduction by MFGIacZ following exposure to TELCeB 
clone 11 supernatant. Up to 80% of the cells stained blue, although they 
failed to produce retroviral particles when subsequently tested with 3T3 cells 
and kératinocytes.
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Favourable reports were obtained of a different amphotropic packaging cell 
line offered for sale by Clontech Laboratories Inc. known as PT67 (Miller et 
al., 1994, Miller et al., 1996) I therefore proceeded to attempt transduction of 
this packaging cell line.
The PT67 cell line is an NIH/3T3 based line infected with the MoMLV gag and 
pol genes and expressing the 10A1 envelope protein. This envelope 
facilitates entrance of cells via both the amphotropic and the GALV (Gibbon 
Ape Leukaemia Virus) receptors thus broadening the host range.
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3.2.4 Transduction of PT67 packaging cell population with MFG
lacZnIs
Newly obtained PT67 was grown up to confluence and then split 1:5. On the 
following day the PT67 cells received two exposures, 8 hours apart, to 
TELCeB clone 11 supernatant (at 50% concentration) with 4pg per ml 
polybrene. The medium was changed at 24 hours. On staining on day 4 the 
PT67 population looked heterogeneous with respect to both proportion of 
nuclei stained and intensity of nuclear staining (see Figure 3.8).
Figure 3.8: X-Gal stained PT67 cells
Photomicrograph (XI GO) of PT67 cells post transduction. Parallel flasks of the 
PT67 packaging cell line were exposed twice to TELCeB clone 11 and one 
flask was stained with X-Gal on day 4. Heterogeneity of staining density is 
evident, so the newly transduced producer cell line was cloned.
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3.2.5 Testing the newly formed PT67 producer cell population
In order to confirm that the transduced PT67 cells were producing virus 
capable of amphotropic transduction it was necessary to test it on 
kératinocytes and 3T3 cells. The method used for transducing 3T3 cells was 
by direct supernatant transduction and for transducing porcine kératinocytes 
utilised the PT67 cells as feeder cells (as for testing of GP+EnvAm12 see 
Chapter 2 for method).
On staining with X-Gal, approximately 30% of the kératinocytes stained blue 
but there was no positive staining of 3T3 cells. The results indicated that an 
amphotropic producer cell line capable of porcine keratinocyte transduction 
had been established. The negative 3T3 result may have been due to 
premature fixing and staining. Subsequent attempts to transduce 3T3s with 
this line have been successful, but only when staining is done after 3 days.
To increase the efficiency of viral output it was decided to clone out the more 
efficient producers from the parent TELCeB transduced PT67 producer 
population.
3.2.6 Cloning the PT67 producer cell population
Transduced PT67 cells were plated out on to petri dishes in concentrations of
20X, 10X, 1X, 0.3X and 0.1X10^ cells per dish. Nine days later, disks of filter
paper (0.75mm diameter) soaked in Trypsin/EDTA (0.05%/0.02%) and
sterilised by irradiation with 66,000 rads per hour for 18hours, were used to
transfer numbered colonies (from a petri dish plated initially with 300 cells) to
a 24 well plate. On the following day the paper disks were removed. Three
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days later 50% of the cells in each well were transferred to duplicate wells in a 
24 well plate. The cells from one of the two 24 well plates were transferred 2 
days later to 6 well plates. The other plate was stained with X-Gal (see Table 
3.2). Colonies with the most favourable staining profile in terms of 
homogeneity, degree and density of staining were from well numbers 
1,8,9,10,13,14,17 and 23. These were transferred from 6 well plates to 25cm^ 
flasks and thence to 75cm^ flasks.
Table 3.2: X-Gal staining of 24 well plate containing PT67 clones
The wells were graded 1 to 5 with respect to increasing homogeneity,
proportion and density of staining.
(V 5 (5) 4 m 4 (13) 5 (17) 5 (21) 4
m 4 (6) 5 (10) 5 (14) 5 (18) — C22) —
m 2 (7) 2 (11) 1 (1b) 3 (19) — (23) 5
(4) 4 4 (12) 2 (10) 2 (20) 4 (24) —
To determine which of these clones was the most efficient retroviral producer 
they were compared with respect to transduction of 3T3 cells. On staining with 
X-Gal, the clone from well 8 showed the highest percentage transduction of 
3T3 cells (see Figure 3.9 and Table 3,3 for results).
Flow cytometry (see Chapter 2 for method) confirmed that E. coli p- 
galactosidase is present in close to 100% of the PT67 clone from well number 
8 (see Figure 3.10).
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Table 3.3: X-Gal staining results of 3T3 transduction by selected PT67
producer cell clones.
2X10® cells from each clone were plated out in a 75cm^ flask. 10® 3T3 cells 
per well were plated out in 6 well plates. Supernatant (from each clone as well 
as from a flask of subconfluent 3T3 cells) at concentrations of 50%, 0.5% and 
0.05% and polybrene (8 pg per ml) were added on the following day. One 6 
well plate acted as a negative control. 24 hours later the medium was 
changed and 2 days later the plates were stained with X-Gai and graded 
according to percentage of 3T3 cel is with blue nuclear staining.
Clone
Number
50% Supernatant
% transduction
0.5% Supernatant
% transduction
0.05% Supernatant
% transduction
3T3 (control) 0 0 0
1 5-10 <1 <1
8 50-75 5-10 <1
9 10-20 1-2 <0.01
10 10-20 1-2 <0.01
13 10-20 1-2 <0.1
14 10-20 1-2 <0.1
17 5 1-2 <0.1
23 2-5 <1 <0.1
133
Figure 3.9: X-gal stained PT67 producer cells (Clone 8) and transduced 3T3
cells
Photomicrograph ((a) X100, (b) X200) of well number 8 (24-well plate) 
containing a clone of MFGIacZ transduced PT67 cells (a) and 3T3 cells 
transduced by this clone (b). The clone from well number 8 achieved a 50- 
75% transduction rate of 3T3 cells (higher than any of the remaining clones 
within the 24-well plate).
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Figure 3.10: Histogram following flow cytometry showing anti-(3-
galactosidase-FITC labelling of PT67 clone 8 cells
One population was primarily labelled with an isotype control (lgG2b) and the 
other with anti-p-galactosidase (lgG2b). Secondary labelling with FITC (sheep 
anti-mouse IgG). Samples were processed in triplicate. The histogram 
illustrates close to 100% expression of p-galactosidase by PT67 clone 8.
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3.2.7 Determination of PT67 clone (8) producer cell line titre
10"^  3T3 cells per well were plated out in triplicate into 6 well plates, 7 serial 
dilutions of PT67 clone 8 supernatant (5X10'\ 10'\ 10 ^ 10 ^ 10"^ , 10 ^ lO^ ®) 
and 1 control (3T3 medium) were added to the wells 24 hours later together 
with 8pg per ml per well of polybrene. The medium was changed after 24 
hours and stained with X-Gal 2 days later.
The titre was determined for each of the 3 highest dilutions (see Figure 3.11). 
The mean of the titres at the top two dilutions (10"®, 10'®) is 1.7X10® colony 
forming units per ml (cfu per ml). High titre > 10®cfu per ml retroviral producer 
lines are reportedly capable of approaching 100% transduction (Carroll et al., 
1993).
Consistently, close to 100% of kératinocytes were now found to have been 
transduced following repeated passage (3 times) on irradiated PT67 feeder 
cells (see Figure 3.12).
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Figure 3.11: Graph showing the distribution of viral titre against supernatant 
dilution
The titre (virus particles per ml of supernatant) is determined as the number of 
blue staining colonies multiplied by the relevant dilution factor (divided by the 
well volume). In this experiment 20 ml of supernatant was diluted to a 10"®, 
10 ® or 10"^ *^  part of the total volume (4ml) within each well in 6 well plates. 
The wells were prepared in triplicate. Count results are shown.
Dilution 10^ 10“® 10^
Blue staining 
colony counts
131 23 8
245 34 5
225 20 20
The viral titre was determined to be 1.7X10^ colony forming units per ml (cfu 
per ml) calculated from the mean of the titres determined at the top two 
dilutions (1(T^ , 10' )^. Error bars represent the standard deviation (n=3).
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Figure 3.12: X-gal stained porcine kératinocytes cultured on PT67 clone 
8 producer feeder cells
The kératinocytes initially passaged on PT67 producer feeder cells were 
subsequently passaged onto irradiated 3T3 cells before fixing and staining 
with X-gal. The percentage of kératinocytes staining blue (illustrated by the 
photomicrographs X200) were approximately 30% after 1 passage (a), 60% 
after 2 passages (b) and approaching 100% following 3 passages (c).
/
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3.2.8 Effect of PT67 clone 8 supernatant on metabolic activity of 3T3
cells
Having observed that high concentrations of PT67 supernatant appeared to 
inhibit 3T3 cell replication during viral titre experiments, an attempt was made 
to see whether progressive dilutions of PT67 supernatant produced significant 
3T3 cell replication inhibition and hence p-galactosidase expression. This 
could lead to a misleading estimate of viral titre.
Alamar blue™, a non-toxic redox indicator dye (see Chapter 2 for method) 
was added (prior to X-Gal staining) to the same set of 6 well plates used to 
determine PT67 (clone 8) titre. Absorbance was measured after 4 hours (see 
Figure 3.13).
Using an all pairwise multiple comparison procedure (Tukey test) within a one 
way analysis of variance test there was a significant difference (P<0.05) in 
metabolic activity of between 60.7 and 72.0% between the cells that had 50% 
supernatant and the cells that received higher dilutions. There was also a 
significant (P<0.05) difference between the control and the cells receiving 
1/10'  ^ and 10"^  dilutions of between 25.0 and 28.8% but not between the 
control and the cells receiving 10 ®, 10*^  or 10 ® dilutions.
PT67 cells are highly metabolically active and require frequent changes of 
medium. It might not be surprising that there could be a negative effect on cell 
metabolism seen with concentrated supernatant. This may be unrelated to the 
concentration of viral particles but instead be due to deficiency of nutrients 
within the supernatant. This however, does not adequately explain the 
negative effects on cell metabolism seen with the 10'^  or 10'  ^ dilution. An
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explanation may lie in a phenomenon observed repeatedly with respect to 
PT67 cells. If within a flask of sparsely plated PT67 cells there Is an isolated 
clump of (highly confluent) cells the rest of the cells will tend not to divide. The 
explanation may be that highly confluent PT67 cells secrete a substance that 
even in small concentrations inhibits cell metabolism.
Figure 3.13: Effect of PT67 supernatant on metabolic activity of 3T3 cells
10"^  3T3 cells per well were plated out in triplicate in 6 well plates. 7 serial 
dilutions of PT67 done 8 supernatant (5X10 \  10'\ 10'^ 10‘®, 10"^ , 10 ®. IC®) 
and 1 control (3T3 medium) were added to the wells 24 hours later together 
with 8pg per ml per well of polybrene. The medium was changed after 24 
hours. 2 days later Alamar Blue was added to the wells at a concentration of 
1/10**^  of the volume of medium contained within the well (prior to staining with 
X-Gal). 4 hours later 200j.il were transferred in triplicate from each well to a 96 
well plate and the absorbance at 570nm minus the absorbance at 600nm 
determined (shown below with standard error bars, n=3).
Using an all pairwise multiple comparison procedure (n=3, Tu key test) within a 
one way analysis of variance test there was a statistically significant 
difference (P<0.05) in metabolic activity of between 60.7 and 72.0% between 
the cells that had 50% supernatant and the cells that received higher dilutions.
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3.2.9 Effect of irradiated PT67 feeder cells on keratinocyte colony
forming efficiency
The purpose of generating and cloning the PT67 producer line was to achieve 
highly efficient MFGIacZ keratinocyte labelling. Although NIH/3T3 cell-derived, 
PT67 cells have been altered genetically and repeatedly cloned. Their use 
instead of irradiated 3T3 cells as feeder cells may therefore deleteriously 
effect kératinocytes. Phenotypically, kératinocytes look different when grown 
on irradiated PT67 cells in that the cytoplasm appears less dense and 
intercellular attachments appear to be fewer. In terms of growth, although they 
initially appear to multiply faster, the colonies formed appear to be smaller and 
the rate of growth subsequently slower (after the initial spurt) than when 
grown on 3T3s. Irradiated PT67 cells die after 2-4 days while irradiated 3T3 
cells often appear to survive for over a week on collagen-coated flasks. It 
therefore was imperative to investigate irradiated PT67 cells as feeder cells 
with respect to colony forming efficiency in terms of numbers and size of 
colonies formed (Barrandon and Green, 1987).
The study was carried out with kératinocytes from 3 separate Large White
pigs. Using PO kératinocytes that had undergone SLA DR antibody
complement pre-treatment (see Chapter 2 for method), 1.1X10^ per cm® were
plated out in triplicate with one of the following feeder cell regimens:
PT67 1.4X10^  ^per cm® (1)
3T3 1.4X10"^  per cm® (1 )
3T3 1.4X10"^  per cm®+ PT67 1 . 4 X 1 per cm® (1) + (1)
3T3 6.9X10® per cm®+ PT67 2.1X10^ per cm® (0.5)+ (1.5)
3T3 6.9X10® per cm®+ PT67 1.4X10"^  per cm® (0.5) + (1 )
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3T3 6.9X10® per cm®+ PT67 6.9X10® per cm® (0.5) + (0.5)
The surface area of a well (within a 6 well plate) Is 9.4cm®. 2.67X1 O'* per cm® is 
the number of irradiated 3T3 cells generally used as feeder cells when 
culturing porcine kératinocytes. In this experiment, the number of 
kératinocytes plated was very low (1.1X10® per cm®), a minimum number of 
1.4X10'^  per cm® was therefore judged to be more than sufficient to reduce bias 
due to differences in cell numbers and focus the study in the direction of 
analysis of qualitative differences between the cell types.
Cells from the 3 pigs were assessed in triplicate.
After 1 week the wells were stained with rhodamine B and X-Gal.
The number of colonies were counted both manually and confirmed with an 
automated image analyser count (see Figures 3.14 and 3.15). In addition the 
image analyser was used to assess the size (area) of colonies (see Chapter 2 
for method).
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Figure 3.14: Study of colony forming efficiency of feeder cell types and
combinations (scanned images)
The images show examples of wells (6 well plate) that were scanned for 
image analysis following fixation and staining of keratinocyte colonies from pig 
number 17. The wells correspond to the following feeder cell types: PT67 (a); 
3T3 (b);PT67+3T3 (c); 0.5X3T3 + 1.5XPT67 (d); 0.5X3T3 + PT67 (e);
0.5X3T3 + 0.5XPT67 (f).
r j r
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Figure 3.15: Study of colony forming efficiency of feeder cell types and
combinations
Photomicrographs (X 40) showing typical keratinocyte colonies from pig 
number 17 grown up on the different feeder cell types. PT67 (a); 3T3
(b);PT67+3T3 (c); 0.5X3T3 + 1.5 X PT67 (d); 0.5X3T3 + PT67 (e); 0.5X3T3 + 
0.5 X PT67 (f), following fixation and staining with X-gal and rhodamine B.
#
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3.2.9.1 Quantitative analysis of colony forming efficiency
Manual Count: The results were analysed using a one way repeated 
measures analysis of variance. This demonstrated (Tukey test) a significant 
decrease of between 38 and 60% in colony numbers in all groups (with the 
exception of the 0.53T3 + 1.5PT67 group), as compared to the 3T3 + PT67 
group (P<0.05) (see Figure 3.16). Note, that although the absolute colony 
numbers vary between each of the three pigs, the pattern due the different 
feeder cell regimens is consistent.
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Figure 3.16: Feeder cell study, manual count of colony numbers
1.1X10^ per cm  ^P3 kératinocytes (following complement lysis see Chapter 2 
for method) from three different pigs plated in triplicate onto collagen-coated 
6 well plates (well surface area = 9.4cm^) with any of 6 possible combinations 
of feeder cells: PT67 1.4X10“' per cm  ^(PT67); 3T3 1.4X10“ per cm^ (3T3);
3T3 1.4X10“ per cm^+ PT67 1.4X10“ per cm^ (3T3 + PT67); 3T3 6.9X10^ per 
cm^+ PT67 2.1X10“ per cm^ (0.5X3T3 + 1.5XPT67); 3T3 6.9X10^ per cm  ^+ 
PT67 1.4X10“ per cm^ (0.5X3T3 + PT67); 3T3 6.9X10^ per cm^ + PT67 
6.9X1 o’  per cm’  (0.5X3T3 + 0.5XPT67).
Cultures were assessed with rhodamine B and X-Gal staining after one week. 
Colonies were counted manually.
One way repeated measures analysis of variance of the absolute values 
showed that there were statistically significant differences (P=0.005) in the 
mean values among the feeder cell groups (b). To isolate the groups that 
differ an all pairwise multiple comparison procedure (Tukey test) was used. 
This showed that the following differences were (P<0.05) statistically 
significant. 59.7% fewer colonies in the PT67 group, 38.8% fewer colonies in 
the 3T3 group, 60.2% fewer colonies in the 0.5X3T3 + PT67 and 41.0% 
fewer colonies in the 0.5X3T3 + 0.5XPT67 group than in the 3T3 + PT67 
feeder cell group.
One way analysis of variance and Tukey test of the relative values 
(calculated as relative to those obtained for the PT67 feeder cell group) was 
performed (a). This confirmed that the differences seen with one way 
repeated measures analysis of variance of the absolute values were 
significant (P<0.05). The error bars refer to standard deviations.
(a) Distribution of colony counts (performed manually) for each feeder cell group (n=3 
pigs) shown relative to those obtained for the PT67 group
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(b) Distribution of absolute colony numbers (manual count) for each feeder cell group (n=3
wells) shown for each pig.
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Automated Count: The absolute values were analysed using a one way 
repeated measures analysis of variance. This demonstrated (Tukey test) a 
significant decrease of between 41 and 50% in colony numbers in the PT67 
group, as compared to the 3T3 group, 3T3 + PT67 group and 0.53T3 + 
1.5PT67 feeder cell group (P<0.05) (see Figure 3.17).
The colony counts (absolute values) observed manually tended to be higher 
than those observed by the image analyser (see Figures 3.16(b) and 3.17(b)). 
These differences may be explained in that with the naked eye it was possible 
to determine whether a single collection of cells was in fact several colonies 
that had become confluent. Attempting to manipulate the image analyser to 
do this was extremely difficult giving rise to inconsistent results and was 
therefore abandoned. Random wells were double checked to further ensure 
consistency. In spite of the differences seen in absolute values between the 
two methods of counting, the relative differences between groups appeared 
very similar (see Figure 3.18)
The results of counting the colonies tend to confirm the observed 
phenomenon that PT67 cells on their own are not as beneficial to 
kératinocytes in terms of colony forming efficiency as 3T3 cells on their own or 
when PT67 cells are combined with 3T3 cells.
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Figure 3.17: Feeder cell study; Automated count of colony numbers
Following staining (see Figure 3.16 legend) wells were scanned and digitally 
analysed with Image Pro Plus® software with respect to numbers and size of 
colonies.
One way repeated measures analysis of variance of the absolute values 
showed that there were statistically significant differences (P=0.005) in the 
mean values among the feeder cell groups (b). To isolate the groups that 
differ an all pairwise multiple comparison procedure (Tukey test) was used. 
This showed that the following differences were statistically significant 
(P<0.05) with respect to colony numbers in the PT67 group in relation to the 
other groups. 50.4% fewer colonies than in the 3T3 + PT67 feeder cell group, 
42.2% fewer colonies in the 3T3 group and 40.7% fewer colonies than in the 
0.53T3 + 1.5PT67.
One way analysis of variance and Tukey test of the relative values 
(calculated as relative to those obtained for the PT67 feeder cell group) was 
performed (a). This confirmed that the observed reduction in numbers of 
colonies in the PT67 group (50.4% fewer) with respect to the number 
observed with the 3T3 + PT67 feeder cell was significant (P<0.05). The error 
bars refer to standard deviations.
(a) Distribution of colony counts (automated digital count) for each feeder cell group 
(n=3 pigs) shown relative to those obtained for the PT67 group
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(b) Distribution of absolute colony numbers (automated count) for each feeder cell
group (n=3 wells) shown for each pig.
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Figure 3.18: Comparison of automated and manual counts
The values for each feeder cell group have been averaged and made relative 
to those for the PT 67 group. The error bars refer to standard deviations.
The feeder cell groups denoted by the X-axis are:
1 = PT67; 2 = 3T3; 3= 3T3 + PT67; 4 = 0.53T3 + 1.5PT67;
5 = 0.53T3 + PT67; 6 = 0.53T3 + 0.5PT67
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3.2.9.2 Analysis of colony size
To further analyse the effects of different feeder cell regimens on keratinocyte 
colony forming efficiency, the different size of the colonies was measured by 
image analysis software (see Figures 3.19-3.22).
For both pigs nos. 17 and 18 there are significant differences in the mean 
values of colony areas (as measured by the image analyser) among the 
feeder cell groups. In both, the mean colony areas are significantly greater 
(Tukey Test P<0.05) with the 3T3, 3T3 + PT67, or with the 0.5 3T3 + 0.5 PT67 
feeder cell combination than with the PT67 or the 0.5 3T3 +1.5 PT67 feeder 
cell combinations. The pattern of differences suggests two things: first, that 
the addition of 3T3 cells may have a positive impact on the size of colonies 
formed; second, that the addition of PT67 cells may have a negative impact 
on the size of colonies formed perhaps favouring early clonal abortion. The 
Tukey test did not reveal significant differences amongst the groups for pig 
no. 20 (see Figures 3.23 and 3.24), but the less conservative Fisher LSD 
method revealed significantly greater mean colony areas (P<0.05) in the 3T3 
+ PT67 and the 0.5 3T3 + 0.5 PT67 feeder cell combination than the 0.5 3T3 
+ 0.5 PT67 feeder cell combination.
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Figure 3.19: Frequency distribution of pig no. 17 keratinocyte colony surface 
areas per feeder cell type 
The graph illustrates the frequency distribution of colony surface areas in 
each feeder cell group. 20 bins were created with the value of each bin rising 
incrementally from 100 to 2000 surface area units. The surface areas for each 
feeder cell group with values corresponding to particular bins were assigned 
to the corresponding bins. The number of surface area values within each bin 
were plotted against the bin designated value to give a frequency distribution 
histogram. The histogram illustrates the general trend of significantly 
greater(Tukey Test P<0.05) mean colony areas with the 3T3, 3T3 + PT67, or 
with the 0.5 3T3 + 0.5 PT67 feeder cell combination than with the PT67 or the 
0.5 3T3 + 1.5 PT67 feeder cell combinations.
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Figure 3.20: Distribution of pig no. 17 keratinocyte colony surface 
areas per feeder cell type 
The graph illustrates the distribution of colony surface area for the largest 100
colonies from each feeder cell group. The smaller colonies have been
eliminated from this graph in order to focus attention on the pattern of
distribution of the larger colonies. The trend is suggestive of consistently more
colonies with a larger surface area in the 3T3 and 3T3 + PT67 groups,
(although the mean colony areas taken over the entire range are significantly
greater(Tukey Test P<0.05) with the 3T3, 3T3 + PT67 and with the 0.5 3T3 +
0.5 PT67 feeder cell combination than with the PT67 or the 0.5 3T3 + 1.5
PT67 feeder cell combinations).
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Figure 3.21: Pig no. 18 frequency distribution of colony surface area per
feeder cell type
The graph illustrates the frequency distribution of colony surface areas in 
each feeder cell group. 20 bins were created with the value of each bin rising 
incrementally from 100 to 2000 surface area units. The surface areas for each 
feeder cell group with values corresponding to particular bins were assigned 
to the corresponding bins. The number of surface area values within each bin 
were plotted against the bin designated value to give a frequency distribution 
histogram. The histogram illustrates the general trend of significantly greater 
(Tukey Test P<0.05) mean colony areas with the 3T3, 3T3 + PT67, or with the 
0.5 3T3 + 0.5 PT67 feeder cell combination than with the PT67 or the 0.5 3T3 
+ 1.5 PT67 feeder cell combinations.
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Figure 3.22: Distribution of pig No. 18 keratinocyte colony surface area per
feeder cell type
The graph illustrates the distribution of colony surface area for the largest 100 
colonies from each feeder cell group. The smaller colonies have been 
eliminated from this graph in order to focus attention on the pattern of 
distribution of the larger colonies. The trend is suggestive of consistently 
fewer colonies with a larger surface area in the PT67 or the 0.5 3T3 + 1.5 
PT67 feeder cell combinations).
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Figure 3.23: Frequency distribution of Pig No. 20 keratinocyte colony
surface area per feeder cell type
The graph illustrates the frequency distribution of colony surface areas in 
each feeder cell group. 20 bins were created with the value of each bin rising 
incrementally from 100 to 2000 surface area units. The surface areas for each 
feeder cell group with values corresponding to particular bins were assigned 
to the corresponding bins. The number of surface area values within each bin 
were plotted against the bin designated value to give a frequency distribution 
histogram. The histogram illustrates the general trend of significantly greater 
(Tukey Test <0.05) mean colony areas with the 3T3, 3T3 + PT67, or with the 
0.5 3T3 + 0.5 PT67 feeder cell combination than with the PT67 or the 0.5 3T3
1.5 PT67 feeder cell combinations.
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Figure 3.24: Distribution of pig no. 20 keratinocyte colony surface
areas per feeder cell type
The graph illustrates the distribution of colony surface area for the largest 100 
colonies from each feeder cell group. The smaller colonies have been 
eliminated from this graph in order to focus attention on the pattern of 
distribution of the larger colonies. The trend is suggestive of consistently 
fewer colonies with a larger surface area in the PT67, the 0.5 3T3 + 1.5 PT67 
and 0.5 3T3 + PT67 feeder cell combinations.
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3.2.10 In vitro stability of lacZnIs transduced kératinocytes
Various reports of retrovirus transduced genes in kératinocytes have indicated 
falling expression of p-galactosidase in vivo, with time (Fenjves et al., 1996; 
Vogt et al., 1994) It was pertinent therefore, having achieved close to 100% p- 
galactosidase expression (see Figure 3.12), to assess its stability in vitro.
Po kératinocytes from 3 separate pigs were passaged three times on 
irradiated PT67 clone 8 cells and these underwent 7 further passages on 
irradiated 3T3 cells and were stained with X-Gal every 2nd passage.
Staining after the first three passages on 3T3 cells showed 100% keratinocyte 
transduction. After the fourth passage on 3T3 cells the growth rate of the 
kératinocytes dropped dramatically and marked clonal abortion was seen. 
However the p-galactosidase expression continued to approximate 100% (see 
Figure 3.25).
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Figure 3.25: X-gal stained porcine kératinocytes illustrating stability of
MFGIacZ expression
This study assessed the in-vitro stability of MFGIacZ expression within 
transduced Large White pig kératinocytes. The kératinocytes were passaged 
3 times (from PO) on PT67 producer cells then onto irradiated 3T3 cells. The 
photomicrographs (after 1 passage on 3T3 cells (a) X100 and (b) X200; after 
3 passages on 3T3 cells (c) X100; after 7 passages on 3T3 cells (d) X200) 
illustrate close to 100% transduction even after 7 passages on 3T3 cells. A 
diminution in the size of colonies and capacity for replication is evident in 
successive passages.
«
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3.2.11 Change of transduced keratinocyte lacZ expression with 
confluence
One method of grafting cultured kératinocytes is to transfer them having 
grown them up as sheets. An experiment was therefore devised to assess in 
vitro, in terms of continued MFGIacZ expression, the consequences of 
replication of labelled cells having first allowed them to form sheets.
Po kératinocytes from 3 separate pigs were passaged three times on 
irradiated PT67 clone 8 cells. Each flask was then divided 1:3 and underwent 
a further passage on irradiated 3T3 cells. After 2 days one flask was stained 
and the other 2 were left to reach confluence. At this time one of the 
remaining flasks was stained with X-Gal and the remaining was split 1:3 and 
plated on irradiated 3T3 cells. One of these flasks was then stained with X- 
Gal 2 days later.
Pre confluenT-cells showed 100% expression of the lacZ gene (see Figure 
3.26(a) and (b)). As they became confluent the number of cells expressing p- 
galactosidase diminished (see Figure 3.26(c) and (d)). When confluent sheets 
were passaged onto irradiated 3T3 cells p-galactosidase expression returned, 
but expression tended to predominate in the cells at the periphery of the 
colony at the interface between kératinocytes and irradiated 3T3 (feeder) cells 
(see Figure 3.26(e) and (f)).
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Figure 3.26: X-gal Stained Porcine Kératinocytes Illustrating the Nature
of MFGIacZ Expression in Relation to Confluence
Kératinocytes from three pigs were passaged 3 times (from PO) on PT67 
producer cells then onto irradiated 3T3 cells in triplicate. 1 set of flasks were 
stained when they were subconfluent, two parallel set of flasks were left to 
reach confluence and 1 further set was then stained. The remaining set was 
passaged onto 3T3 cells and stained with X-gal after 2 days. 
Photomicrographs ((a), (c) and (e) at X100 and (b), (d) and (f) at X200 
magnification), illustrate level of expression in relation to confluence Sub 
confluent cells showed 100% expression of the MFGIacZ nis gene (a) and (b). 
As they became confluent the number of cells expressing p-galactosidase 
diminished (c) and (d). When confluent sheets were passaged onto irradiated 
3T3 cells p-galactosidase expression returned (e), but tended to predominate 
in the cells at the periphery of the colony at the interface between 
kératinocytes and irradiated 3T3 (feeder) cells (f).
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3.3 Discussion
One of the aims of this part of the study was to achieve high levels of stable 
transduction. This appears to have been successful in vitro. Following three 
passages on PT67 feeder cells, close to 100% of kératinocytes expressed p- 
galactosidase. This level of expression persisted over a series of 7 further 
passages. Other researchers have achieved high in vitro transduction rates, 
but these have not always been borne out following grafting (Fenjves et al., 
1996). To achieve long term transduction it would be necessary to transduce 
the stem cells and not just the transient amplifying (TA) cells (Kolodka et al., 
1998; De and Pellegrini, 1997). Stem cells are postulated to be slow cycling 
cells that give rise to the epidermal keratinocyte population (De Luca and 
Pellegrini, 1997). Using clonal analysis, three types of kératinocytes have 
been Identified that have different capacities for multiplication. These are 
holoclones, meroclones and paraclones (Barrandon and Green, 1987). 
Holoclones have the greatest capacity for multiplication. A single holoclone 
can generate more than 1X10"^ ° progeny. The holoclone in culture behaves 
characteristically like a stem cell. The paraclone is generated by a transient 
amplifying cell and is limited to no more than 15 divisions. Subcultivated 
paraclones do not generate colonies indicating their terminality (Barrandon 
and Green, 1987). The meroclone has an intermediate capacity for replication 
and conforms to the generally conceived notion of transient amplifying cell 
(Barrandon and Green, 1987). Viral integration is dependant on cell division 
(Miller, 1990). It is thus far easier to achieve stable transduction in rapidly 
dividing cells than it is in slowly cycling cells. Perceived wisdom is that the 
keratinocyte stem cell population is characterised by its relative quiescence
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and the greatest proliferative capacity, compared with the TA cells 
characterised by reduced proliferative potential and more rapid terminal 
differentiation in culture (Barrandon and Green, 1987). This may not be true 
in our culture conditions where unlike with Green's medium, the culture 
conditions for porcine kératinocytes, deliberately maintain them in an 
immature, non differentiating state (Bevan et al., 1997). This may favour 
continued replication by the meroclonal TA cells rather than terminal 
differentiation. It Is possible that the holoclonal stem cells may remain 
quiescent in these conditions. The stem cells represent a very small 
percentage of the total keratinocyte population. Stem cells may escape 
transduction and not be detected even in situations where apparently high 
percentage transduction rates prevail. Moreover, the cultured keratinocyte 
population may appear to be stably transduced over ensuing cell cycles and 
multiple passages in vitro because the meroclonal transiently dividing cells 
have been successfully transduced. Following grafting, marker gene 
expression may be far shorter lived owing to terminal differentiation (‘turning 
paraclonal’) of the transduced meroclones with reactivation of the non­
transduced stem cells.
Loss of expression in vivo (following in vitro transduction) has been noted in a 
variety of other cell types. These include fibroblasts (Scharfmann et al., 
1991), and myoblasts (Dai et al., 1992). Precise mechanisms are still being 
characterised but selective inactivation of viral promoters including by 
méthylation of specific bases in the promoter has been proposed (Challita 
and Kohn, 1994).
As well as achieving stable long term keratinocyte transduction, it is important
that the clonal potential of these cells are not compromised by highly efficient
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multiple retroviral transductions. We found that the incorporation of 3T3 cells 
into the feeder cells is necessary to avoid the appearance of small irregular 
colonies which would suggest premature senescence. Others using a similar 
system have been able to demonstrate a healthy 150 cell divisions of p-gal 
transduced kératinocytes before losing proliferative ability (Mathor et al., 
1996).
Having optimised keratinocyte lacZ transduction, exciting possibilities are 
opened up with respect to tracking the fate of grafted cultured allogeneic 
kératinocytes.
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Chapter 4
Evaluation of antibody complement pre-treatment as a method of 
Langerhans cell elimination in Large White pig keratinocyte
cultures
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4.1 Introduction
Skin allotransplantation, since the days of Medawar (Gibson and Medawar,
1943; Medawar, 1944; Medawar, 1945) has provided a powerful paradigm for
acute organ allograft rejection. Over the years however, it has become
apparent that skin allografts may behave differently when compared to organ
grafts. Rejection of skin grafts can occur across minor histocompatibility
barriers that do not result in organ graft rejection (Mahabir et al., 1969; White
et al., 1969; Fabre and Morris, 1975). Immunosupression preventing graft
rejection is much more difficult to achieve with skin grafts (Fabre and Morris,
1975). Long surviving recipients of cardiac or renal transplants reject donor
skin in a normal (Jenkins and Woodruff, 1971; Kawabe et al., 1972), or only
slightly delayed fashion (Marquet et al., 1971; Stuart et al., 1970; Fabre and
Morris, 1972; Mullen et al., 1973). Cultured kératinocytes that were grafted
beneath the renal capsule in two rat strains, responded to cyclosporin in a
manner typical of skin grafts rather than renal grafts (Fabre and Cullen, 1989).
In spite of the eccentric behaviour of skin grafts there are major similarities to
the model of acute organ rejection that remain valid. Initiation of the effector
mechanism of graft rejection, involves complex interactions between naive T
helper cells (Th cells) and APCs expressing the appropriate antigenic ligand
and providing requisite costimulatory signals (Singer et al., 1987). Lymphoid
organs provide anatomical structures in which critical intercellular interactions
are properly guided and where appropriate cells are likely to make contact
sufficiently frequently and in a critical milieu (Zinkernagel et al., 1997). Central
sensitisation occurs when APCs migrate out of the ‘peripheral’ graft to
draining nodes where an immune response is generated. The evidence for
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this has accumulated since the skin flap experiments of the 1950s (Frey and 
Wenk, 1957; Barker and Billingham, 1967; Tilney and Gowans, 1970). In 
these, the necessity for intact afferent draining lymph vessels and nodes for 
skin graft rejection was demonstrated. Further evidence came from studies in 
which APCs had been depleted prior to grafting (Lafferty et al., 1976; Talmage 
et al., 1976; Lafferty and Woolnough, 1977; Faustman et al., 1984). In both 
thyroid and pancreatic grafts survival was demonstrated until the 
réintroduction of donor APCs (Talmage et al., 1976; Lafferty and Woolnough, 
1977; Faustman etal., 1984).
Over the years, strong evidence has accumulated concerning the role played
by epidermal dendritic cells (LC), in an antigen presenting capacity.
Phenotypically, the mature LC are stellate with many fine dendritic processes
that extend in all directions from its cell body which appear highly motile
(Winzler et al, 1997). This shape and motility suggest a specialised central
antigen presenting role. Resting epidermal LC are less dendritic in
appearance and are functionally better suited to antigen capture and
processing. They are weak T - cell stimulators and have fewer MHC and
accessory molecules but many more antigen-capturing Fey and Fee receptors
(Banchereau and Steinman, 1998). These resting LC can be mobilised by the
stimulus of transplantation (both in vivo and as an explant). The evidence
suggests that maturation is associated with a marked increase of MHC II gene
and B7 molecule expression (Larsen et al., 1990b; Larsen et al., 1994).
Following migration to draining nodes, maturation is completed and the
mature LC becomes specialised in clustering and activating T-cells (Romani
and Schuler, 1992; Knight and Stagg, 1993). In classical skin allograft
rejection the assertion that the donor (rather than recipient) LC are
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responsible for antigen presentation is synonymous with the ‘passenger 
leucocyte’ phenomenon described by Snell (Snell, 1957). This assertion was 
lent credence by the skin flap and alymphatic pedicle experiments of the 
1950s and 60s (Frey and Wenk, 1957; Barker and Billingham, 1967; Tilney 
and Gowans, 1970). More recently, Larsen and coworkers demonstrated that 
within the classical skin and cardiac allorejection scenario, no host dendritic 
cells were found to migrate into the graft (Larsen et al., 1990a).
The centrality of donor APCs to the picture of classical acute allograft 
rejection led many to experiment with dendritic cell depleted allografts. These 
showed a survival advantage following APC cell depletion and included 
thyroid epithelial cell and pancreatic isleT-cell grafts (Lafferty et al., 1976; 
Talmage et al., 1976; Lafferty and Woolnough, 1977; Faustman et al., 1984). 
The picture with regard to APC-depleted cultured keratinocyte grafts is more 
mixed. In the 1980s, studies involving cultured epidermal cells demonstrated, 
that increasing time spent in culture, resulted in diminishing MHC II detection 
within the cultured population. Additionally, there was decreased ability of this 
population to activate T-cells within an MELR (mixed epidermal cell 
lymphocyte response) test as well the inability to detect typical LC with 
electron microscopy (Morhenn et al., 1982; Hefton et al., 1984; Demidem et 
al., 1986; Thivolet et al., 1986).
The sum of these studies was taken by many as proof that LC do not survive 
keratinocyte culture. The results however were mixed with one study showing 
persistence of 30% of original level of HLA DR expression remaining after three 
weeks in culture (Demidem et al., 1986). The LC phenotype following culture is 
known to alter quite profoundly (Larsen et al., 1990b; Teunissen et al., 1990; 
Witmer-Pack et al., 1988; Banchereau and Steinman, 1998). The culture
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conditions used in our laboratory for porcine keratinocyte is designed to maintain 
kératinocytes in a relatively dedifferentiated state and encourage proliferation 
(Bevan et al., 1997). This raises the question as to whether in this medium, LC 
may also revert to an immature state, resulting in its reduced detection and loss 
of ability to stimulate the proliferation of allogeneic T-cells.
The clinical picture is mixed too. Early workers claimed success with 
prolonged survival of cultured allogeneic keratinocyte grafts with no overt 
evidence of rejection (Hefton et al., 1983; Thivolet et al., 1986; Madden et al., 
1986; Gielen et al., 1987). Subsequently overt rejection of cultured allogeneic 
keratinocyte grafts at just over 2 weeks was demonstrated (Aubock et al., 
1988). Studies using DNA fingerprinting to identify donor kératinocytes failed 
after 21 days to detect any donor cells (van der Merwe et al., 1990). Studies 
using sex mismatched donor-recipient groups failed to detect donor cells, 
using in situ DNA hybridisation techniques, after 1 week (Brain et al., 1989; 
Burt et al., 1989). In the Large White pig initial reports were of acute rejection, 
as with Aubock's study only slightly delayed, occurring at 14 days (Carver et 
al., 1991). Subsequent studies have demonstrated survival of porcine 
allogeneic kératinocytes at 14 days with no evidence of rejection, using 
marker genes to identify donor and recipienT-cells. At 21 days, both 
autologous and allogeneic labelled cells were hard to find (Ng et al., 1996b). 
One difference between the two studies may lie in method of keratinocyte 
culture and frequency of passage, which may affect the probability of survival 
and or the phenotype of surviving LC within the culture.
From the above it would appear that the key to delayed rejection of cultured 
allogeneic kératinocytes may lie in the complete elimination of the LC
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population. It has been argued that culture and repeated passage may
eliminate a substantial proportion of LC (see above). Culture of LC with
porcine kératinocytes however, may merely alter LC phenotype with detection
made more difficult, although there is as yet no direct evidence to support this
view. Yet even if LC were greatly reduced in number, they may still
theoretically pose a significant survival threat to the graft. This study has
looked at whether active methods of elimination may be used to increase the
probability that a cultured graft is rendered APC cell free.
Active elimination of LC may be achieved in a variety of ways. Ultraviolet B
radiation and glucocorticoid steroids have been shown to reduce the numbers
of LC detected within cadaver split skin (Alsbjorn, 1983; Alsbjorn and
Sorensen, 1985). More recent evidence suggests that cryopreserved skin
loses its LC population (Abe et al., 1995). Other techniques include the use of
immunomagnetic bead separation (magnetic beads coated with antibody
specific for certain LC determinants) (Nakano, 1998); flow sorting using
electrostatic droplet deflection (Carter, 1996); and by antibody and
complement (antiserum) pre-treatment (Nakano, 1998). In the antibody and
complement pre-treatment method, antibody specific to LCs are added to a
mixed epidermal cell suspension. Following a period of incubation during
which time antibody will bind to specific antigen, complement is added.
Complexing of antibody with antigen induces conformational change in the Fc
portion of the antibody molecule that exposes a binding site for the Clq
molecule within the macromolecular Cl component of the complement
system. Activation of the complement cascade via the classical activation
pathway is achieved following the binding of two such Fc sites by the Clq
molecule. The membrane attack complex formed following complement
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activation results in cells lysis (Kuby, 1997), through disruption of cell 
membrane integrity such that osmotic and chemical equilibrium cannot be 
maintained (Frank, 1991).
Successful transplantation following antiserum pre-treatment to deplete 
passenger lymphocyte populations, without the need for immunosupression, 
has been reported with a variety of tissues including pancreatic isleT-cell 
(Faustman et al., 1981; Faustman et al., 1982a; Faustman et al., 1982c; 
Faustman et al., 1982c; Faustman et al., 1984)., heart (Faustman et al., 
1982b; Sone et al., 1987) and kidney (Brewer et al., 1989a; Brewer et al., 
1989b).
The use of antibody and complement to deplete Large White pig epidermal 
cell populations of LC has not previously been evaluated. The process of 
antibody complement pre-treatment may adversely affect kératinocytes, which 
appear to be sensitive to culture conditions. Criteria to be evaluated therefore 
include the efficacy of this method and its effect on Large White pig 
kératinocytes. Media used for keratinocyte culture (Green et al., 1979; Bevan 
et al., 1997) have been optimised to minimise clonal abortion and promote 
maximal growth and proliferation. Hence there is a need to examine the effect 
of antiserum pre-treatment on size and numbers of colonies produced.
Various techniques are available for detecting the presence of LC. Flow 
cytometry (or fluorescence activated cell sorting, FACS) involves the detection 
of specific antigens using labelled antibodies. It conveniently enables semi 
quantitative (proportional) analysis to be performed.
172
AIMS:
Define an antibody-complement pre-treatment method for eliminating the 
majority of LC from disaggregated Large White pig epidermal cells 
Determine the effect of antibody-complement pre-treatment on colony 
forming efficiency of Large White pig kératinocytes.
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4.2 Results
4.2.1 MHC II expression in freshly trypsinised epidermal cells
The aim of this study was to determine the percentage of LC found in freshly 
trypsinised epidermal cells relative to the remaining epidermal cells.
For this study, cell suspensions were prepared from freshly trypsinised 
epidermal cells from n=4 pigs (see Chapter 2 for method). These were 
labelled in duplicate with either test antibody (MSA3 specific for SLA DR) or 
isotype control (lgG2a) at a concentration of 1/100 (see Chapter 2 for 
method).
The results (see Figure 4.1) indicate there is a mean difference in cell 
labelling of 0.732 between test and control (t-test, P=0.042). Other studies 
contain estimates of LC within the epidermis of between 1 - 4% (Hefton et al., 
1984; Demidem et al., 1986). The observed difference may relate to our 
method of preparing epidermal cell suspensions as well as FACS.
In this study and in all subsequent experiments, peripheral blood lymphocytes 
extracted from peripheral blood (see Chapter 2 for method) labelled in an 
identical fashion to epidermal cells functioned as a positive control (see 
Figures 4.2 and 4.3).
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Figure 4.1: MHC II expression in freshly trypsinised epidermal cells
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Flow cytometry results following labelling of freshly trypsinised epidermal cells 
with either test antibody (MSA3 specific for SL:A DR) or isotype control 
(lgG2a) at a concentration of 1/100. Cells have been gated to exclude debris 
and clumps as well to exclude dim or non fluorescing cells (see Chapter 2 for 
method for method). All test and control cells have been gated identically. 
Four pigs (n=4) were used in this study represented by the blue dots, the 
black dots the mean and the vertical lines the standard deviation. The blue 
lines connect the test and isotype control results for each pig. There is a mean 
difference of 0.732 between test and control (t-test, P=0.042).
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Figure 4.1: MHC II expression in freshly trypsinised epidermal cells (continued)
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Figure 4.2: MHC il expression in porcine peripheral blood lymphocytes
Assessment of SLA DR expression in peripheral blood lymphocytes (PBLs) in 
n=3 pigs. MSA 3 was the antibody used and lgG2a the isotype control. 
Peripheral blood lymphocytes were prepared with density gradient separation 
and then used as positive controls in experiments to assess porcine 
epidermal cell or cultured keratinocyte SLA DR expression. The PBLs from 
the three pigs were used as controls in three separate studies and were not 
therefore processed in parallel. They were however, all processed, gated and 
analysed in exactly the same way.
The mean difference between the groups is 14.7 (P=0.03). The vertical lines 
indicate the standard deviation.
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Figure 4.3: Histogram representation of SLA DR expression in
peripheral blood lymphocytes in the Large White pig
Flow cytometric histograms of MSA3-FITC labelling (b) and lgG2a (a) FITC 
labelling (isotype control) of peripheral blood lymphocytes. One population 
was primarily labelled with the isotype control (lgG2a) and the other with anti- 
SLA DR (MSA3) (lgG2a). Secondary labelling was achieved with FITC 
(sheep anti-mouse IgG). The histogram illustrates a population of 
lymphocytes with 13.7% SLA DR expression. Note the Ml marker delineating 
the population of brighter (higher Geometric mean fluorescence value) SLA 
DR labelled cells.
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4.2.2 MHC II expression in P1 cultured epidermal cells
Previous studies have suggested that the LC population appears to diminish 
with each successive passage such that they are thought not to pose a threat 
with regard to allograft take (Demidem et al., 1986; Hefton et al., 1984; 
Morhenn et al., 1982; Thivolet et al., 1986).
Even very low numbers of LC may however pose a threat to allograft survival. 
The aim of this study was therefore to determine, using FACS, the presence 
of LC in mixed epidermal Large White pig cell culture.
The results show a 0.5% difference between test and control results following 
the first passage (see Figure 4.4). The figures although not statistically 
significant are similar to those seen with non incubated PO epidermal cells 
(see Figure 4.1) which raises the possibility that LC may indeed have survived 
for over a week in culture with kératinocytes. Although repeated passage is 
thought by most to passively eliminate LC (Demidem et al., 1986; Hefton et 
al., 1984; Morhenn et al., 1982; Thivolet et al., 1986) there remains a small 
risk of some surviving (Demidem et al., 1986) to act as passenger 
lymphocytes initiating rejection in subsequent allografting. Additionally poor 
detection rates of LCs might be accounted for through cell phenotype 
alteration in the keratinocyte culture medium with marked downgrading of SLA 
DR expression. Indeed following further passages I failed to detect LCs. This 
may reflect how difficult it is to determine very low percentages given that 
there is a degree of non-specific binding.
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Figure 4.4: SLA DR expression in P1 cultured epidermal cells
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The point plot illustrates flow cytometry results following labelling of epidermal 
cells with test antibody (MSA3 SLA DR-specificity) or isotype control (lgG2a). 
The antibody concentration was 1/100. The cells which had not previously 
undergone antibody complement pre-treatment, had been passaged once 
(PI). Cultures from n=2 pigs (represented by blue dots) were used in this 
study. Cells were processed simultaneously and identically for FACS and 
subsequently analysed in a similar fashion to the freshly trypsinised cell study 
(section 4.1). Mean values are represented by the black dots and the vertical 
lines indicate the standard deviation. The blue lines connect the test and 
isotype control results for each pig. The observed difference between test and 
control was not significant (t-test and Mann-Whitney Rank Sum).
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Figure 4.4: SLA DR expression in P1 cultured epidermal cells (continued)
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As discussed in the introduction, antibody and complement pre-treatment of 
epidermal cells with selective targeting of SLA DR-expressing cells (i.e. LC) 
induces complement mediated lysis of targeted cells. To ensure elimination of 
the LC population, antibody and complement pre-treatment of freshly 
trypsinised epidermal cells was therefore undertaken.
4.2.3 Determination of the effect of antibody complement pre-
treatment on SLA DR expression in freshly trypsinised 
epidermal cells
Freshly trypsinised cells from three pigs were divided into two groups for 
comparison. One group underwent antibody complement pre-treatment (see 
Chapter 2 for method) and the other did not. All groups were then prepared 
for flow cytometry (see Chapter 2 for method).
The results (see Figure 4.5) indicate a difference of 0.72 between the means 
of the two groups. The values for SLA DR expression within the antibody- 
complement pre-treated group approximate zero. These results suggest that 
antibody complement pre-treatment is effective at eliminating LC.
182
Figure 4.5: Determination of SLA DR expression in freshly trypsinised
epidermal cells following antibody complement pre 
treatment
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The point plot illustrates flow cytometry results following labelling of epidermal 
cells with test antibody (MSA3 SLA DR-specificity) or isotype control (lgG2a). 
Following trypsinisation of cells from three pigs they were divided into two 
groups. One group underwent antibody complement pre-treatment and the 
other did not. The group that unden/vent antibody complement pre-treatment 
contained a test limb which was incubated with MSA3 at a concentration of 
1/100 and then incubated with complement and a control limb which had 
isotype control and complement. All groups both were subsequently prepared 
(with test or control antibodies) for flow cytometry without any further 
incubation. Preparation for FACS as well as subsequent gating and analysis 
used the same procedures and parameters as the previous studies.
The difference between the means of the two groups is 0.72.
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Figure 4.5: Determination of SLA DR expression in freshly trypsinised
epidermal cells following antibody complement pre-treatment
(continued)
co%II
■ 0)
oO 
ro o
0  V)Cl  CO
1  "S
C  Xm LU
2 -
1 -
O
8
Non Complement 
Lysed
Complement
Lysed
184
4.2.4 Determination of the effect of Incubation on SLA DR
expression in porcine epidermal cells
Trypsinisation of porcine cells strips off membrane antigens (personal 
communication M Bailey, Division of Molecular and Cellular Biology, 
Department of Clinical Veterinary Science, University of Bristol) and may 
result in cleavage of SLA DR determinants from LC. The cleaved membrane 
determinant may subsequently regenerate following a period of incubation. It 
has additionally been observed that immature LC evolve a more mature 
phenotype after a relatively short period in culture (Witmer-Pack et al., 1988; 
Larsen et al., 1990b; Teunissen et al., 1990) with markedly increased SLA DR 
expression. Bearing these observations in mind, antibody and complement 
pre-treatment might be more effective in eliminating LC following a period of 
incubation in culture than immediately following trypsinisation.
To test this hypothesis, freshly trypsinised cells from three pigs were 
incubated overnight in keratinocyte culture medium (see Chapter 2 for 
method) at 37°C in 10% CO2 , and were prepared for flow cytometry on the 
following morning. These were compared with results obtained previously 
from freshly trypsinised cells from four pigs prepared in the same way except 
that fixing and staining was performed without prior incubation. FACS results 
were similarly gated and analysed (see Chapter 2 for method).
The results (see Figure 4.6 and 4.7) suggest that following a period of 
incubation there is increased SLA DR expression (a mean of 4.1% of gated 
cells in the incubated group compared to 0.73% in the non incubated group, 
P=0.047). In addition, the density of expression is markedly increased (5 fold.
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p =<0.001 ) as demonstrated by the geometric mean fluorescence values (see 
Figure 4.7).
Figure 4.6: Determination of the effect of incubation on SLA DR
expression in porcine epidermal cells
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The point plot illustrates flow cytometry results following labelling of epidermal 
cells with test antibody (MSA3 SLA DR-specificity) or isotype control (lgG2a). 
This study compares epidermal cells that were incubated overnight following 
trypsinisation (n=3) and subsequently fixed and stained to those that were 
fixed and stained immediately following trypsinisation (n=4), in terms of their 
SLA DR expression. Each group of n=3 pigs and n=4 pigs was processed 
separately, although the same procedures and parameters were used in 
preparation for FACS as well as subsequent gating and analysis.
The results suggest that an increased number of cells express SLA DR, a 
mean of 4.1% in the incubated group compared to 0.73% in the non incubated 
group, following a period of incubation (P = 0.047, t-test).
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Figure 4.6: Determination of the effect of incubation on SLA DR 
expression in porcine epidermal cells (continued)
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Figure 4.7: Determination of the effect of incubation on the
brightness of SLA DR expression in porcine epidermal 
cells
The point plot illustrates the same flow cytometry results resulting from the 
study described in Figure 4.6 in terms of geometric mean fluorescence (G 
mean) rather than relative quantification of positive' cells (as in Figure 4.6). 
The geometric mean fluorescence is five times greater in the incubated group 
(t-test, P = <0.001. This suggests that incubation results in an upgrading of 
SLA DR expression. Hence, antibody - complement pre-treatment may be 
more efficient following a period of incubation.
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4.2.5 SLA DR expression following incubation of antibody -
complement pre treated porcine epidermal cells
Incubation following trypsinisation results in the detection of a higher number 
of cells expressing SLA DR antigens (see 4.2.4). It follows therefore that 
antibody complement pre-treatment might be more effective at eliminating LC 
following a period of incubation. This is because antibody may fail to combine 
with (and complement fail to lyse) LC poorly expressing SLA DR (the antigens 
having been cleaved by trypsin).
To test the hypothesis that increased numbers of SLA DR-expressing cells 
may be detected following incubation of antibody-complement treatment of 
freshly trypsinised cells, cells from two pigs were incubated overnight 
following antibody-complement treatment and then prepared for FACS the 
following morning. The results were compared with results previously 
obtained from cells from three pigs similarly treated but which were not 
incubated prior to FACS (see Figure 4.5). Results from both studies were 
similarly gated and analysed (see Chapter 2 for method).
The results (see Figure 4.8 where a difference in mean SLA DR expression 
between the two groups of 2.2%% is apparent (P = 0.037, t-test)) suggest that 
lysis immediately following trypsinisation may not eliminate all the LC. The 
LCs that are not eliminated, if allowed to persist in culture, may act as 
passenger lymphocytes following allografting of keratinocyte sheet allografts, 
and initiate an alloimmune response.
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Figure 4.8: Determination of the effect of incubation following
antibody complement pre-treatment on SLA DR expression in 
porcine epidermal cells
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The point plot illustrates flow cytometry results indicating SLA DR expression, 
following labelling of epidermal cells with test antibody (MSA3, SLA DR- 
specificity) or isotype control (lgG2a). This study compares freshly trypsinised 
epidermal cells from (n=2 pigs) that underwent antibody complement pre­
treatment and were incubated overnight prior to fixing and staining, to those 
(n=3), that were fixed and stained immediately following antibody complement 
pre-treatment (without prior incubation). Each group (of n=2 pigs and n=3 
pigs) was processed separately, although the same procedures and 
parameters were used in preparation for FACS as well as subsequent gating 
and analysis.
The difference between the means of the two groups is 2.2% (P = 0.037, t- 
test) which suggests that incubation may allow Langerhans to reform SLA DR 
antigens following their cleavage by the trypsinisation process.
190
Figure 4.8: Determination of the effect of incubation following antibody complement
pre-treatment on SLA DR expression in porcine epidermal cells 
{continued)
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4.2.6 Comparison of different sources of complement
Low Tox H® rabbit complement (from Cedarlane Laboratories) was used in all 
the experiments described above. This product is designed to have a 
relatively low rate of non-specific lysis of human lymphocytes and it was 
hypothesised that it would be similarly less toxic than other complement types 
to porcine kératinocytes.
In previous experiments involving antibody complement pre-treatment, to 
identify live cells, propidium Iodide was included in preparation for FACS 
(propidium iodide binds to DNA but can only enter dead cells whose cell 
membrane quickly becomes permeable). This had revealed a high proportion 
of dead epidermal cells, often as high as 40-60%.
Additionally, antibody-complement pre-treatment performed immediately 
following trypsinisation (see Section 4.2.5) may not be effective in generating 
lysis of LC whose membrane determinants are poorly expressed.
An experiment was designed to compare 4 different types of complement in 
terms of efficacy as well as to compare the proportion of non-specific cell 
death.
The four different types of complement-tested, included: the afore mentioned 
Low Tox H® rabbit complement (with low human lymphoid toxicity); Low Tox 
M® rabbit complement (designed to be of low toxicity to mouse lymphocytes); 
baby rabbit complement and guinea pig complement.
Following trypsinisation the epidermal cells from one pig were incubated 
overnight. The cells were then treated with isotype control or SLA DR-specific
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antibody and complement on the following morning and immediately 
processed for FACS (with test and control antibody-FITC labelling).
The results suggest (see Figures 4.9 and 4.10) that antibody -  complement 
pre-treatment following overnight incubation on freshly trypsinised epidermal 
cells is effective at eliminating SLA DR-expressing cells. They do not 
however, suggest that any particular type of complement is more effective 
than another.
A consistent finding was that where (as in this experiment) harvested skin had 
been refrigerated for a couple of days prior to processing, the proportion of 
cells expressing SLA DR antigens diminished. This may account for values 
that are lower than previously seen (see Figure 4.6).
With regard to relative toxicity to porcine kératinocytes of the varieties of 
complement the results (see Figure 4.11) suggest that there is no difference 
between the complement types. There is also no significant difference In 
proportion of dead cells between the isotype-specific control antibody (lgG2a) 
or MSA 3 groups. One limb of this experiment involved a sample being placed 
on ice for 90 minutes (as a further control to samples undergoing incubation 
on ice with complement) but did not have antibody or complement added. The 
mean proportion of dead cells within this sample was 13.4% higher (-59%) 
than within those samples that had antibody and complement added (-46%). 
One explanation for this may be the increased number of times the 
‘complement added group’ undergo centrifugation and resuspension, which 
may fragment and eliminate dead cells.
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Figure 4.9: Comparison of complement types (a)
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This graph illustrates a study involving freshly trypsinised epidermal cells from 
one pig in a comparison of complement types. Cells were divided into 6 
groups. 4 of these groups were incubated overnight and then underwent 
antibody complement pre-treatment with one of four sources of complement. 
In each of the four groups cells either received isotype control and 
complement or anti-SLA DR and complement. Following antibody 
complement pre-treatment the cells were stained in duplicate with either 
isotype-FITC or SLA DR-FITC. The remaining two groups consist of cells that 
did not undergo antibody complement pre-treatment and were either 
incubated or not.
The groups, apart from the one that one not incubated and was processed 12- 
18 hours before the other groups, were all processed together. The same 
procedures and parameters were similarly used in preparation for FACS as 
well as subsequent gating and analysis.
The results suggest that antibody -  complement pre-treatment following 
overnight incubation on freshly trypsinised epidermal cells is effective at 
eliminating SLA DR-expressing cells. They do not however, suggest that any 
type of complement is more effective.
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Figure 4.9: Comparison of complement types (a) (continued)
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Figure 4.10: Comparison of complement types (b)
The point plot illustrates the same flow cytometry results resulting from the 
study described in Figure 4.9, in terms of geometric mean fluorescence (G 
mean) rather than relative quantification of ‘positive’ cells (as in Figure 4.9).
As with Figure 4.9 this graph illustrates several points. The first is that 
incubation appears to result in upgrading of SLA DR expression. The second 
is that antibody -  complement pre-treatment following overnight incubation 
on freshly trypsinised epidermal cells is effective at eliminating SLA DR- 
expressing cells. The third is that all four sources of complement appear to 
be effective.
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Figure 4.11: Comparison of complement type with regard to non 
specific cytotoxicity
This graph illustrates a comparison of complement types with regard to cell 
death. In the one pig study described earlier (see Figure 4.9), propidium 
iodide (1/50) was added after the first wash to the cells in the five groups that 
were incubated. Propidium iodide allows identification and quantification of 
dead cells with red fluorescence that can be detected at flow cytometry. All 
samples were prepared in duplicate and a mean taken (hence the vertical 
standard deviation lines). The value for the group that did not undergo 
antibody-complement pre-treatment (red triangle) is a mean of four values 
(isotype-FITC and anti-SLA DR-FITC limbs duplicated).
The results indicate that there is no significant difference in this sample 
between the complement types. There is also no significant difference in 
proportion of dead cells between the isotype-specific control antibody (lgG2a) 
or MSA 3 groups. The cells not subjected to complement appear to 
paradoxically have more dead cells (see text).
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4.2.7 Determination of the effect of antibody complement pre
treatment on colony forming efficiency of porcine 
kératinocytes
The process of antibody complement pre-treatment involves incubation for 90 
minutes on ice with complement. The cells are washed several times prior to 
counting and plating. The resultant keratinocyte 'soup' appears cleaner, 
containing less debris which undoubtedly results from a higher number of cell 
washes than is normally employed. Kératinocytes are however, extremely 
sensitive to handling and culture environment. It is conceivable therefore that 
the manipulation and conditions Involved in the antibody complement pre­
treatment process may have an undesirable effect on keratinocyte colony 
forming efficiency in terms of the numbers and size of colonies formed.
Skin from three pigs was used in this study. Freshly harvested skin was 
trypsinised. The disaggregated epidermal cells were divided into two groups. 
One group underwent treatment with antibody and complement (using Low 
Tox H® rabbit complement) whilst the other had identical treatment except that 
isotype control antibody was substituted for the anti-SLA DR antibody.
Using P3 cells from each group, 1.1X10^ per cm  ^were plated in triplicate onto 
6 well plates (seeded with 2.67X10"  ^ irradiated 3T3 cells per cm^). Medium 
was changed every 2-3 days. After 1 week of culture, the wells were stained 
with rhodamine blue.
The number of colonies were counted manually and confirmed with an 
automated image analyser count (Figures 4.12 -  4.16). In addition the image 
analyser was used to assess the size (area) of colonies (Figures 4.17 -4.23).
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Figure 4.12: Scanned 6 well plates (colony forming efficiency / feeder 
cell study)
The digitally scanned images show examples of the wells (6 well plate) 
containing keratinocyte colonies that were manually counted as well as 
scanned for image analysis following fixation and staining (see Figure 4.14 for 
description of study).
The wells correspond to the following pigs: Pig no. 17 (a) and (b); Pig no. 18 
(c) and (d): Pig no. 20 (e) and (f). Wells (a), (c) and (e) contain antibody- 
complement pre-treated kératinocytes; Wells (b), (d) and (f) contain 
kératinocytes that were not antibody-complement pre-treated.
These images demonstrate the trend for colonies from the non antibody- 
complement pre-treated group to be more numerous, larger and less 
eccentric in shape. r
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Figure 4.13: Cultured keratinocyte colonies (colony forming efficiency
/ feeder cell study)
The photomicrographs (X40) show examples of keratinocyte colonies (pigs 
17-20) that were manually counted as well as scanned for image analysis 
following fixation and staining (see Figure 4.14 for description of study).
The wells (stained with rhodamine blue) correspond to the following pigs: Pig 
no. 17 (a) and (b); Pig no. 18 (c) and (d); Pig no. 20 (e) and (f). Wells (a), (c) 
and (e) contain antibody-complement pre-treated kératinocytes; Wells (b), (d) 
and (f) contain kératinocytes that were not antibody complement pre treated. 
As with Figure 4.12, these images demonstrate the trend for colonies from the 
non antibody-complement pre-treated group to be more numerous, larger and 
less eccentric in shape.
*
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Figure 4.14: Antibody - complement pre-treatment:
colony forming efficiency study - manual count of colony 
numbers
Freshly trypsinised disaggregated epidermal cells from three pigs were 
divided into two groups. One group undenwent treatment with antibody and 
complement (using Low Tox H® rabbit complement) whilst the other did not. 
At the P3 stage, cells from each group, 1.1X10^ per cm  ^ were plated in 
triplicate onto 6 well plates (seeded with 2.67X10"* irradiated 3T3 cells per 
cm^). After 1 week the wells were stained with rhodamine blue. Colonies 
were manually counted (as well as digitally scanned and analysed see Figure 
4.15).
Using the t-test the differences between the means of the absolute values 
(graph (c)) between the ‘antibody complement pre-treatment group’ and the 
‘no antibody complement pre-treatment group’ in each pig were shown to be 
significant (p=0.002 for pigs 17 and 18 and 0.0026 for pig no. 20). The one 
way repeated measures analysis of variance (Tukey test) confirmed that the 
relative increase in numbers of colonies seen in the non complement lysed 
group (from 26% in pig no. 17 to 226% in pig no. 20) is significant (p=0.004). 
One way analysis of variance and Tukey test of the relative values (graphs 
(a) and (c)) confirmed that the differences seen with one way repeated 
measures analysis of variance of the absolute values were significant 
(P=0.008).
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Figure 4.15: Antibody - complement pre-treatment:
colony forming efficiency study - automated count of colony
numbers
Following the experiment delineated in the legend to Figure 4.14 wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
numbers and size of colonies.
One way repeated measures analysis of variance of the absolute values 
(graph (c)), showed that there were significantly (P=<0.001) higher colony 
counts among the non complement lysed group (of between 18% higher in 
pig no. 17 to 176% higher in pig no. 20) than the complement lysed group. 
This was confirmed with the t-test in pigs 17 and 18 (P=0.035 and P=0.02 
respectively).
This was further confirmed by a one way analysis of variance (P=0.038) and 
Tukey test of the relative values (graphs (a) and (b)).
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Figure 4.16: Antibody - complement pre-treatment:
colony forming efficiency study - comparison of automated and 
manual count of colony numbers
The relative values for both manual and automated counts (see Figures 4.15
and 4.16) have been made relative to those for the antibody complement pre-
treatment group and the overall mean calculated pertaining to the method of
colony counting. The error bars refer to standard deviations. The results
indicate no significant differences between the mean relative values
(obtained with both manual and automated methods) of the no antibody
complement pre-treatment group'
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Figure 4.17: Antibody - complement pre-treatment:
colony forming efficiency study (pig no. 17) -  analysis of colony
surface areas (frequency distribution)
Following the experiment described in the legend to Figure 4.14, wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
numbers and size of colonies. The graph illustrates the frequency distribution 
of colony surface areas for keratinocyte colonies from pig number 17 in both 
the antibody-complement pre-treatment and the non pre-treatment groups.
9 bins were created with the value of each bin rising incrementally from 100 to 
3000 surface area units. The surface areas for each feeder cell group with 
values corresponding to particular bins were assigned to the corresponding 
bins. The total number of surface area values within each bin were plotted 
against the bin designated value to give a frequency distribution histogram. 
The histogram illustrates the general trend of significantly greater (t-test 
P=0.021) mean colony areas with the no antibody-complement pre-treatment 
groups than with antibody-complement pre-treatment group.
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Figure 4.18 : Antibody - complement pre-treatment:
colony forming efficiency study (pig no. 17) -  analysis of colony
surface areas
Following the experiment described in the legend to Figure 4.14, wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
numbers and size of colonies. The graph illustrates the distribution of colony 
surface areas from pig number 17 for the largest 100 colonies from each of 
the antibody-complement pre-treatment and the non pre-treatment groups. 
The smaller colonies have been eliminated from this graph in order to focus 
attention on the pattern of distribution of the larger colonies. The trend is 
suggestive (t-test, P=<0.001) of consistently more colonies with a larger 
surface area in the non pre-treatment group, which follows the general trend 
(see Figures 4.20 and 4.22).
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Figure 4.19: Antibody - complement pre-treatment:
colony forming efficiency study (pig no. 18) -  analysis of colony
surface areas (frequency distribution)
Following the experiment described in the legend to Figure 4.14, wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
numbers and size of colonies. The graph illustrates the frequency distribution 
of colony surface areas for keratinocyte colonies from pig number 18 in both 
the antibody-complement pre-treatment and the non pre-treatment groups.
11 bins were created with the value of each bin rising incrementally from 100 
to 3300 surface area units. The surface areas for each feeder cell group with 
values corresponding to particular bins were assigned to the corresponding 
bins. The total number of surface area values within each bin were plotted 
against the bin designated value to give a frequency distribution histogram. 
The histogram illustrates the general trend of higher (t-test P=<0.001) mean 
colony areas with the non pre-treatment groups than with antibody- 
complement pre-treatment group.
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Figure 4.20: Antibody - complement pre-treatment:
colony forming efficiency study (pig no. 18) -  analysis of colony
surface areas
Following the experiment described in the legend to Figure 4.14, wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
numbers and size of colonies. The graph illustrates the distribution of colony 
surface areas from pig number 18 for the largest 100 colonies from each of 
the antibody-complement pre-treatment and the non pre-treatment groups. 
The smaller colonies have been eliminated from this graph in order to focus 
attention on the pattern of distribution of the larger colonies.
The trend is suggestive (t-test, P=<0.001) of consistently more colonies with a 
larger surface area in the no antibody-complement pre-treatment group, which 
follows the general trend (see Figures 4.18 and 4.22).
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Figure 4.21: Antibody - complement pre-treatment:
colony forming efficiency study (pig no. 20) -  analysis of colony
surface areas (frequency distribution)
Following the experiment described in the legend to Figure 4.14, wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
numbers and size of colonies. The graph illustrates the frequency distribution 
of colony surface areas for keratinocyte colonies from pig number 20 in both 
the antibody-complement pre-treatment and the non pre-treatment groups.
11 bins were created with the value of each bin rising incrementally from 50 to 
550 surface area units. The surface areas for each feeder cell group with 
values corresponding to particular bins were assigned to the corresponding 
bins. The total number of surface area values within each bin were plotted 
against the bin designated value to give a frequency distribution histogram. 
The histogram is suggestive of the general trend of significantly greater mean 
colony areas with the nom pre-treatment groups than with antibody - 
complement pre-treatment group (see Figures 4.17 and 4.19).
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Figure 4.22: Antibody - complement pre-treatment:
colony forming efficiency study (pig no. 20) -  analysis of colony
surface areas
Following the experiment described in the legend to Figure 4.14, wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
numbers and size of colonies. The graph illustrates the distribution of colony 
surface areas from pig number 20 for all the colonies from the antibody- 
complement pre-treatment group and the largest 60 colonies from the non 
pre-treatment group. The smaller colonies are eliminated from this graph in 
order to focus attention on the pattern of distribution of the larger colonies.
As seen with pig numbers 17 and 18 (Figures 4.18 and 4.20) the trend is 
suggestive of consistently more colonies with a larger surface area in the non 
pre-treatment group.
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Figure 4.23: Antibody - complement pre-treatment:
colony forming efficiency study: comparison of mean surface
area values
This histogram compares mean values of colony surface areas (pig numbers 
17-20, experiment described in the legend to Figure 4.14). The wells were 
scanned and digitally analysed with Image Pro Plus® software with respect to 
size of colonies.
Using a one way analysis of variance where P is shown to = <0.001, the 
Tukey test confirms significant differences between the area means of the 
pre-treatment and non pre-treatment groups in pigs 17 and 18 (31% and 99% 
higher in the non pre-treatment groups in pigs 17 and 18 respectively). This is 
confirmed by individual t-tests (P=0.021 for pig no. 17 and P=<0.001 for pig 
no. 18).
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4.2.7.1 Quantitative analysis of colony forming efficiency
Manual Count: The results were analysed (Figure 4.14) using a t-test looking 
aT-cells from each pig separately and using a one way repeated measures 
analysis of variance. The t-test demonstrated significant (P =0.002 for pigs 17 
and 18 and 0.0026 for pig no. 20) differences between the means of the 
absolute values between the ‘antibody complement pre-treatment group' and 
the ‘no antibody complement pre-treatment group’ in each. The one way 
repeated measures analysis of variance (Tukey test) confirm the t-test results 
that the increase in numbers of colonies seen in the non complement lysed 
group (from 26% in pig no. 17 to 226% in pig no. 20) is significant (P=0.004). 
This was also confirmed by a one way analysis of variance (P=0.008) and 
Tukey test of the relative values.
Automated Count: Following scanning of the wells (Figure 4.12), they were 
digitally analysed with Image Pro Plus® software with respect to numbers and 
size of colonies.
Results suggest (Figure 4.15) significant differences between the means of 
the two groups (absolute values) for two out of the three pigs (t-test, P=0.035 
and P=0.02). One way repeated measures analysis of variance looking at all 
three pigs demonstrated a significantly (P=<0.001) increased numbers of 
colonies in the non complement lysed group (of between 18% in pig no. 17 to 
176% in pig no. 20). This was also confirmed by a one way analysis of 
variance (P=0.038) and Tukey test of the relative values.
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As with a different study (comparing feeder cell types see 3.3.1.1) the colony 
counts observed manually were higher than those observed by the image 
analyser (Figures 4.14 - 4.15). These differences may be explained in that 
with the naked eye it is possible to differentiate between genuinely large 
colonies and those that appear to the image analyser to be single and large 
but are in fact several small confluent colonies. Attempting to manipulate the 
image analyser to obtain a higher level of discrimination was extremely 
difficult giving rise to inconsistent results and was therefore abandoned. 
Random wells were double checked to further ensure consistency. In spite of 
the apparent differences in absolute values between the two methods of 
counting, there are no significant differences in the relative values between 
the groups (Figure 4.16).
The results of counting the colonies suggest strongly that kératinocytes that 
have undergone treatment with antibody and complement have an inferior 
colony forming ability as result.
4.2.7.2 Analysis of colony size
Following scanning of the wells (Figure 4.12), they were digitally analysed 
with Image Pro Plus® software with respect to numbers and size of colonies. 
For both pigs nos. 17 and 18 there are significantly greater mean values of 
colony areas, as measured by the image analyser, of the no antibody- 
complement pre-treatment groups (31% and 99% respectively greater than 
the antibody-complement pre-treatment groups). This is confirmed using the 
t-test (P=0.021 for pig no. 17 and P=<0.001 for pig no. 18) and the one way
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analysis of variance between the groups (P=<0.001, Tukey test) (Figures 4.17 
- 4.20 and Figure 4.23).
The control and treatment groups were treated identically except that the anti- 
SLA DR monoclonal antibody was replaced by an isotype control. This would 
suggest that antibody-complement pre-treatment negatively impacts the 
colony forming efficiency of kératinocytes in culture both in terms of numbers 
of colonies and size of colonies formed.
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4.3 Discussion
The use of antibody-complement pre-treatment to eliminate passenger 
lymphocytes is not new (Faustman et al., 1981; Faustman et al., 1984; Sone 
et al., 1987; Brewer et al., 1989a). Its use however with regard to cultured 
epithelial allografts has not previously been reported.
The above series of experiments demonstrate that antibody-complement pre­
treatment is efficacious with regard to epidermal cell suspensions. They 
demonstrate the need for incubation in order to maximise LC upregulation of 
MHC II membrane determinant expression. Complement from a variety of 
animal sources were tested and found to be equally efficacious. Equally, there 
was no apparent difference between complement types in terms of non­
specific cell death.
The effect of antibody-complement pre-treatment on the ability to form and 
expand colonies does however appear to be detrimental. Both the number 
and the type of colony formed in terms of size and shape were affected. This 
would suggest that keratinocyte clonogenic potential (Barrandon and Green,
1987) is affected by pre-treatment. The kératinocytes tested were P3 
(passaged 3 times) following complement exposure. One explanation might 
be that the antibody-complement pre-treatment process prematurely ages the 
kératinocytes. This may be related to damage caused by released C5b67 
complexes formed following complement activation which can bind to 
“innocent bystander" kératinocytes (Kuby, 1997). This may have implications 
for grafting in that the pre-treated grafts might survive for a significantly 
shorter period. Premature ageing of the kératinocytes would defeat the
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purpose of antibody-complement pre-treatment which is to prolong survival 
following grafting by eliminating the APCs.
Some earlier studies have demonstrated the capacity for significant 
Langerhans survival in human epidermal cell culture (Demidem et al., 1986). 
Future work might focus on whether or not LC have the capacity to survive 
under the particular keratinocyte culture protocols relevant to the porcine 
model in the present study. If they do survive, it will be important to determine 
any alterations in LC phenotype (Teunissen et al., 1990; Witmer-Pack et al.,
1988) and whether these are reversible. It remains unclear as to the 
mechanism by which the anti-SLA DR antibody and complement affects 
kératinocytes. It would therefore be of interest to isolate the particular element 
within the process of antibody-complement pre-treatment that may be 
detrimental to keratinocyte population expansion and clonal growth.
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Chapter 5
Immunophenotyping skin in the Large White pig
216
5.1 Introduction
It is generally well accepted that acute rejection of allogeneic skin grafts 
occurs following ‘direct’ sensitisation, that is by donor dendritic cells, centrally 
in a regional draining lymph node, and involves an allogen directed response 
(Schuurman, 1994; Rosenberg and Singer, 1992). Besides allospecific 
cytotoxic T-cells, a highly destructive non-specific inflammatory infiltrate is 
also thought to be involved (Doody et al., 1994) consistent with the effect of 
inflammatory cytokines released by activated T-cells (Rosenberg and Singer, 
1992).
Cultured allogeneic keratinocyte grafts are thought to be devoid of LC 
(Morhenn et al., 1982; Hefton et al., 1984; Demidem et al., 1986; Thivolet et 
al., 1986). Some researchers felt that rejection therefore probably did not 
occur (Hefton et al., 1986; Thivolet et al., 1986; Madden et al., 1986; Gielen 
et al., 1987). Subsequently overt rejection was demonstrated in humans 
(Aubock et al., 1988) and pigs (Carver et al., 1991c), and others 
demonstrated early loss of donor DNA from recipient tissue (Burt et al., 1989; 
Brain et al., 1989).
These apparently conflicting reports are consistent with variable graft bed and 
culture conditions and the difficulty of differentiating between an 
immunologically mediated event and keratinocyte death due to natural 
differentiation pathways with failure of donor stem cells to function effectively. 
In the absence of donor dendritic cells, infiltration of the graft bed by host 
APCs may initiate rejection. These may then present antigen either to locally 
infiltrating memory T-cells (peripheral sensitisation) or more likely migrate to 
regional draining nodes to present there (central sensitisation) (Mason and
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Morris, 1986). In either case the evidence from CD4 and CD8 T-cell depleted 
models suggests that cytotoxic CD8-positive cytotoxic T-cells are the principle 
effector cells generated (Rosenberg and Singer, 1992). Where foreign MHC 
class II determinants are present a highly destructive massive inflammatory 
infiltrate is generated (Doody et al., 1994; Rosenberg and Singer, 1992). 
Where they are not, the cytotoxic T-cell response may be delayed and 
attenuated (Rosenberg and Singer, 1992). The cytokines released by 
infiltrating activated T-cells giving rise to the inflammatory response may thus 
also be reduced. This may result in prolonged graft survival. Residual host 
epidermal remnants within a dermal graft bed may thus very gradually 
replace graft elements.
To help understand the events associated with rejection of cultured 
keratinocyte allografts it may be useful to immunophenotype or examine the 
phenotype of infiltrating cells at meaningful time points.
There are many different ways of identifying infiltrating cell types. These 
include light and electron microscopic morphological examination, cytokine 
profiling, functional studies including observations of cell-cell interactions and 
stimulus response studies and examination of cell membrane molecules. This 
last method has been used extensively in recent decades to classify 
leucocytes according to their surface molecule expression. An understanding 
of the function of these surface molecules helps elucidate the function of cells 
that express them.
Early work on immunophenotyping included cytotoxicity assays that helped 
delineate T from B cells and discover T-cell subsets (Kisielow et al., 1975; 
Barclay et al., 1997; Shiku et al., 1975). Further advances were made with
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affinity purification of F(ab’ )2 antibody fragments which allowed saturate 
binding and the development of flow cytometry (Bonner et al., 1972) and 
Western or immunoblotting (Barclay et al., 1997; Shiku et al., 1975). These 
enabled binding serology to replace cytotoxicity assays to facilitate a 
quantitative and biochemical approach to the cell membrane.
A major remaining problem was how to produce specific antibodies against a 
single cell surface molecule. Immunisation across a species barrier tended to 
produce antibodies active against the variety of xenogeneic cell surface 
molecules. This problem was resolved in 1975 with the development of the 
hybridoma method which enabled production of monoclonal antibodies with 
predefined specificity (Kohler and Milstein, 1975; Shiku et al., 1975). Use of 
the hybridoma method quickly expanded to Include analysis of xenogeneic 
cell surfaces using monoclonal antibodies. Flow cytometric studies on human 
antigens formed the basis for grouping antigens in “Clusters of Differentiation” 
or CD antigens (Shiku et al., 1975). Monoclonal antibodies (moAB) resulting 
from different hybridoma cell lines were considered to label the same CD 
antigen if they produced the same pattern of staining on differenT-cell types 
(Barclay et al., 1997). Workshops were co-ordinated to standardise and 
formalise the testing and naming of moABs against CD determinants on 
human leucocytes.
Monoclonal antibodies reactive with porcine leucocytes were first reported in 
1984 (Pescovitz et al., 1984; Jonjic and Koszinowski, 1984). The First 
International Swine CD Workshop took place between 1989 and 1992 with 
proceedings published in 1994 (Lunney et al., 1994b). Although pigs had 
served as allotransplantation models with regard to a variety of organs
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(Kenmochi et al., 1994) including skin (Carver et al., 1991), the search for 
moABs was boosted by renewed interest in the pig as a potential xenograft 
donor (Sachs, 1994). The need for porcine-specific reagents is exemplified by 
the relative paucity of species cross reactivity between human and pig (Sopp 
et al., 1998). Two further International Swine CD Workshops have been 
organised and proceedings published (Saalmuller et al., 1998b; Haverson et 
al., 2001). We now have reagents to 27 porcine homologues of human CDs 
and to 9 swine-specific clusters, as well as to other cell surface molecules 
such as MHC determinants and surface immunoglobulin. As agreed at the 
Second International Swine CD Workshop; ''swine CD numbers are given to 
clusters of moAb to swine orthoiogues of human CD molecules when 
homology is proven by (1) suitable tissue distribution and lymphoid cell 
subset expression, (2) appropriate molecular mass of the antigen recognized 
by the moAbs, and (3) reactivity of moAbs with the cloned swine gene 
products, or cross- reactivity of the moAb on the human gene products. In 
some cases, this reactivity would not be fully proven, mainly due to the lack of 
cloned gene products; for these CD antigens, the respective clusters will be 
assigned by the prefix W' which will lead to 'wCD' antigens" (Saalmuller et al., 
1998b).
The two principle means of immunophenotyping a graft bed infiltrate are flow 
cytometry or immunohistochemistry. Advantages of flow cytometry include 
sensitivity and reliability of the technique (all available swine moABs have 
been tested with this technique) as well as the relative lack of background 
staining. One disadvantage is the lack of spatial visualisation of cellular 
relationships.
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Immunohistochemistry on the other hand allows differential examination of 
cells within a 2-dimensional (or 3-dimensional with con-focal microscopy) 
context. A disadvantage is that not all the moABs that work well with fresh 
flow cytometric preparations, work with fixed cryostat preparations. The 
available panel of monoclonal antibodies available for immunohistochemistry 
is therefore smaller than that for FACS.
One of the eventual goals of this study was to examine the wound infiltrate 
beneath LC depleted cultured allogeneic grafts at various time points 
immunohistochemically, employing a panel of porcine-specific moABs in 
order to understand the immunological events involved in their rejection. 
Immunohistochemistry might thus allow quantification of infiltrating leucocyte 
subtypes as well as representation of spatial interrelationships between 
leucocyte subtypes in allografted skin wounds. Before this however, it was 
important for two principle reasons to determine the immunohistochemical 
activity of each antibody in the present population of animals.
The first is that all the available antibodies were shown to be effective with 
flow cytometry, but only a proportion have been demonstrated to be effective 
Immunohistochemically. Indeed, antibodies from several sources were tested 
to determine an effective monoclonal antibody for certain of the antigen- 
specificities (CD2, CD3 and CD4).
The second reason concerns swine heterogeneity. Although these moABs 
were determined to be effective in swine it was felt important to ensure, 
particularly as they are so newly established, that they label effectively in the 
Large White pig population employed in the present study.
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Porcine jejunum was used as a positive control since this has a well 
characterised lymphoid population (Haverson et al., 2000) (Vega-Lopez et al., 
1993; Stokes et al., 1996). Additionally, peripheral porcine blood leucocytes 
were used as a positive control.
Following confirmation that staining with the panel of moABs conforms to the 
established pattern, it was important to characterise the baseline leucocyte 
population in normal porcine skin so as provide a basis for comparison with 
regard to later analyses of grafted wounds.
The aims of this study were therefore:
• To confirm the immunohistochemical activity of each antibody, using 
porcine jejunum and PBLs in the population of animals used in this 
research program.
• To type the baseline leucocyte population within porcine skin.
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5.2 Results
Jejunum, a positive control for many of the determinants tested (Vega-Lopez 
et al., 1993); (Haverson et al., 1997; Haverson et al., 2000) was harvested 
from a female Large White pig aged 11 weeks following the termination of an 
experiment (see Chapter 2 for method).
Blood was harvested from female Large White pigs aged 12-13 weeks and 
weighing approximately 65Kg at termination. Peripheral blood mononuclear 
leucocytes were extracted from the blood kept in citrated phosphate dextrose 
at room temperature for up to 48 hours.
Whole skin was obtained from two female Large White pigs aged 12-13 
weeks and weighing approximately 65Kg (see materials and methods). 
Following primary labelling with each of the sixteen monoclonal antibodies 
(table 5.1) the jejunal and skin sections were then secondarily stained using 
the immunoperoxidase avidin biotin complex (ABC) method (with or without 
Xgal). Sections stained with moABs specific for CD4 and IgXLC were 
however secondarily stained using immunofluorescent techniques (see 
Chapter 2 for method). Skin sections were always stained in conjunction with 
jejunal sections (positive controls) as well as with skin section negative 
controls. All peripheral blood mononuclear leucocyte samples were stained 
secondarily using FITC and counterstained with propidium iodide (see 
Chapter 2 for method). Table 5.2 gives the expected cellular distribution as 
well as function of the CD antigens (which may be detected using the 
monoclonal antibodies in Table 5.1).
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Table 5.1 : This table indicates the cell lines and their source for the
“panel” of monoclonal antibodies tested
moAB CELL LINE SOURCE
GDI 76-7-4 VMRD
CD2 MSA4 Dr. J.K. Lunney, Beltsville, USA
CD3 FY1H2 Dr. H. Yang, Pirbright, UK
CD4 STH293 Dr. M. Shimizu, Ibaraki, Japan
CDS PG114A VMRD
006 PG90A VMRD
CDS PT81B VMRD
IgXLC K139.3E1 Serotec
CD25 K231.3B2 Serotec
CD45 K252.1E4 Serotec
SWC3 74-22-15 VMRD
SWC6 MAG320 Serotec
SLA DP H42A VMRD
SLA DQ TH81A5 VMRD
SLA DR TH14B VMRD
SLADR MSA3 VMRD
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Table 5.2: This table summarises the expected
function of those membrane determinants tested 
monoclonal antibodies indicated in Table 5.1.
cellular distribution and 
for with the “panel” of
Membrane
Determinant
Cellular Distribution Function
GDI Dendritic cells, activated monocytes, 
some B cells, LG
Domain organisation similar 
to that of MHO Class 1 may 
serve to present lipids and 
peptides to T-cells
CD2 Pan a/pT-cell, NK cells, subset of y/ô 
Tcells, (B cells)
Enhances T-cell Antigen 
recognition
CD3 a/p and y/ô T-cells Part of TCP complex (Ag 
recognition leads to signal 
transduction and ultimately T- 
cell activation)
CDS CD5- population: all the NK activity 
CDS"^ '"" cells: y/ô cells and the a/p CD4- 
8^^ population 
CDsbright population: contain the rest
Postulated role in T-cell 
signal transduction 
(stimulatory effects of 
moABs)
CDS a/pT-cell subsets (all CD4+ cells and the 
CDS'" cells)
Postulated role in T-cell 
signal transduction
CD4 Subsets of a/pT-cells Involved in the recognition by 
T-cells of foreign antigen 
associated with MHC class II 
antigens
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Membrane
Determinant
Cellular Distribution Function
CDS high expression: a/p T-cells with the T
suppressor phenotype
low expression: up to 60% of peripheral
CD4+T-cells (helper T-cells with memory
to viral antigens);
subset of y/ô T and NK cells
co-receptor with MHC class 1 
restricted TCRs in antigen 
recognition
CD45 All cells of haemopoeitic origin except red 
blood cells
T-cell receptor signalling, 
may effect activation 
threshold
CD25 Activated cells including T-cells, B cells 
NK cells and monocytes
component of the IL-2 
receptor expressed on a 
variety of activated cells
SWC3 High expression: monocytes, 
macrophages and granulocytes 
Low expression: dendritic cells
signal regulatory protein 
receptor associated with 
SHP-1
SWC6 Null cell: CD2‘ surface Ig" y/ô T-cell Not yet known
SLA DR
(MSA3)
SLA DR
(TH14B)
dendritic cells, B cells, monocytes, 
macrophages, activated T-cells and 
endothelium
Present exogenously derived 
antigen to CD4+ T 
lymphocytes
SLA DQ
SLA DP
(equivalent)
similar to SLA DR
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Each of the antibodies in Table 5.1 was tested using porcine jejunum and 
peripheral blood mononuclear leucocytes. Negative controls were always 
carried out (not shown).
5.2.1 Immunohistochemical confirmation of monoclonal
antibodies using porcine jejunum and peripheral blood 
mononuclear leucocytes
The results of these tests are detailed below for each antibody.
Panleucocyte (Anti-CD45)
Almost all the PBLs stained positive with the monoclonal antibody (clone 
K252 1E4, Serotec Ltd, Oxford, UK; (Zuckermann et al., 1998)), (see Figure 
5.1(a)).
There was ubiquitous positive staining of cells within all compartments of 
jejunal villi, (see Figures 5.2 and Figure 5.3(a)).
SWC3
SWC3 is an epitope conserved on cells of myeloid extraction including 
macrophages and granulocytes, SWC3 has recently been identified as a 
signal regulatory protein receptor associated with SHP-1 (Alvarez et al., 
2000). The staining pattern of the monoclonal antibody 74-22-15 in PBL 
appears to be consistent with a study carried out by the source laboratory for 
the monoclonal antibody in which it was found to stain 12-27% of PBL 
(Pescovitz et a I., 1984).
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Within porcine jejunal villi SWC3-positive cells were found principally in the 
subepithelial region of the lamina propria (see Figure 5.3(a)). Other 
researchers have reported SWC3+ cells in crypts and to a lesser extent in the 
villous core (Vega-Lopez et al., 1993). Flow cytometric studies have shown 
that eosinophils, macrophages and dendritic cells express this marker and 
are found in this site (Haverson et al., 1994).
T-cells
Staining of PBL for the pan T-cell antigens CD2, CD3, CD5 and CD6 was 
variable and may reflect their differential distribution (Pauly et al., 1996; 
Saalmüller and Bryant, 1994; Saalmuller et al., 1994; Yang and Parkhouse, 
1996) (Figure 5.1(a) and Figure 5.5).
A differential staining pattern of porcine jejunal villi was also seen. Both CD5 
and CD2 were seen to strongly stain cells both within the intraepithélial 
compartment and lamina propria (core). CD6 and CD3-posltive cells were 
mainly in the intraepithélial compartment (Figures 5.3(b) and 5.3(c)).
Staining of the PBL with antibodies specific for CD 4 and CDS revealed low 
proportions of CD4 and CD8-positive cells of varying staining intensity (Figure 
5.1(b)) consistent with previously published reports (Yang and Parkhouse, 
1996).
The pattern of staining within porcine jejunum proved similar to that reported 
by others (Vega-Lopez et al., 1993). CD8-positive cells were concentrated 
around the basement membrane associated with the intraepithélial 
compartment. CD4-positive cells were located mainly within the core of the 
lamina propria (Figure 5.3(c)). This was confirmed by double and triple
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staining studies (see Figure 5.4) in which CD8-positive cells were mainly 
intraepithélial with CD45-positive but CD8-negative cells mainly within the 
lamina propria, with some more apically placed within the intraepithélial 
compartment.
CD1
Staining of PBL with anti-CDI revealed low numbers of low intensity staining 
cells (Figure 5.1(b)). Within the specimens of porcine jejunum examined, cells 
expressing the GDI antigen were found to be sparsely dispersed throughout 
the lamina propria core and additionally were seen around the crypts (Figure 
5.3d).
Immunoglobulin (Ig) Light Chain
Although a variety of recent studies have revealed proportions of B cells 
within PBL of between 8.4% (Boeker et al., 1999) and 17.3-21.3% (Denham 
et al., 1994), staining of PBL with the antibody derived from K189.3E1, 
revealed few positively staining cells (Figure 5.1(b)). Recent reports, not 
available at the time of this study, have found that this antibody is specific for 
only a subset of Ig lambda chains (Sinkora et al., 2001). In porcine jejunum 
plasma cells are located mainly in the crypts (Lackovic et al., 1999) (Figure 
5.3(d)) (Bianchi and van der Heijden PJ, 1994).
SWC6
SWC6 is a marker specific for porcine yô T-cells, originally termed 'null cells' 
(Davis et al., 1998). Very few of the PBL stained positively for the SWC6
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determinant (Figure 5.1(b)). Other workers however, have reported a 
population of 16.2 +/- 9.9 % (Boeker et al., 1999) and 30-65% (Binns et al., 
1992; Binns et al., 1994) SWC6-positive cells within peripheral blood 
lymphocytes in young pigs (Binns, 1994).
In porcine jejunum there are few identifiable null cells (Figure 5.3(d)) which 
accords with the findings of others concerning non circulating SWC6+ cell 
numbers (Boeker et al., 1999; Binns et al., 1994).
CD25
Within PBL only a small proportion of cells stained positively (Figure 5.1(c)). 
Published data reveals 5-7% of circulating B cells to be positive (Denham et 
al., 1994) Within porcine jejunum, CD25-posltive cells were evenly distributed 
within the lamina propria (Figure 5.3(f)) and this is consistent with reported 
studies (Vega-Lopez et al., 1993).
MHC class II
Staining of PBL with antibodies reactive to different SLA class II determinants 
revealed an apparently (not formally counted) higher proportion of PBL 
staining positive for the SLA DR than the other two determinants (Figure 
5.1(c)). This is consistent with the findings of others (Lunney, 1994).
Within porcine jejunum MHC class II (SLA DP, DR, DQ see Figure 5.3(e)) 
expression was found almost exclusively within the lamina propria. It is 
apparently expressed mainly on endothelium and on cells situated between 
the capillary network and the core of the lamina propria, identified as
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functional dendritic cells (Haverson et al., 2000). There is also low level 
expression on CD2^ cells in this site (Wilson et al., 1996).
Figure 5.1: Immunolabelling Peripheral Blood Mononuclear Cells
Peripheral blood mononuclear cells were obtained from fresh whole (Large 
White pig) blood using density gradient separation medium (see Chapter 2 for 
method). Cells were then immunolabelled (as described in Chapter 2) using 
the panel of monoclonal antibodies (see Table 5.1).
Figures (a) -  (c) contain photomicrographs (all at X400 except for those of 
mononuclear cells stained for CD45, SWC3 and SLA DR (MSA3) which are 
shown at both X200 and X400) of immunolabelled mononuclear cells taken 
on the day of staining.
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Figure 5.2: Photomicrograph (X40) of an H&E cryostat section of porcine
jejunal villus. The adjacent cartoon diagram illustrates the different 
compartments.
Capillaries lie immediately beneath the enterocytes (epithelium) with small 
lymphatics draining into lacteals situated closer to the core of the lamina 
propria. Studies have demonstrated MHC II negative CD2+CD8+ cells lying 
mainly in the intraepithélial compartment (below the enterocytes adjacent to 
the basement membrane) with MHC II positive CD2+CD4+ cells lying mainly 
within the core of the lamina propria (Vega-Lopez et al., 1993). MHC II 
positive capillary endothelium is present in the sub epithelial lamina propria 
(Wilson et al., 1996).
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Figure 5.3: Immunolabelling Porcine Jejunum
The jejunum was obtained from a single Large White pig approximately 11 
weeks old and prepared as described in Chapter 2. Frozen sections were 
immunolabelled (as described in Chapter 2) using the panel of monoclonal 
antibodies (see Table 5.1).
Figures (a) -  (g) contain photomicrographs (magnification as labelled) of the 
immunolabelled porcine jejunal villi (and jejunal crypts with regard to 
immunoglobulin light chain staining).
236
5. 3 (a)
v< /> /
JiL
%
t ^ 4 4
SWC 3
X400
237
&% h
:-■' •»- cA -'> '-
^  Û . r t
. A g a ,f  j » r  r s . : * g K >  #
CDS
^ '^ "•*^> ■ > *2 0 0 X400
238
5.3 (c)
m
X200' X400CD6CD6
CD 4X 200CD 4 X 400
a  • „
■ * ' î
239
5.3 (d)
X400CD1CD1 X200
X400X200
'
SWC6 X200
* *
SWC6 X400
240
5.3 (e)
t •
-
. > .
SLADP X100 SLADP . VX400
X200SLADQ
X400SLADQ
SLADfÇ, SLADR
(TH14B)
Û
%
V . m
à
S  My /  P ■ '-ÿ j ,? ^ L A D ft- X400 'Ï V  /  •
\ êJÛ. ‘it ', '. . ;*? x < o d " '1
241
5.3(f)
t
CD25 X200
X400CD25
X200control control X400
242
Figure 5.4: Photomicrographs (X400) of dual ((a)-(f)) and triple (g)-(i)
labelled porcine jejunum.
Double staining (c) and (f) was achieved with CD45-FITC (b) and SLA DR- 
Phycoerythrin (a), and CD45-Texas Red (d) and CD 8-FITC (e). Double 
stained cells (arrows) are yellow-orange ((c) and (f)) and indicate dual CD45 
SLA DR (c) or dual CD45 and CD8 expression (f).
Triple staining ((g)-(i)) is shown with GD8-F1TC (g), SLA DR-Phycoerythrin (h) 
and CD45-AMCA (not shown). Cells show either dual CD45 and SLA DR 
expression (purple) or dual CD45 and CD8 expression (turquoise) or single 
SLA DR expression (red) or single CD45 expression (blue -  not easily seen). 
This confirms earlier findings with SLADR-positive cells confined to the 
lamina propria, CD8-positive cells mainly intraepithélial and CD45 cells found 
in all compartments. Intraepithélial leucocytes (CD 45 expressing) that do not 
express CD8 (green) are seen in images (f) and (I) (arrow) and these tend to 
be more apically positioned than the intraepithélial CD8-positive cells.
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Figure 5.5: Diagrammatic representation of distribution of CD2, CD3, CD4,
CD5, CD6 and CD8 antigen expression in porcine peripheral 
blood lymphocytes.
All the a/p T-cells express CD2 as well as a subset of the y/0 T-cell population 
and in addition non-T-non-B lymphocytes with CD2+3-4-8lo surface 
immunoglobulin-negative phenotype containing natural killer (NK) activity 
(Pescovitz et al., 1988; Saalmüller and Bryant, 1994; Saalmuller et al., 1994; 
Saalmuller et al., 1994a; Saalmuller et al., 1994b; Pescovitz et al., 1988).
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In summary all the monoclonal antibodies in “the panel” were shown to label 
a proportion of peripheral blood mononuclear leucocytes. Table 5.3 contains 
a summary of the results following labelling and staining of porcine jejunal 
villi. With minor exceptions these reagents gave results from immunostaining 
that were comparable to those reported by other investigators (see above).
Table 5.3: This table summarises the distribution of membrane
determinants within porcine jejunal villi tested for with the “panel” of 
monoclonal antibodies indicated in Table 5.1.
Membrane Determinant Porcine Jejunal Distribution
CD45 within lamina propria and epithelium
SWC3 Lamina propria only
CD2 Both within Lamina propria and 
Intraepithélial compartments;
CDS predominantly in Intraepithélial 
compartments, low intensity in LP
CDS Similar distribution to CD2
CDS mostly intraepithélial
CD4 Lamina propria almost exclusively
CDS Mostly adjacent to/lntra epithelial
CD1 Dispersed in Lamina propria
SWC6 Sparse Distribution
SLA DR (MSA3)
Lamina propria only 
SLADR>DQ>DP equivalents
SLA DQ
SLA DR (TH14B)
SLA DP equivalent
CD25 Lamina propria
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5.2.2 Immunophenotyping skin in the Large White pig
Each of the antibodies checked through PBL and jejunal staining were in turn 
used to examine normal skin from 2 pigs.
Table 5.4 contains a summary of the distribution of cells expressing the 
antigens described in Table 5.2, following labelling and staining of normal 
Large White pig skin. The histogram in Figure 5.7 illustrates the relative 
density of leucocytes following manual counts, with staining patterns 
illustrated in Figure 5.6.
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Table 5.4: This table summarises the distribution of membrane
determinants within porcine skin tested for with the “panel” of monoclonal 
antibodies indicated in Table 5.1, as well as the number of pigs, sections and 
random fields looked at for each antibody. All were counts were at X200 
magnification except where indicated (IgÀLC, CD4 and CD1 in blue).
Membrane Determinant • Porcine Cutaneous 
Distribution
Number of 
pigs
sections fields
CD45 • Intraepidermal: similar to 
GDI,
• Dermal: throughout 
dermis however papillary 
dermis »  reticular dermis
• Also present within 
sheath of cells around 
hair follicles
2 3 15
SWC3 • Papillary dermis
• Intraepidermal LG cell 
population
2 2 10
CD2 • Mainly papillary dermis
• Occasional Intraepidermal 
cells
2 2 10
CD3 2 2 10
CDS 2 2 10
CD6 1 1 5
CD4 • Mainly papillary dermis 2 2 11
CDS • Mainly papillary dermis 2 4 20
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Membrane Determinant # Porcine Cutaneous 
Distribution
Number of 
pigs
sections fields
CD1 # Basai and suprabasal 
epidermis
• Mainly papillary dermis
2 2 11
GDI 2 2 12
\gXLC • Subepidermal papillary 
dermis
2 3 15
SWC6 Sparse, seem more 
concentrated around hair 
follicles and in papillary 
ridges
2 2 10
CD25 Sparse, mainly papillary 
dermis
2 2 10
SLA DP (H42A) • Intraepidermal LG (but 
only ‘weakly’ positive for 
SLADP
• Mainly papillary dermis 
and around hair follicles
• Appearance consistent 
with expression by 
endothelial cells in the 
sub epidermal plexuses 
(cf. jejunal villi)
• Within the reticular dermis 
SLA DR>DQ>DP
1 2 10
SLA DQ (TH14B) 1 1 5
SLA DR (TH81A5) 1 1 5
SLA DR (MSA3) 1 1 5
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Figure 5.6: Immunolabelling Porcine Skin
The skin was obtained from two Large White pigs approximately 1 1 - 1 3  
weeks old and prepared as described in Chapter 2. Frozen sections were 
immunolabelled (as described in Chapter 2) using the panel of monoclonal 
antibodies (see Table 5.1) and subsequently photomicrographed (Figures (a) 
-  (h), power of magnification as labelled). Negative control sections without 
primary antibody were always performed.
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5.3 Discussion
It is important to note that there are important differences between 
Immunohlstochemistry and flow cytometry, so that results based on these two 
techniques are not always correlated. In contrast to flow cytometry, 
immunohlstochemistry will also label antigens expressed intracellularly, such 
as Immunoglobulins in plasma cells and MHC class II in immature dendritic 
cells. However, immunohlstochemistry can be less sensitive and can only 
provide information abouT-cells expressing a particular antigen in a high 
enough density for it to be seen following immunohistochemical staining. Cells 
seen to express an antigen dimly' by flow cytometry may have a low density 
of expression and not show up as positive upon immunohistochemical 
staining. Where cells are shown immunohistochemically to express certain 
antigens, the distribution of these cells within tissues may be demonstrated as 
well as their anatomical relationships with neighbouring cells.
Most of the antigen labelling work in this chapter utilised skin from 2 pigs (a 
few were tested on only 1 pig, see Section 5.2 and Table 5.4).
Within the epidermis, LCs accounted for approximately 4.7% of nucleated 
epidermal cells (n=2 pigs, staining with clone 76-7-4 (anti-CD 1) combined with 
haematoxylin counter staining). The LCs stained positively with a number of 
other monoclonal antibodies including SWC3 (Figure 5.6(a)), which is 
expressed on cells of myeloid origin including monocytes, macrophages and 
granulocytes. LCs also stained positively for MHC II antigen expression 
although SLA DP staining was not as intense as SLA DQ or SLA DR (Figure 
5.6(e)). Kératinocytes did not stain positively for MHC II antigens.
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The majority of leucocytes within the dermis were found within the papillary 
dermis, principally in the region of subepidermal vascular plexuses (Figure 
5.8).
Figure 5.8: Porcine Skin; Photomicrographs (X40 (a), X200 (b)) H&E stained
formalin fixed cryostat sections. PD = papillary dermis; RD = reticular dermis; HF 
= hair follicle; LA = leucocyte aggregates in the region of the subepidermal 
plexuses
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Approximately one fifth of dermal leucocytes appeared to be CD1-positive, 
although it Is not possible to determine what percentage of these were dermal 
dendritic cells.
The human CD2 antigen is expressed on virtually all thymocytes, T 
lymphocytes and NK cells (Barclay et al., 1997). As in other species the 
porcine analogue is a pan-a/pT-cell antigen characterised by its ability to bind 
to xenogeneic red blood cells (E-rosette receptor) (Hammerberg and Schurig, 
1986). CD2 in pigs is ubiquitous, it is also expressed on a subset of y/0 Tcells 
(Saalmuller et al., 1990), comprising CD2^4'8'° and CD2^4"8' subsets (Davis 
et al., 1998; Yang and Parkhouse, 1996)) and at low intensity on B cells 
(Sinkora et al., 1998). In addition there are non-T-non-B lymphocytes with 
CD2^3‘4‘8'° surface immunoglobulin-negative phenotype containing natural 
killer (NK) activity (Yang and Parkhouse, 1996) (see Figure 5.5).
The CD3 antigen is closely associated with the T-cell receptor. Functionally, It 
is involved in signal transduction leading to T-cell activation following antigen 
recognition (Barclay et al., 1997). Within pigs the CDS antigen is expressed on 
both a/p and y/6 T-cells. The density of CDS on y/ô T-cells tends to be at a 
higher and more homogeneous level than on a/p T-cells (Yang et al., 1996) 
the significance of which is unclear.
The CDS antigen in humans and swine expressed on all mature T-cells and 
on a subset of mature B cells is involved In signal transduction (Saalmuller 
and Bryant, 1994; Appleyard and Wilkie, 1998; Barclay et al., 1997).
Within the peripheral blood cell population there are three differential levels of 
CDS expression. The CDS- population contains all the NK activity, the CD5^ '"^  
cells contain the y/6 cells and the a/p CD4‘8^ "^  population and the CDS"^ "^ '^ *^
262
contain the rest (see Figure 5.5) (Saalmuller et al., 1994b; Saalmuller et al.,
1994).
The CD6 antigen is expressed by 76% of porcine peripheral T-cells 
(Saalmuller et al., 1994a). Only the a/p T-cell receptor subset expresses CD6. 
Within these, all the CD4^-positive cells express CD6, and only the (CD4‘) 
CD8 '^ cells express CD6 (see Figure 5.5) (Pauly et al., 1996; Saalmuller et al., 
1994a). Functionally, CD6 may have a role in intrathymic T-cell development 
as well as signal transduction (Barclay et al., 1997)
There does not appear to be any significant difference between expression of 
different pan T-cell antigenic determinants. This would be consistent with the 
majority of T-cells being of the a/psubset. SWC6-positive cells (‘null’ cells) 
which have been shown to consist of CD2'3+ y/0 T-cells (Binns et al., 1992) 
were seen in only small numbers.
B cells labelled by IglLC were also only sparsely seen, this may be due to the 
fact that this antibody is specific for only a subset of lambda chain, 
unfortunately not known at the time of these experiments. A proportion of 
these dermal B cells may stain positively for GDI. Additionally a proportion of 
resting B and T-cells stained positively for CD25 albeit at low intensity 
(upregulated upon activation) (Denham et al., 1994; Stokes et al., 1996; 
Bailey et al., 1998). The CD25 antigen forms a component of the IL-2 receptor 
(IL-2R), which is expressed on a variety of activated cells Including T-cells, B 
cells NK cells and monocytes via which IL-2 induces their activation, 
maturation and proliferation (Barclay et al., 1997).
In the human the CD4 antigen is expressed on two thirds of peripheral blood T 
lymphocytes, expression of GD4 is predominantly mutually exiusive to GD8
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expression (Barclay et al., 1997). In pigs, CD4+ cells are a more 
heterogeneous population with significant proportions of the population co­
expressing low levels of CD8 (see Figure 5.5) (Yang and Parkhouse, 1996). 
The CD4 antigen functions as an accessory molecule Involved in the 
recognition of foreign antigens in association with MHC class II by T-cells 
(Barclay et al., 1997).
The CD8 antigen acts as a co-receptor with MHC class I restricted antigen 
recognition. In the pig in peripheral blood the CD8 antigen is expressed on a 
variety of cell types (see Figure 5.5). These include a/p T-cells with the T 
suppressor phenotype and up to 60% of peripheral T-cells expressing dual 
helper/suppressor (CD4‘*‘CD8‘^ ) phenotypes (Pescovitz et ai., 1994), as well as 
on a subset of y/ô T-cells (Davis et al., 1998) and those with natural killer (NK) 
activity (Yang and Parkhouse, 1996). The density of surface antigen 
expression as indicated by degree of fluorescence in flow cytometry varies 
between the groups (Yang and Parkhouse, 1996). Low surface antigen 
expression (denoted as or in relation to flow cytometric measurement 
of fluorescence) detectable on flow cytometry is more difficult to interpret 
immunohistochemically.
Results suggest a higher proportion of CD4-positive cells than CD8-positive 
cells within porcine dermis. It is difficult do draw any meaningful conclusions 
however, as skin from only two pigs was examined. In addition different 
staining techniques were used, with ABC being the optimum staining method 
for all the antigens bar CD4 and Ig^LC which were better revealed with 
Immunofluorescence. Lastly it was necessary to perform the counts of CD4- 
positive cells at the higher magnification of X400.
264
MHC class II molecules are expressed on dendritic cells, B cells, monocytes, 
macrophages and activated T-cells in the human and present exogenously 
derived antigen to CD4^ T-cells (Barclay et al., 1997). Monoclonal antibodies 
reactive with SLA DR (swine leucocyte antigen -  HLA equivalent) and SLA 
DQ are well characterised (Lunney, 1994). There is evidence to suggest that a 
further moAB (H42A) reacts with SLA DP (HLA DP equivalent) (Ababou et al.,
1995): and personal communication from Davis WC, Department of Veterinary 
Microbiology and Pathology, College of Veterinary Medicine, Washington 
State University). It reacts with a unique allomorph in mice that appears to be 
equivalent to DP, and it appears the determinant is conserved in humans on 
DP (Davis WC personal communication).
Within porcine dermis the results (Figure 5.6) suggest there is no significant 
difference in expression of the different MHC class II antigens. Without dual 
staining it is not possible to determine what percentage of T-cells are MHC II 
expressing, although it would be reasonable to assume that the majority of 
expression is seen on SWC3-positive cells with some occurring on dermal 
dendritic cells. The moAB 74-22-15 reactive against swine myeloid cells was 
found to recognise macrophages and granulocytes and assigned a swine 
workshop cluster (SWC) number 3 in the first international workshop 
(Pescovitz et al., 1984); (Blecha et al., 1994). The pattern of cellular binding 
reactivity differs from any known human CD antigen hence a swine workshop 
cluster number was assigned, SWC3 has recently been identified as a signal 
regulatory protein receptor associated with SHP-1 (Alvarez et al., 2000).
Within porcine jejunal villi, a network of dendritic cells as well as capillary 
endothelium have been shown to express SLA DR and SLA DQ antigens and
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this is occurring in close association with T-cells (Haverson et al., 2000). The 
expression of MHC molecules appears ubiquitous on porcine endothelium and 
has also been found in many other tissues (Wilson et al., 1996). Suggestions 
have been made regarding the possible role of endothelial cells In lymphocyte 
trafficking and the maintenance of local tolerance (Wilson et al., 1996). The 
staining studies suggest that the subepidermal capillary plexus endothelium 
does express MHC class II antigens. Similarities have been proposed 
between gut-associated lymphoid tissue (GALT) and skin-associated 
lymphoid tissue (SALT) (Streilein, 1983). There are however marked 
differences in localisation of white cells in porcine gut and skin.
There are no published reports of immunohistochemical staining of porcine 
dermis with the vast majority of the antibodies tested within the above study. It 
has been a useful exercise therefore, to establish a baseline distribution of 
numbers and types of cells bearing different CD antigens within normal skin in 
the Large White pig.
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Chapter 6
The immuno cellular response to split skin allografts in the Large
White pig
267
6.1 Introduction
The Large White pig is well established as a model in the field of 
allotransplantation (Kenmochi et al., 1994). Indeed, epidermal regeneration in 
the Large White pig was first characterised nearly forty years ago (Winter, 
1962). In the last decade, studies using allogeneic cultured porcine 
keratinocyte sheets were Initiated (Carver et al., 1991), and a model using 
semi-isolation chambers in the Large White pig was developed (Kangesu et 
al., 1993).
Acute rejection of a split thickness skin graft follows sensitisation and is 
principally mediated by antigen-specific effector cells (Rosenberg and Singer, 
1992). Sensitisation is thought to be dependant upon the presence of APCs 
which migrate to regional nodes (Lafferty et al., 1983), mature and give rise to 
a sequence of events that result in the generation of Class I restricted (CD8^) 
cytotoxic T lymphocytes (Rosenberg and Singer, 1992). These infiltrating 
activated lymphocytes that are primarily responsible for effecting the rejection 
process are thought to produce cytokines promoting influx of non-specific 
inflammatory cells that result in a degree of non cell-specific damage or 
‘bystander damage’ (Lafferty et al., 1983).
It has been demonstrated that the duration of survival of split skin allografts is 
related to degree of heterogeneity at certain leucocyte antigen loci (Koch et 
al., 1971). The Large White pigs in use in this series of experiments came 
from one of two farms. Due to previous inbreeding these may be related, 
although in these experiments care was taken to use non-littermates. With the 
degree of inbreeding that may have occurred there was concern to ensure the
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validity of the model with regard to the degree of allogenicity. Indeed it 
required only 5 generations of in breeding to generate the Babraham herd as 
opposed to the usual 20 generations of brother X sister matings (Signer et al., 
1999). If indeed the Large White pig populations in use in my (and other) 
experiments were too closely related, then one may expect allogeneic split 
skin to be rejected only after a prolonged period of take. Additionally, one may 
expect rejection to be a more subdued process (more akin to sub acute or 
chronic rejection).
A study was set up therefore to test the hypothesis that non-litter mate 
‘outbred’ Large White pigs reject split skin allograft acutely within the classical 
time frame (Koch et al., 1971).
Although attempts to characterise the infiltrate with respect to the overlying 
allogeneic epithelium have been made in other species (Mayer et al., 1988), 
there has been no such study to date in the pig. With the steady development 
in the last decade of porcine-specific monoclonal antibodies that have been 
raised against membrane antigens (Lunney et al., 1994; Lunney, 1994; 
Saalmuller, 1996; Saalmuller et al., 1996; Saalmuller et al., 1998b) it has 
become possible to immunophenotype the cells contained within a porcine 
wound infiltrate.
The aims of this study were
■ To show that the non-litter mate Large White pig population in this series 
of experiments reject split skin allograft acutely within the classical time 
frame.
■ To develop a positive control as a basis for comparison of wound infiltrates 
beneath skin substitutes containing cultured cells.
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6.2 Results
One Large White pig received four allogeneic split skin grafts from two non- 
littermate donors and two autologous split skin grafts. By day 10 each of the 
four allogeneic grafts had been rejected whilst the autologous grafts remained 
healthy (see Figures 6.1-6.2 and Table 6.1).
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Table 6.1:
(a)
Wound Harvest Time Points 
(Days)
10
Types of Graft 
Applied to 
wounds (no. of 
wounds)
Autologous Split 
Skin
2
Allogeneic Split 
Skin
4
(b)
Wound Harvest Time Points (Days) 10
Fraction of wounds that 
showed epithelium as 
identified histologically 
with H&E staining at 
time of harvest
Autologous 
Split Skin
2/2
Allogeneic 
Split Skin *4/4
* Grossly and histologically the epithelium (although still present) was 
observed to be undergoing acute rejection.
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Figure 6.1: Photographs of harvested wounds 10 days after grafting with 
autologous split skin (a) and allogeneic split skin (b). Whilst the autologous 
grafted wounds remained healthy, the wounds grafted with allogeneic skin 
showed signs of early necrosis and graft rejection.
Chamber no.4 Day 10 post graft
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Figure 6.2: Photomicrographs (X100) of wounds harvested at 10 days 
following grafting with autologous and allogeneic split skin ((a) and (b) 
respectively) and stained with H&E. Note the intense infiltrate in (b).
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6.2.1 Immunophenotyping of split skin grafted wounds
Blocks from allogeneic and autologous wounds were examined (as was 
normal porcine paravertebral skin) with each of the twelve monoclonal 
antibodies (see Table 6.2 and Figure 6.3). Two to five sections per wound 
were stained using the nickel-enhanced ABC method (apart from GD4 and 
Ig^LC which were detected using Cy3 -  an immunofluorescent dye). Using an 
optical grid, counts were taken from approximately five random fields per 
section at X200 magnification to a depth of 0.5mm below the epidermis, apart 
from CD4 and IgXLC which were counted at X400 magnification (see Table 
6.3(a)-(c)).
All antibody counts within the allogeneic split skin grafted wounds were 
consistently higher than in wounds grafted with autologous split skin or within 
normal pig skin with the exception of SWC6 (null cells) which was not 
convincingly seen in any of the wounds (see Figures 6.4 and 6.5). The 
majority of white cells (CD45) were shown to be SWC3-positive 
(macrophage/monocyte and granulocytes) with the remainder mainly T-cells 
(CD2, 3 and 5) which consist both of T helper (CD4) and T 
cytotoxic/suppressor (CDS) phenotypes (many of which may well be of dual 
CD4 - CDS phenotype).
Density counts of the SLADR determinant (the human equivalent may be 
expressed by monocytes, macrophages and activated T-cells as well as 
dendritic cells and some B cells) were increased, as were those for the CD25
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(IL-2 determinant which denotes activation) in the wounds grafted with 
allogeneic split skin graft.
The IgA, LC determinant (B cell) appeared to be increased in the allogeneic 
split skin graft section examined. The null cell determinant SWC6 was difficult 
to detect in any section.
The number of cells staining with the CD1 determinant was not significantly 
increased in wounds grafted with either allogeneic or autologous split skin 
graft and equated with that found in normal skin.
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Table 6.2: Summary of the monoclonal antibodies used in wound
infiltrate immunophenotyping.
ANTIBODY
SPECIFICITY
PHENOTYPE CELL
LINE
SOURCE
CD1 Dendritic Cell 76-7-4 VMRD
CD2 T-cell MSA4 Dr. J.K. Lunney, Beltsville, 
USA
CD3 T-cell FY1H2 Dr. H. Yang, Pirbright, UK
CD4 T helper STH293 Dr. M. Shimizu, Ibaraki, 
Japan
CDS T-cell PG1114A VMRD
CDS T Cytotoxic/Supressor PT81B VMRD
lg?.LC Plasma Cell/Mature B cell K189.3E1 Serotec
CD25 IL-2 Receptor 281.3B2 Serotec
CD45 Pan Leucocyte K.252.1E4 Serotec
SWC3 Macrophage & Granulocyte 74-22-15 VMRD
SWC6 Null Cell MAC320 Serotec
SLADR Macrophages, Monocytes, 
Dendritic cells, B cells Activated 
T-cells (in humans and rats)
MSA3 VMRD
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Table 6.3: Wound processing log (a)
Monoclonal
Antibody
Specificity
Microscope
magnification
Field Surface 
Area
Skin Auto
SSG
Alio
SSG
CD1 200X 40,000pm^ sections 1 2 2
Animals 1 1 1
Wounds 1 2 2
Blocks 1 2 2
Non littermate 
donors
— — 2
Random fields 5 10 10
Fields/section 5 5 5
CD2 200X SSG:
40,000^im^
Skin:
192,000tim^*
sections 2 1 2
Animals 2 1 1
Wounds 2 1 1
Blocks 2 1 1
Non littermate 
donors
— — 1
Random fields 10 5 10
Fields/section 5 5 5
CD3 200X SSG:
40,000pm^
Skin:
192,000jam^*
sections 2 1 1
Animals 2 1 1
Wounds 2 1 1
Blocks 2 1 1
Non littermate 
donors
— 1
Random fields 10 5 5
Fields/section 5 5 5
CD5 200X SSG:
40,000pm^
Skin:
192.000 i^m^*
sections 2 1 1
Animals 2 1 1
Wounds 2 1 1
Blocks 2 1 1
Non littermate 
donors
— — 1
Random fields 10 5 5
Fields/section 5 5 5
CD4 400X SSG:
10,000nm^
Skin:
48,000pm^*
sections 2 1 1
Animals 2 1 1
Wounds 2 1 1
Blocks 2 1 1
Non littermate 
donors
— — 1
Random fields 11 5 5
Fields/section 5.5 5 5
*to equate skin with SSG, skin values were therefore multiplied by 0.208
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Table 6.3: Wound processing log (b)
Monoclonal
Antibody
Specificity
Microscope
magnification
Field Surface 
Area
Skin Auto
SSG
Alio
SSG
CD8 200X SSG:
40,000pm^
Skin:
1 section 
40,000|im^ 
and 2 
sections
192,000pm^*
sections 4 2 2
Animals 2 1 1
Wounds 2 2 2
Blocks 3 2 2
Non littermate 
donors
— — 2
Random fields 20 10 10
Fields/section 5 5 5
SLADR 200X SSG:
40,000p,m^
Skin:
1 section 
40,000pm^ 
and 2 
sections
192,000|iim^*
sections 3 2 2
Animals 1 1 1
Wounds 1 2 2
Blocks 2 2 2
Non littermate 
donors
— — 2
Random fields 15 10 10
Fields/section 5 5 5
CD45 200X SSG:
40,000Dm^
Skin:
1 section 
40,0000m^ 
and 2 
sections 
192,000|um2*
sections 3 2 2
Animals 2 1 1
Wounds 2 2 2
Blocks 3 2 2
Non littermate 
donors
— — 2
Random fields 15 10 10
Fields/section 5 5 5
SWC3 200X SSG:
40,000jam^
Skin:
1 section 
40,000|im^ 
and 2 
sections
192,000nm^*
sections 3 2 2
Animals 2 1 1
Wounds 2 2 2
Blocks 3 2 2
Non littermate 
donors
— — 2
Random fields 15 10 14
Fields/section 5 5 5-9
t^o equate skin with SSG, skin values were therefore multiplied by 0.208
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Table 6.3: Wound processing log (c)
Monoclonal
Antibody
Specificity
Microscope
magnification
Field
Surface
Area
Skin Auto
SSG
Alio
SSG
IgXLC 400X SSG:
10,000|um^
Skin:
48,000|um^*
sections 3 1 2
Animals 2 1 1
Wounds 2 1 2
Blocks 2 1 2
Non littermate 
donors
— — 1
Random fields 15 5 11
Fields/section 5 5 5-6
CD 25 200X SSG:
40,000j^m^
Skin:
192,000pm2*
sections 2 1 1
Animals 2 1 1
Wounds 2 1 1
Blocks 2 1 1
Non littermate 
donors
— — 1
Random fields 10 5 5
Fields/section 5 5 5
SWC6 200X SSG:
40,000|im^
Skin:
192,000pmZ*
sections 2 1 1
Animals 2 1 1
Wounds 2 1 1
Blocks 2 1 1
Non littermate 
donors
— 1
Random fields 10 6 5
Fields/section 5 6 5
Ho equate skin with SSG, skin values were therefore multiplied by 0.208
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Figure 6.3: Photomicrographs of normal porcine skin labelled with anti CD45 
((a) X200 and (b) X400); and wounds harvested at 10 days following grafting 
with allogeneic split skin labelled with anti CD45 ((c) X400 and anti SWC3 (d) 
X400), control ((e) X400). All (bar the H&E stained section) were stained 
using the ABC method. The arrow indicates positive cells
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Figure 6.4: Bar charts illustrating manual counts of positively staining cells 
within the infiltrate of wounds grafted with allogeneic or autologous split skin 
graft (SSG), harvested at day 10 as well as in normal porcine skin. One Large 
White pig received four allogeneic split skin grafts from two non-littermate 
donors and two autologous split skin grafts. By day 10 all four allogeneic 
grafts had been rejected unlike the autologous grafts which remained healthy. 
Sections (see Table 6.2 (a)-(c)) from allogeneic and autologous wounds were 
stained with monoclonal antibody with antigen-specificities as delineated in 
table 6.1 and then stained using the avidin biotin complex (ABC) 
immunoperoxidase technique. All determinants were consistently seen in 
greater numbers in the wounds grafted with allogeneic split skin (the results 
for normal porcine skin are the same as those in Figure 5.5). The majority of 
white cells (CD45) were shown to be macrophages (SWC3) with the 
remainder mainly T-cells (CD2, 3 and 5) which consist both of T helper (CD4) 
and T cytotoxic/suppressor (CD8) phenotypes (and probably of dual CD4 and 
8 phenotypes too).
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Figure 6.5: Bar charts illustrating manual counts of positively staining cells 
within the infiltrate of wounds grafted with allogeneic or autologous split skin 
graft (SSG), harvested at day 10 as well as in normal porcine skin. One Large 
White pig received four allogeneic split skin grafts from two non-littermate 
donors and two autologous split skin grafts. By day 10 all four allogeneic 
grafts had been rejected unlike the autologous grafts which remained healthy. 
Sections (see Table 6.2(a)-(c)) from allogeneic and autologous wounds were 
stained with monoclonal antibody with antigen-specificities as delineated in 
table 6.1 and then stained using the avidin biotin complex (ABC) 
immunoperoxidase technique.
The CD1 determinant (Langerhans/dendritic cells), is not significantly 
increased in any of the sections (the results for normal porcine skin are the 
same as those in Figure 5.5). The SLADR determinant (dendritic cells, B cells, 
monocytes, macrophages and activated T-cells) is increased as expected, as 
is the CD25 (IL-2 determinant) in the wounds grafted with allogeneic split skin 
graft (SSG). The lg>.LC (B cell) determinant appears to be increased in the 
allogeneic split skin graft (SSG section) section examined. The null cell 
determinant SWC6 was difficult to detect in any section.
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6.3 Discussion
It was important to examine the immune infiltrate associated with acute 
allorejection as well as to demonstrate that the Large White pig population 
used for this series of experiments was capable of mounting a classical 
allorejection reaction. As a positive control therefore, allogeneic split thickness 
skin was grafted directly onto fascia and was paired with wounds that had 
autologous split skin applied.
Classically allogeneic split skin grafts in unrelated humans are rejected at 
approximately 10 days after grafting (Koch et al., 1971). By day 10 gross 
inspection (followed by histological confirmation) revealed that all the 
autologous split skin grafts had taken whilst the allogeneic grafts were acutely 
rejecting which is consistent with the work of others (Carver et al., 1991). 
Additionally the cellular infiltrate involved in acute rejection classically consists 
of T-cells (positive for CD4 and CDS antigens) and a non-specific 
inflammatory infiltrate consisting mainly of macrophages (Rosenberg et al., 
1988). The pattern seen beneath rejecting allogeneic split skin grafts in this 
experiment demonstrated a rise in numbers of all immunophenotypes looked 
for except for CD1 (dendritic cell) and null cell phenotypes. In humans the 
CD1 determinant may be expressed on some dendritic cells, activated 
monocytes and some B cells (Barclay et al., 1997). In the present study in 
pigs, within the infiltrate associated with rejecting allogeneic split skin grafts, 
SWC3 counts and SLA DR (an activation marker) counts were considerably 
increased with a moderate increase in Ig l (LC)-positive B cell infiltration. The 
CD 1-positive cellular infiltrate however, was similar to normal porcine skin and 
autologous split skin grafts. This pattern of staining suggests that the GDI
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antigen is expressed in highest density by porcine dendritic ceils and that 
these are the cells staining positive for CD1.
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Chapter 7
The fate of cultured allogeneic keratinocyte sheet grafts in the
Large White pig
285
7.1 Introduction
In 1995 an estimated 24,986 patients were hospitalised due to burn injuries in 
Europe (Wed 1er et al., 1999). In the UK, in the 1980’s, there were reportedly 
over 10,000 burns patients requiring hospital treatment with 600 deaths a year 
(Muir et al., 1987). The deaths are due to a variety of causes, not least smoke 
inhalation (Muir et al., 1987). The evolution of critical care techniques in 
combination with a more aggressive excisional approach has however led to 
enhanced survival in patients with massive burns (Herndon et al., 1987). 
Hampering further progress is a lack of suitable skin substitutes. This is 
acutely felt in massive burns where there is insufficient autologous skin 
available for grafting. The aim of achieving a good long term outcome in terms 
of contracture-free, stable healing is still far off. New wound healing related 
products emerge commercially on a regular basis although few have achieved 
widespread acceptance. Cost effectiveness (for the NHS as well as for 
research and development departments of biotechnology companies) is a 
further issue that blights progress (Shakespeare, 1999).
The ideal skin substitute would display properties (see Table 7.1) similar to 
those of a medium thickness autologous split skin graft which forms the gold 
standard. Although some may claim to have achieved certain of the properties 
listed, there are no contemporary skin substitutes that conform to the 
aforementioned ideal.
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Table 7.1: Properties of an ‘ideal’ skin substitute
Manufacture & 
Storage
Early Biological 
Function
Late Biological 
Function
Surgical
Considerations
Cost effective Non immunogenic Non
immunogenic
Pliable
Easy to store Durable Durable Conforms well to 
surfaces
Long shelf life Skin-like barrier functions 
(microorganisms, water 
loss)
Minimal
contracture
Good take results 
in the average 
surgeons hands
Ready
availability
Non-toxic Minimal
hypertrophic
scarring
Single stage 
procedure
Non-toxic
Ready availability (within 7-10 days of injury) of the skin substitute is important 
both to the patient and the health service. With regard to the patient, ready 
availability facilitates earlier treatment with the attendant advantages of a 
reduction in sepsis and organ failure and the psychological benefits of earlier 
mobilisation. With regard to the health service it may imply cost effectiveness 
with reduced in-patient and time spent in critical care.
Integra™ is one such skin substitute that is engineered to form a neo-dermis. 
It is a non-regenerative dermal template consisting of a dermal substitute of 
bovine collagen and chondroitin-6-sulfate and an epidermal layer of synthetic 
polysiloxane polymer (Silastic) (Stern et al., 1990). The silicone epidermal 
membrane is removed following biointegration of the dermal component which 
takes approximately 10 days in the pig (Grant et al., 1998), and 3-6 weeks in 
humans.
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Epidermal replacement options include cultured autologous kératinocytes 
(Boyce et al., 1993), cultured allogeneic kératinocytes (Falanga et al., 1998) 
or a mixture (chimera) of the two (Rouabhia et al., 1995; Rouabhia, 1996; 
Suzuki et al., 1995). These may be delivered in a confluent, subconfluent 
(Myers et al., 1997; Harris et al., 1998) or dispersed form (Stark and Kaiser, 
1994; Harris et a!., 1998). Only examination of the application of split skin and 
cultured autologous keratinocyte grafts to Integra™ has occurred to date 
(Lorenz et al., 1997; Pandya et al., 1998; Boyce et al., 1999).
To generate sufficienT-cells to cover the adult body surface area at a cell 
density of 5-8X10"  ^per cm  ^ in a dispersed form would take over three weeks 
starting from a Icm^ sample of skin (see Table 7.2). This time delay severely 
limits the use of autologous kératinocytes. The delay is further exacerbated if 
kératinocytes are to be used in a confluent sheet form, as extra culture time is 
necessary to develop additional sheets to compensate for sheet contracture 
that occurs with detachment of sheet from plastic flasks. Additionally further 
culture time is necessary to develop bilayered or multilayered sheets that 
have sufficient integral strength to allow for manipulation. The delay in 
cultured sheet grafting is less of a limitation when cultured grafts are used in 
the context of Integra™, in view of the 3-6 weeks necessary in humans for 
biointegration during which time the silicone membrane remains in place. 
Kératinocytes from an allogeneic source may be cultured, frozen and banked 
in advance for later use. Using the techniques described earlier (see Chapter 
4), the cultures may be rendered free of ‘passenger lymphocytes’, and thus 
potentially prove a useful resource.
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Table 7.2: This table illustrates the maximal cover available from a 1 cm 
piece of split skin from which 5X10® viable epidermal cells may be obtained 
based on pig culture methods. It is assumed that the number of cells required 
to primarily seed a 75cm^ flask is 4X10® and that thereafter subconfluent 
flasks may be subcultured 1:3 every 3 days (Bevan et al., 1997). In order to 
generate sheets for grafting, extra culture time of between 5 and 7 days is 
required to develop a sheet with integral strength and more than one layer 
deep. Additionally, more flasks than indicated will be required because the 
graft contracts as it is separated from the flask plastic. Its surface area will 
therefore be less than 75cm^
Passage No. Day Cell Nos. 
(10®)
# of 75cm^ 
flasks that could 
be seeded
Cover 
(cm^) 
(area of 
confluent 
flasks)
% Body Surface 
Area Cover 
(BSA = 1.8m^)
PO 0 5 1 0 0
PI 8 6 3 75 0.4
P2 11 18 9 225 1
P3 14 54 27 "A. 675 4
P4 17 162 81 2025 11
P5 20 486 243 "A. 6075 34
P6 23 1458 729 "A. 18225 101
P7 26 4374 2187 54675 304
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Host sensitisation to allogeneic skin is thought to be initiated directly (by donor 
LC) and take place centrally within draining regional lymph nodes, as opposed 
to peripherally within the graft itself (Rosenberg and Singer, 1992). Host 
sensitisation to cultured keratinocyte grafts if devoid of LC, is thought to occur 
as a result of infiltration by host APCs (Mason and Morris, 1986). In mice 
Larsen and coworkers demonstrated that host dendritic cells do not infiltrate 
allogeneic split grafts within the first eight days (Larsen et al., 1990a). The rate 
of APC infiltration (Aubock et al., 1988) may vary with the model used and site 
of grafting. The observed delay in rejection may therefore reflect delayed APC 
infiltration.
Within allogeneic split skin grafts, rejection is thought to principally be effected 
by class I restricted (CD8^) cytotoxic T lymphocytes (Rosenberg and Singer, 
1992). These infiltrating activated lymphocytes that are primarily responsible 
for effecting the rejection process, are thought to produce cytokines promoting 
influx of non-specific inflammatory cells that result in a degree of non cell- 
specific damage or ‘bystander damage’ (Rosenberg and Singer, 1992). 
Reports indicate (Doody et al., 1994) that the degree of selective but non 
antigen-specific inflammatory infiltrate may be related to the extent of foreign 
class II expression within the graft. Where there is no foreign class II antigen 
apparent (as in a cultured graft that is presumed to be LC deficient), reports 
differ as to whether there Is acute graft rejection as seen in the pig model 
(Carver et al., 1991; Au bock et al., 1988) the rat model (Fabre and Cullen,
1989) and in the murine model (Rouabhia et al., 1995; Suzuki et al., 1995), or 
a more gradual replacement by host elements as in human patients (Gielen et 
al., 1987; Otto et ai., 1995), or even no rejection at all in one report in mice
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(Hammond et al., 1987). The differences between these reports may reflect a 
number of factors including the species involved, the method of culture and 
elimination of passenger lymphocytes’ and the bed to which the graft was 
applied. The reports suggesting more gradual graft replacement undetectable 
clinically, may reflect either a rejection process in which the non-specific 
bystander damage was minimal or a process by which the grafted
kératinocytes are gradually lost by a means other than rejection.
Further evidence of gradual allogeneic keratinocyte loss with minimal
bystander damage emerged with regard to chimeric grafts consisting of
allogeneic and autologous cells co-cultured in predetermined proportions in 
murine species (Rouabhia et al., 1995; Suzuki et al., 1995).
Classically allorejection is thought to occur directly, via donor dendritic cells 
present within the graft (Rosenberg and Singer, 1992). Immunosupression is 
generally required to minimise the rejection response to allotransplantation of 
tissue containing cells capable of presenting antigen. Where these cells have 
been eliminated prior to transplantation, take is prolonged without the need for 
immunosupression (Faustman, 1995). This is consistent with work showing 
delayed entry of host APCs into these tissues (Larsen et al., 1990a).
The system used in this series of experiments is devoid of APCs upon grafting 
(see Chapter 4). With no antigen presentation, graft take may be expected to 
be prolonged (Faustman, 1995). Additionally, one would expect infiltrating 
host APCs to be responsible for sensitisation (indirect presentation) (Mason 
and Morris, 1986). If this was the case one might expect early detection of 
infiltrating host dendritic cells.
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Ordinarily kératinocytes do not express MHC class II antigens. Within cultured 
keratinocyte allografts (processed as detailed in Chapter 4) therefore, only 
foreign MHC Class I antigens are expressed and presented by host APCs. 
Thus class I restricted CD8-positive cytotoxic T-cells would be expected to be 
generated as the principle effector cell of the rejection process (Rosenberg 
and Singer, 1992).
This chapter brings together the techniques evolved previously (including 
lacZnIs keratinocyte labelling, LC elimination by complement lysis and 
immunophenotyping) to examine the fate of allogeneic kératinocytes within 
grafts.
The aims of this chapter are to examine the following hypotheses:
(a) that LC depleted allogeneic keratinocyte sheet grafts applied to Integra™ 
in the Large White pig are rejected after a more prolonged period of take than 
allogeneic skin grafts
(b) that host APCs are seen to infiltrate the graft bed prior to rejection and 
therefore may be involved in (indirect) antigen presentation
(c) that rejection is primarily effected through alio specific cytotoxic T 
lymphocytes.
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7.2 Results
Seven pigs were used in this study. Six wounds per pig were fashioned and 
were randomly allocated to receive either autologous, allogeneic or no sheet 
graft (see Chapter 2 for method). All wounds were grafted with Integra™ ten 
days prior to the application of cultured sheet graft (see Figure 7.1).
Figure 7.1:
Time line showing progression from split skin harvest to cultured keratinocyte 
sheet grafting
Day 8 Day 11
Skin harvest PI P2
Day 14 Day 22+
P3 Cultured keratinocyte 
sheet grafting
Integra® grafting
Wounds were harvested at six time points: days 7, 10, 14, 18,21 and 28 post 
grafting (see Table 7.3 (a)). The amount of surviving epithelium (see Table 
7.3(b)) as well as MFGIacZn/s expression was assessed following sectioning 
and staining (see Figures 7.2 and 7.3) of each wound in a pre-specified 
fashion (see Chapter 2 for method). The immunoinfiltrate was assessed using 
a panel of porcine-specific monoclonal antibodies (see Chapter 6 table 6.1).
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Table 7.3: Table (a) illustrates the types of wounds harvested at particular
time points. Table (b) illustrates the fraction of wound types 
harvested that were shown to have epithelial cover.
a)
Wound Harvest Time Points 
(Days)
7 10 14 18 21 28
Types of Graft 
Applied to 
wounds (no. of 
wounds)
Autologous Sheet 2 2 4 2 2 2
Allogeneic Sheet 3 3 6 3 3 3
Control 1 1 2 1 1 1
b)
Wound Harvest Time Points (Days) 7 10 14 18 21 28
Fraction of wounds that 
showed epithelium as 
identified histologically 
with H&E staining at 
time of harvest
Autologous
Sheet
1/2 1/2 3/4 1/2 0/2 2/2
Allogeneic
Sheet
2/3 1/3 1/6 1/3 0/3 0/3
Control 0/1 0/1 0/2 0/1 0/1 0/1
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Figure 7.2:
(a) Photograph of a block from a wound grafted with cultured allogeneic 
keratinocyte sheet graft applied to Integra™. The block has been incubated in 
X-gal in order to detect p-gal expression (see Chapter 2 for method). The blue 
stain confirms the presence of p-galactosidase indicating that the epithelial 
cover is due to MFG lacZnIs transduced cultured allogeneic kératinocytes. 
The photomicrograph (b) illustrates a section from the same wound stained 
with H&E (at X100 magnification) in addition to incubation in X-gal.
PR10
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Figure 7.3:
Photomicrograph of an H&E and X-Gal stained sections from wounds grafted 
with an autologous or allogeneic cultured keratinocyte sheet grafts 7, 10 or 18 
days previously. The blue stain confirms the origin of the kératinocytes. Note 
that within the allogeneic sheet graft p-gal expression is still evident at day 18.
D-7 auto
X400
Id
D-iVa l
X100 ‘
D-18 alio
X200
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7.2.1 Survival of cultured autologous and allogeneic
keratinocyte grafts applied to Integra™ in the Large 
White pig
Early studies performed with Integra™ reported infiltration with macrophage 
derived giant cells and eosinophils but this did not appear to have clinical 
significance (Stern et al., 1990). Additionally a significant humoral response to 
bovine collagen was not detectable (Michaeli and McPherson, 1990). Good 
results have been reported following the clinical use of Integra™ and split 
thickness autograft (Lorenz et al., 1997) and the use of Integra™ with cultured 
autologous sheets in acute burns has also been reported (Pandya et al., 
1998). Within the experimental setting moderate success was reported with 
the use of Integra™ with cultured autologous sheets in the Large White pig 
(Grant et al., 1998) using wound Isolation chambers devised a few years 
previously (Kangesu et al., 1993).
The use of cultured allogeneic sheets as applied to Integra™ has so far not 
been examined.
In this series of experiments both the processes of repeated retroviral 
transduction and antibody complement pre-treatment were employed. These 
appeared to compromise the in vitro colony-forming efficiency of porcine 
kératinocytes (see Chapters 3 and 4) which in turn may impact on take and in 
vivo survival. The efficiency of initial take therefore ought to be considered, in 
order to appreciate the context in which the fate of allogeneic kératinocytes is 
explored. In this series of experiments early graft biopsies to confirm initial 
take were not undertaken. The reason for this omission was that it was
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thought that trauma resulting from early punch biopsies may have been 
responsible for the disappointing graft survival that was experienced in prior 
pilot studies. These inflict a degree of wound trauma, result in exposure of a 
part of the wound that is then more vulnerable to infection and additionally 
may encourage a local inflammatory response. Additionally it was thought 
advisable to maximise the material available for later studies.
Survival of grafted epithelium at the time of wound harvest was however 
assessed, and was detected on only 37% of grafted wounds (see Table 7.3b).
7.2.2 Lac Z marking of cultured kératinocytes forming
autologous and allogeneic keratinocyte grafts 
applied to Integra™ in the Large White pig
PO kératinocytes underwent 3 passages on feeder cells comprising the 
retroviral producer cells PT67 clone 8 and 3T3 fibroblasts in a 2:1 ratio. This 
was followed by a further passage on feeder cells consisting of 3T3 fibroblasts 
alone.
Marking was intense at the day 10 time point and evident still at the day 18 
time point (see Figure 7.3). At days 21 and 28 no allogeneic epithelium could 
be detected (in 6 wounds -  2 animals). Two wounds grafted with autologous 
keratinocyte sheets had epithelial cover when harvested at day 28 although 
MFG lacZ expression was not detected. It is likely therefore that on pre­
grafted Integra™ cultured allogeneic kératinocytes are lost through 
immunorejection at anything from between 1 8 - 2 8  days, whereas allogeneic 
SSGs are in the process of rejection by 10 days.
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7.2.3 Immunophenotyping of infiltrates beneath autologous
and allogeneic keratinocyte grafts appiied to integra™ 
in the Large White pig
Seven pigs were used in this study in which autologous and allogeneic 
cultured sheet grafts were applied to wounds which were harvested at six time 
points: 7, 10, 14, 18, 21 and 28 days post grafting (see Table 7.3 (a) for 
wound allocation). Graft survival was variable (see Table 7.3(b)) as assessed 
following sectioning and staining (see Figure 7.2) of each wound in a pre­
specified fashion (see Chapter 2 for method). Autologous and allogeneic 
blocks with the best cover were selected for analysis (see Table 7.4(a)-(f) and 
Figures 7.4-7.6) at these (post grafting) time points.
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Figure 7.4:
Photomicrographs illustrating ABC and X-Gal staining showing a blue staining 
epithelium in association with CD45 phenotypes (a)-(c); CD8 (d)-(e); SWC3 
phenotypes (f)-(g) and SLA DR phenotypes (h). The sections shown were taken 
from a wound (10 days after grafting) that had cultured allogeneic sheet applied 
to Integra™. Images (a), (d) and (f) were photographed at X200 and the rest at 
X400 magnification.
2
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Figure 7.5: Bar charts illustrating manual counts of positively staining cells 
within the infiltrate of wounds grafted with allogeneic or autologous cultured 
porcine keratinocyte sheet graft onto Integra™ and harvested at days 7, 10, 
14 and 18 (see 7.2.3). Blocks from all allogeneic and autologous grafted 
wounds were examined and sections (see Table 7.4(a)-(e)) from wounds with 
surviving epithelium were stained with monoclonal anübody with antigen- 
specificities delineated in chapter 6 table 6.1 and then secondarily stained 
using the avidin biotin complex (ABC) immunoperoxidase technique (except 
for CD4 and ^XLC labelling which was detected with immunofluorescence). 
Included on the right hand side of each graph are the results for normal 
porcine skin and autologous and allogeneic split skin graft 10 days post 
grafting (adapted from chapter 6 Figures 6.4 and 6.5).
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Figure 7.6: Bar charts illustrating manual counts of positively staining cells 
within the infiltrate of wounds grafted with allogeneic or autologous cultured 
porcine keratinocyte sheet graft onto Integra™ and harvested at days 7, 10, 
14 and 16 (see 7.2.3). Blocks from all allogeneic and autologous grafted 
wounds were examined and sections (see Table 7.4(a)-(f)) from wounds with 
surviving epithelium were stained with monoclonal antibody with antigen- 
specificities delineated in chapter 6 table 6.1 and then secondarily stained 
using the avidin biotin complex (ABC) immunoperoxidase technique (except 
for CD4 and Ig^LC labelling which was detected with immunofluorescence). 
Included on the right hand side of each graph are the results for normal 
porcine skin and autologous and allogeneic split skin graft 10 days post 
grafting (adapted from chapter 6 Figures 6.4 and 6.5).
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The study was initially designed so as to generate sufficient material for 
analysis to enable significant conclusions to be drawn. Poor graft survival 
unfortunately, precludes the drawing of significant conclusions. Sufficient 
material was available with epithelial cover at the various time points however, 
to allow for useful analysis of their infiltrates.
A panel of 12 porcine-specific monoclonal antibodies was used (see Chapter 
6 table 6.1). This included markers for pan leucocyte (CD45), pan T-cell (CD2, 
3 and 5), plasma cell, mature or activated B cell (IgXLC), 
macrophage/granulocyte (SWC3), ARC (CD1), null cell (SWC6) phenotypes. 
Additionally markers for CD4, usually associated with the T helper phenotype, 
CD8, usually associated with the T suppressor/cytotoxic phenotype, the IL-2 
receptor (CD25) and SLA DR expression were used (see Chapter 5 for a 
more in depth discussion of the markers).
Two to five sections per wound were stained using the nickel-enhanced ABC 
method and additionally incubated for twenty minutes in X-Gal (apart from 
CD4 and (glLC which were detected using Cy3 -  an immunofluorescent dye). 
Using an optical grid counts were taken from five random fields (0.04mm^) per 
section at X200 magnification to a depth of 0.5mm below the epidermis apart 
from CD4 and !gA.LC which were counted at X400 magnification and there 
each field was 0.01 mm^ (see Tables 7.4(a)-(f)).
Infiltration by CD 1-positive cells was seen to occur early. It appeared to be 
moderately increased in wounds grafted with allogeneic keratinocyte sheet 
graft, although the density of infiltrating cells as early as day 7 was close to
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that of normal porcine skin as well as autologous or allogeneically grafted 
wounds on day 10 (see Figure 7.6).
Pan leucocyte staining (CD45) showed remarkably little difference in infiltrate 
density until day 18 (see Figure 7.5). Staining for the SWC3 
(macrophage/monocyte), pan T-cell, CD8, CD4 and SLADR antigens allowed 
an appreciation of the components that made up this observed increase in 
panleucocytic infiltrate in wounds grafted with allogeneic keratinocyte sheet 
graft.
Staining with SWC3 (see Figure 7.5) revealed that macrophages/granulocytes 
did not appear to form a significant proportion of the increased pan leucocyte 
infiltrate seen at day 18.
Pan T-cell (CD2, CD3 and CD5 see Chapter 5) staining (see Figure 7.5) 
revealed a variable pattern. There was little difference in density of CD2+ or 
CD3+ infiltrate at any of the time point. With CD5 however, a three to fourfold 
increase in infiltrate density was seen at the day 18 time point, in wounds 
grafted with allogeneic keratinocyte sheet graft. This increase in infiltrate 
density was further seen in CD4 and CD8 labelling. CD5 is expressed at high 
density in CD4+ and CD8+ a/(3T-cells, and thus might be detected 
immunohistochemically more readily than CD2 or CD3 antigens (local 
experience of this study with staining for these antigens tends to support this). 
The density of SLA DR (porcine equivalent of HLA DR) staining approximated 
that for SWC3 until day 18 when there was a 50% increase in infiltrate density 
in wounds grafted with allogeneic keratinocyte sheet graft.
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staining for B cells (Ig l LC) and null cells (SWC6) detected only small 
numbers of positive cells beneath both types of graft at all time points.
CD 25 is an antigen associated with the IL-2 receptor and hence with cell 
activation (Barclay et al., 1997). Few cells stained positive for CD25 although 
there was an increase in detected expression at day 18 consistent with 
infiltration by activated T-cells.
7.3 Discussion
This study has succeeded in developing protocols for immunophenotyping the 
leucocytic infiltrate beneath MFG lacZnIs marked autologous and allogeneic 
cultured keratinocyte grafts in the pig. Overall, the number of surviving grafts 
at different time points was low for both autologous and allogeneic cultures. 
Nevertheless differences were detectable between autologous and allogeneic 
grafts.
Reasons for disappointing graft survival Figures may be due to a combination 
of keratinocyte compromise through in vitro manipulation; graft trauma; wound 
infection; chamber extrusion and the pro-inflammatory nature of Integra.
There are several routes by which grafts may have become infected (see 
Figure 7.7). Wounds were dressed every 4 days. The dressings are required 
to protect the graft both mechanically and from infection, whilst at the same 
time not leeching any substances that may be toxic to kératinocytes. Due to 
the protrusive nature of the chambers, it proved difficult to fashion an 
occlusive dressing. Microorganisms may have contaminated the dressings or 
may have tracked along silk stitches that secured the chamber to skin,
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contaminated and then infected the graft. The model is additionally flawed in 
that the raw wound edge circumferentially abuts onto the chamber leaking 
copious exudate that readily finds its way to the graft. Although swabs were 
not routinely taken, infection characteristic of Pseudomonas was intermittently 
seen affecting the outer dressings and gross cellulitis affected 3 pigs (15 
grafts) in which routine dressings changes were delayed due to a long Bank 
holiday weekend. Swabs taken for culture by a colleague using an earlier 
version of the model indicated rapid colonisation by coliforms (Martin R., 
personal communication).
312
Figure 7.7:
Diagram (a) illustrates various routes by which grafts applied to the wound bed
(b) may become infected.
Wound/flap edges 
abutting onto the
Contamination of 
moist dressings
chamber leaking exudate
Pathogenic microbia may 
track along suture material
(a)
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Between three and four weeks the flaps surrounding chambers contract (the 
term flap here referring to the skin and subcutaneous tissue surrounding the 
PTFE chamber that has been undermined in order to insert the chamber). 
With progressive flap contraction the chamber is gradually extruded. This on 
occasion was associated with partial flap necrosis constituting a further 
potential source of graft or wound bed infection.
Cultured sheet grafts are fragile and easily damaged. Additionally, when the 
graft is first applied to Integra™ there is no basement membrane and so graft 
adherence is initially tenuous. Removal of dressings therefore, may easily 
have resulted in some graft loss.
Integra™ is engineered to encourage cellular infiltration and may encourage a 
mild inflammatory reaction (Stern et al., 1990). Consequently a more severe 
reaction may occur to wound infection. Similarly with APCs forming a 
proportion of the infiltrative inflammatory response to Integra™, allorejection 
may occur earlier with consequent graft loss. Autologous controls were 
present on all pigs and the same cells were used on other animals as 
allogeneic grafts.
In preparation for grafting, keratinocyte sheets were lifted from culture flask 
plastic following incubation in Dispase. Sheets were in Dispase for between 
25 minutes and an hour if slow to detach, following which they were incubated 
in 1-2 ml of culture medium. It took between 3 and 6 hours to detach all the 
necessary sheets, depending on the numbers of wounds needing grafts, after 
which the sheet grafts were transported in sealed 6 well plates at room 
temperature to the animal facility 70 miles away by car prior to grafting. 
Conditions for maintaining grafts optimally were thus compromised.
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Lastly both the processes of retroviral transduction and active elimination of 
LC with antibody complement pre-treatment were seen to negatively impact 
on in vitro colony forming efficiency (chapters 3 and 4). In vivo efficiency of 
epidermal development may have similarly been compromised. Significantly, 
both auto and alio cell populations had undergone MFG lacZnIs gene 
transduction and antibody complement pre-treatment.
Positive lacZ staining seen at day 18 within the epithelium covering a wound 
grafted with allogeneic sheet graft demonstrated the contribution of allogeneic 
kératinocytes to that epithelium. The presence of allogeneic kératinocytes at 
day 18 after grafting onto Integra™ suggests that the hypothesis that LC 
depleted allogeneic keratinocyte sheet grafts are rejected after a more 
prolonged period of take than allogeneic skin grafts may be valid.
Expression of the CD1 antigen as discussed earlier (Chapter 5), by dendritic 
cells (including LC) may be related to their role in antigen presentation 
(Barclay et al., 1997). In normal porcine skin there appear to be two main 
populations of CD 1-positive cells. One population includes the epidermal LC 
population and the other is present in the papillary dermis, mostly to be found 
in relation to the superficial vascular plexuses (see Chapter 5).
Infiltration by CD 1-positive cells was seen as early as day 7 in this experiment 
(see Figure 7.6). There is no direct evidence to suggest that the CD1-positive 
cells are dendritic cells. This is however suggested by the staining pattern 
with regard to autologous and allogeneic split skin grafts (see Chapter 6.3). 
This would imply that infiltration by ARC cells such as dendritic cells occurs as 
early as 7 days. This suggests that the hypothesis ‘that host APCs are seen to
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infiltrate the graft bed prior to rejection and therefore can be involved in 
(indirect) antigen presentation’ may be true.
The staining patterns (see Figure 7.5) with regard to the pan leucocyte 
(CD45), T-cell (CD2, CD3 and CD5), T helper (CD4), T cytotoxic (CD8) and 
macrophage/granulocyte (SWC3) markers suggests that most of the observed 
day 18 pan leucocytic infiltrate is comprised of T-cells; moreover these consist 
of approximately equal proportions of CD4 and CD8-positive cells.
The pattern of SLA DR staining suggests that it may at least partly be 
accounted for by up-regulation of SLA DR expression by activated T-cells. 
The day 18 pattern would be consistent with infiltration by activated (and 
hence SLA DR upregulated) cytotoxic T-cells. Thus there is no evidence from 
this series of experiments to refute the hypothesis that rejection Is primarily 
effected through alio specific cytotoxic (CD8-positive) T lymphocytes.
The low numbers of B cell (IgX, LC) and null cell (SWC6) staining (see Figure 
7.6) is consistent with expected infiltrate densities as neither cell is thought to 
play a significant role in acute rejection.
CD25 (an antigen associated with the IL-2 receptor) was detected at 
disappointingly low rates. A small increase in expression consistent with 
infiltration by activated T-cells was seen at day 18. There might however be a 
greater number (undetected) CD25-positive T-cells which might not be 
expressing CD25 at a high enough density to be seen 
immunohistochemically, and were therfore not seen with alio SSGs either, but 
may be detected with FACS.
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Chapter 8
The fate of cultured chimeric and allogeneic keratinocyte-dermis 
composite grafts in the Large White pig
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8.1 Introduction
Skin is a complex organ in which both epidermal and dermal elements are 
interdependent and are both necessary for optimal function. The dermal ECM 
consists of an ordered insoluble matrix and attached to it are soluble proteins. 
The ECM has a variety of functions which include maintaining epidermal 
strength in the face of shearing forces, providing a cushion to forces of stress, 
as well as in mediating cutaneous wound healing (MacNeil, 1994). The evidence 
suggests that ECM function is related inherently both to the three dimensional 
structure of the insoluble matrix and the soluble proteins found within it 
(MacNeil, 1994).
Composite grafts are composed principally of dermal and epidermal elements. A 
number of centres have developed composites using a variety of techniques 
(Bell et al., 1981; Ghosh et al., 1995; Ralston et al., 1997; Dawson et al., 1996; 
Ghosh et al., 1997; Medalie et al., 1998). With regard to the dermal component, 
different types of dermal equivalent have been produced and these may be 
grouped into one of two categories.
The first consists of a biopolymer which serves to act as a three dimensional 
substitute for the insoluble elements present within extra cellular matrix 
(MacNeil, 1994). One example is Integra™ a non-regenerative dermal template 
consisting of a dermal substitute of bovine collagen and chondroltin-6-sulfate 
and an epidermal layer of synthetic polysiloxane polymer (Silastic) (Stern et al.,
1990). Many have incorporated fibroblasts into such collagen-GAG (Hansbrough 
et al., 1989; Boyce et al., 1993; Cooper et al., 1990; Cooper and Hansbrough, 
1991; Cooper et al., 1993; Eaglstein et al., 1995; Meana et al., 1998) and fibrin
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gel (Meana et al., 1998) biopolymers in an effort to reintroduce soluble proteins 
present within ECM that are conducive to maintaining a healthy Integument 
(MacNeil, 1994).
The second approach is to use natural dermis that has been rendered a cellular 
(Ghosh et al., 1997; Medalie et al., 1996a; Medalie et al., 1996b). The dual aims 
when using this approach are to rid the dermis of any cellular elements that may 
prove to be immunogenic, whilst at the same time attempting to maximise the 
preservation of basement membrane elements. With keratinocyte seeding, an 
epidermal-dermal structure resembling normal skin is apparently achieved in a 
far shorter space of time than in biopolymer alternatives (Cooper et al., 1993; 
Medalie et al., 1996a; Medalie et al., 1997).
The model described earlier (see Chapters 2 and 7) utilised skills previously 
developed in the centre which involved the application of cultured keratinocyte 
sheets onto Integra™ (Grant et al., 1998). The methods used for culturing 
keratinocyte sheets were modified, to include a different feeder cell combination, 
PT67/3T3 to enable highly efficient MFG lacZnIs transduction and SLA DR 
mediated complement lysis, to reduce LCs as described earlier (see Chapters 2, 
3 and 4). The resulting kératinocytes had reduced colony forming efficiency (see 
Chapters 3 and 4), a more limited ability to withstand successive passage and 
sheets that seemed inferior in terms of mechanical strength. Additionally, 
Integra™ appears to be mildly pro-inflammatory (Stern et al., 1990) and it was 
therefore perhaps not surprising that poor graft survival and relatively early loss 
resulted (see Chapter 7).
In an effort therefore, to produce a more robust graft with better handling 
properties and which already had basement membrane elements in place,
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methods were sought to develop a skin equivalent or composite graft with which 
to conduct further assessments of immune cell infiltrates.
There are a minimum of five steps involved in composite production; harvesting 
partial thickness skin, keratinocyte culture, de-epidermalisation of the harvested 
skin, rendering the dermis acellular, culturing kératinocytes with the dermis as 
substrate (see Chapter 2 for method and Figure 8.1).
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With regard to partial thickness skin harvest it is important to achieve a 
consistent and optimum dermal thickness. Dermis that is too thick may 
compromise the early nutrition of kératinocytes. In contrast dermis that is 
harvested too thin tends be lacy and difficult to handle. Accordingly the 
relationship between Zimmer® dermatome setting and resultant dermal 
thickness (in a single operators hands) was examined.
Several of the reported ways in which partial thickness skin may be de- 
epithelialised (Medalie et al., 1996a; Takami et al., 1996; Ghosh et al., 1997; 
Ralston et al., 1997) were evaluated. Ghosh and coworkers compared the use 
in human cadaver skin, of 1M NaCI (for 2-4 days) with PBS (7-14 days) and 
Dispase (for 1-2 hours). That study looked at the effectiveness of de- 
epidermalisation and the preservation of basement membrane elements and 
concluded that 1M NaCI and PBS are equally effective and both preserve 
basement membrane elements (Ghosh et al., 1997). An advantage with using 
1M NaCI over PBS is that de-epidermalisation is achieved far more quickly. 
Dispase was shown to remove basement membrane components (Ralston et 
a!., 1997). Medalie and colleagues subjected partial thickness human cadaver 
skin to three freeze-thaw cycles prior to a week of immersion in PBS in order 
to de-epithelialise the skin (Medalie et al., 1996a).
Accordingly in this study, a comparison of methods of de-epithelialising partial 
thickness porcine skin (immersion in 1M NaCI both on its own and preceded 
by three freeze-thaw cycles) was undertaken.
Previous researchers have immersed de-epithelialised human dermis in 
distilled water (Ralston et al., 1997), or PBS (Ghosh et al., 1997; Medalie et 
al., 1996a) for 4 weeks to render it acellular. Accordingly a study comparing
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the effectiveness of PBS In rendering porcine dermis acellular against distilled 
water was undertaken.
The results obtained using the keratinocyte-lntegra™ model described in 
Chapter 7 were inefficient owing to difficulties in maintaining the grafts for a 
sufficient period to obtain statistically valid results when significant numbers of 
grafts were lost. The aim therefore with this series of experiments was to 
develop a more robust model in the form of viable keratinocyte - dermal 
composites and to then test the hypotheses set out in the last chapter, within 
this new context.
To re-capitulate, the hypotheses were:
(a) that LG depleted allogeneic kératinocytes (within composite grafts) are 
rejected after a more prolonged period of take than allogeneic skin grafts
(b) that host APCs are seen to infiltrate the graft bed prior to rejection and 
therefore may be involved in (indirect) antigen presentation
(c) that rejection is primarily effected through alio specific cytotoxic T 
lymphocytes.
Additionally I sought to examine the fate of chimeric composite grafts. These 
are keratinocyte-dermal composites with the epidermal element consisting of 
allogeneic and autologous cells co-cultured in predetermined proportions. 
There is evidence emerging (in murine species), that these may have a 
considerable survival advantage (Rouabhia et al., 1995; Suzuki et al., 1995). 
This may be due to only gradual allogeneic keratinocyte loss with minimal 
bystander damage. The hypothesis to verify was therefore, that composites 
containing allogeneic and autologous keratinocyte elements in a 50:50 ratio
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may last Indefinitely with gradual replacement of the alio kératinocytes by the 
cultured autologous elements.
In developing the composite model the techniques of lacZnIs keratinocyte 
labelling were utilised and LC elimination by complement lysis evolved 
previously. The immunohistochemica! immunophenotyping techniques 
employed were as previously described (Chapter 2 for method and Chapters 
5-7). In order to focus just on the host animal response to cultured allogeneic 
kératinocytes an important aspect of the study was to ensure that autologous 
dermis was used. It was essential though that this was rendered acellular, 
otherwise regeneration of autologous epidermal elements would complicate 
the analysis for immuno infiltrates, as might the survival of dermal dendritic 
cells.
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8.2 Results
8.2.1 Evaluation of methods for deepidermalisation of split
thickness skin and methods for rendering the resultant 
dermis acellular
Four regimes were compared, two of which commenced with 96 hours in 1M 
NaCI following which the epidermis was peeled off. This was then followed 
either by immersion for four days in distilled water and antibiotics and 
incubated at a constant 37°C, 98% relative humidity and 10% CO2
concentration or by immersion for an identical period under the same
conditions in phosphate buffered saline (PBS) and antibiotics. The other two 
regimes were identical except for initially undergoing 3 freeze thaw cycles in 
liquid nitrogen (see Chapter 2 for method).
At day eight, the processed dermis was assessed for the presence of cellular 
elements (propidium iodide and H&E), and for the presence of basement 
membrane zone collagen VII (see Figures 8.2 - 8.3).
Freeze thawed strips appeared to have reduced anti-collagen VII staining, 
possibly indicating a relative reduction in basement membrane integrity. Of 
the non freeze thawed preparations, the distilled water treated group
appeared to be rendered more acellular, with less evidence of cellular
remnants, with no impairment in collagen VII staining. It was therefore 
apparent that the method of choice is to use distilled water in order to render 
the dermal strips acellular, without prior freeze thawing so as to maximally 
preserve basement membrane elements.
325
Figure 8.2: Photomicrographs of processed dermis stained with H&E 
All sections were taken from dermis harvested with the Zimmer® dermatome 
at setting numbers 8 (a-d), and 16 (e-h). Dermal strips were initially subjected 
to three freeze thaw cycles and immersed in 1M NaCI for 4 days followed by 4 
days of PBS (a and e) or immersed in 1M NaCI for 4 days followed by 4 days 
of distilled water (b and f); (c and g) and (d and h) were treated in an identical 
manner to (a and e) and (b and f) respectively,, with the exception of the initial 
freeze thaw cycles. All media had 2.5pg per ml of amphotericin, lOOiu per ml 
penicillin, lOOpg per ml streptomycin and lOpg per ml ciprofloxacin added.
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Figure 8.3: Processed dermis stained with FITC anti-collagen VII and
propidium iodide
Photomicrographs were taken at X 100 ((a), (d), (g), (j), (m), (o), (q) and (s)), 
X 200 ((b), (e), (h), (K)) and X400 ((c), (f), (i), (I), (n), (p), (r) and (t)) 
magnification.
All sections were taken from dermis harvested with the Zimmer dermatome at 
setting numbers 8 ((a)-(l), and 16 ((m)-(t)).
Dermal strips were initially subjected to three freeze thaw cycles and 
immersed in 1M NaCI for 4 days followed by 4 days of PBS ((a)-(c) and (m)- 
(n)) or immersed in 1M NaCI for 4 days followed by 4 days of distilled water 
((d)-(f) and (o)-(p)); Dermal strips ((g)-(i) and (q)-(r)) and ((j)-(l) and (s)-(t)) 
were treated in an identical manner to ((a)-(c) and (m)-(n)) and ((d)-(f) and (o)- 
(p)) respectively, with the exception of the initial freeze thaw cycles. All media 
had 2.5pg per ml of amphotericin, lOOiu per ml penicillin, lOOpg per ml 
streptomycin and lOpg per ml ciprofloxacin added.
The two principle conclusions from this study were that freeze thaw cycles 
appeared to diminish the quality of basement membrane zone collagen VII 
(BM) but not the degree of dermal cellularity. Additionally treatment with 
distilled water is superior to PBS in rendering dermis acellular (denoted by 
lack of propidium iodide staining) in the time period examined (without causing 
gross damage to the quality of basement membrane zone collagen VII).
Zimmer setting 8 Zimmer setting 16 ^
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8.2.2 Evaluation of the variation of dermal thickness with
Zimmer® dermatome setting
The thickness of the dermal element needs to be such that nutrition both in 
vitro and in vivo in the days prior to ‘bio-integration’, and consequently survival 
of the epidermal elements is not compromised. Skin harvested too thin 
however, tends to be ‘lacy’ (containing large holes), and to be difficult to 
handle. In the following evaluation therefore, partial thickness skin harvested 
from the paravertebral region using the dermatome at 3 different settings were 
compared. The lowest setting was 8, below which harvested skin was too thin 
and ‘lacy’. The highest setting was 16 above which skin was too deeply 
harvested amounting almost to full thickness.
After the first four days (in 1M NaCI) the epidermis was peeled off and 
thickness of dermis gauged (see Figure 8.4). The was no significant 
difference in measurements between the freeze thawed and non freeze 
thawed groups. The dermatome setting of 12 which produced dermis of 
approximately 14P|im following processing was adopted for future use. This 
dermatome setting consistently produced thin dermis with workable 
mechanical strength. Additionally, holes (occurring at regular intervals and 
relating to emerging hair follicles) were not too numerous or too large as to 
render the dermis difficult to use.
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Figure 8.4: Assessment of processed dermis thickness
Following 96 hours in 1M NaCI epidermis was stripped off and the thickness 
of the dermis measured using a dial gauge micrometer. Dermal thickness was 
measured in 3 places after the gauge had settled (the pressure of the spring 
dial gauge tended to reduce the initial reading by at least 10 pm by 
compressing the dermis). The measurement was repeated and an average 
recorded. There were two groups compared, (n=2 in each group). One which 
undenwent three freeze thaw cycles (placed in cryostat tube and immersed in 
liquid nitrogen for 3 minutes followed by immersion in a 37°C water bath) and 
one which did not. The measurements between the two groups are not 
significantly different. Inconsistencies seen at settings 10,14 and 18 may be 
related to the pressure applied when harvesting the split skin (lower pressure 
= thinner strips) and to minor inconsistencies in the area from which partial 
thickness skin was obtained from (harvesting the flanks away from the 
paravertebral region tends to result in less even and thinner strips).
The dermatome setting of 12 which produced dermis of approximately 140pm 
was adopted for future use as dermis excised at a lower setting consistently 
proved too full of holes and flimsy for use.
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8.2.3 Evaluation of keratinocyte seeding numbers onto
acellular dermis and culture media
Plating efficiency of pig kératinocytes (using Opti-MEM®1 with 1% fetal calf 
serum at 0.5mM calcium on collagen-1 and 3T3 feeders) varies from 
approximately 1.2% for primary and secondary kératinocytes to between 11 
and 17% for multiply passaged kératinocytes and varies considerably with 
medium and plating substrate (Bevan et al., 1997). The composites under 
investigation did not have prior seeding of fibroblasts and differ in surface 
structure from collagen-coated plastic flasks. The quality of epithelium 
achieved at different seeding densities was compared. Seeding densities 
used by other researchers in the manufacture of composites range from 
5X10"^  to 1.3 X 10® per cm^ (Bell et al., 1981; Ghosh et al., 1997; Medalie et 
al., 1996a; Ralston et al., 1997).
P4 porcine kératinocytes that had not undergone complement lysis or 
retroviral transduction were seeded onto acellular dermis (previously treated 
with 1M NaCI followed by distilled water with no freeze thawing -  see Section 
8.2.1) at densities of 1.38X10® per cm ,^ 4X10® per cm  ^and 1.38X10® per cm  ^
(see Figure 8.5). Composites were cultured for eight days with either with the 
traditional Rheinwald and Green’s medium (Rheinwald and Green, 1975) or 
with Opti-MEM®1 with 1% fetal calf serum at 0.5mM calcium (Bevan et al., 
1997).
Composites were assessed by H&E staining (see Figure 8.6) and 
immunohistochemically with moABs specific for collagen VII (basement 
membrane) (see Figure 8.7), keratin 14 (expressed by most kératinocytes)
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(see Figure 8.8), keratin 6 (expressed by proliferating kératinocytes) (see 
Figure 8.9), and keratin 10 (expressed by mature epidermal kératinocytes). 
Quality of cover was assessed in terms of numbers of epithelial layers and 
adherence to the underlying papillary dermis. Prior to freezing, the composites 
were folded (rather than rolled) into a tube. A single section taken 
longitudinally from the tube therefore allowed assessment of the composite at 
multiple levels.
Results (Figure 8.6) suggest that the best quality of cover in terms of numbers 
of epithelial layers and adherence to the underlying papillary dermis is 
achieved at a seeding density of 1.38X10® per cm  ^when cultured with Opti- 
MEM®1 (with 1% fetal calf serum at O.SmM calcium).
The marker for keratinocyte differentiation, cytokeratin 10, could not be 
detected in any of the systems (although it was seen in skin sections used as 
the positive control).
There was more even and apparently increased expression of cytokeratin 14 
and 6 (Figures 8.8 and 8.9) with higher seeding densities.
Collagen VII is normally present at the dermo epidermal junction (as part of 
the basement membrane complex). Some reports have suggested that 
kératinocytes alone may synthesise collagen VII (Konig and Bruckner- 
Tuderman, 1991; Konig and Bruckner-Tuderman, 1994). Results here 
suggest (although tests were not quantitative) that collagen VII expression 
(Figure 8.7) did not appear to grossly increase or diminish with any particular 
seeding density.
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Figure 8.5: Development of composite grafts
When epidermis is separated from dermis a marker stitch (s) is placed to 
indicate the papillary aspect. It is then placed in a 5cm diameter petri dish 
held to the bottom with suction and seeded with kératinocytes and culture 
medium made up to 3ml. On the second day following seeding, the sheets 
were gently transferred to and stretched over sterile stainless steel meshes 
(a) and held in place with integral clips (b). The meshes or grids are placed in 
9cm diameter petri dishes and culture in 20-30ml of medium.
Y
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Figure 8.6: Comparison of keratinocyte seeding densities and culture
media
Photomicrographs of H&E stained sections of acellular dermis seeded with 
kératinocytes at varying seeding densities and cultured with either Green’s 
((g)-(k)) or Opti-MEM®1 ((a)-(f)) (with 1% fetal calf serum and 0.5mM CaCI) for 
10 days. Images (a), (e), (h) and (j) were photographed at X I00, (c), (g), (i) 
and (k) at X200 and (b), (d) and (f) at X400 magnification. Composites were 
cultured in duplicate (in terms of culture medium and seeding density). Quality 
and consistency of cover was poorest following a seeding density of 1.38X10® 
per cm  ^with either Green’s (g) or Opti-MEM®1 (a) and (b), and best at a 
seeding density of 1.38X10® per cm^ with a more consistently multilayered 
epithelium when grown with Optimem (1% fetal calf serum and 0.5mM CaCI) 
(e) and (f) than with Green’s (j) and (k).
The most stark difference in quality of epithelial cover depending on the 
culture medium used was seen with composites seeded at a density of 4X10® 
per cm  ^ , with superior cover in terms of numbers of layers (2-3 with >3 in 
places) and quality of adherence to underlying dermis seen when cultured 
with Opti-MEM®1 (c) and (d) as opposed to Green’s (h) and (i).
(d)«î tf
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Figure 8.7: Comparison of keratinocyte seeding densities and culture
media with regard to collagen VII 
Photomicrographs of collagen VII - FITC stained sections of normal porcine 
skin ((a) and (b)) and acellular dermis seeded with kératinocytes at varying 
seeding densities (1.38X10® per cm  ^(c) and (h); 4X10® per cm  ^(d), (e), (i) and 
(j) and 1.38X10® per cm  ^ (f), (g) (k) and (I)) and cultured with either Green’s 
((h), - (I)) or Opti-MEM®1 (with 1% fetal calf serum and 0.5mM CaCI) ((c) - 
(g)) for 10 days. All images were photographed at X200 magnification with the 
exception of (b) and (I) (both at X400). Composites were cultured in duplicate 
(in terms of culture medium and seeding density). There was no discernible 
difference in consistency of collagen VII expression at any seeding density or 
with any medium.
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Figure 8.8: Comparison of keratinocyte seeding densities and culture
media with regard to cytokeratin 14 
Photomicrographs of Cytokeratin 14 - FITC stained sections of normal porcine 
skin ((a) and (b)-hair follicle) and acellular dermis seeded with kératinocytes at 
varying seeding densities (1.38X10® per cm  ^ (c), (d), (i) and (j); 4X10® per cm  ^
(e), (f), (k) and (i) and 1.38X10® per cm  ^(g), (h) (m) and (n)) and cultured with 
either Green’s ((i), - (n)) or Opti-MEM®1 (with 1% fetal calf serum and O.SmM 
CaCI) ((c) - (h)) for 10 days. Images (a), (b), (c) and (I) were photographed at 
X I00, (j), (k) and (I) at X200 and (d), (e), (f) and (h) at X400 magnification. 
Composites were cultured in duplicate (in terms of culture medium and 
seeding density). As with collagen VII, there was no discernible difference in 
consistency of K-14 expression at any seeding density or with any medium.
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Figure 8.9: Comparison of keratinocyte seeding densities and culture
media with regard to cytokeratin 6 
Photomicrographs of cytokeratin 6 - FITC stained sections of normal porcine 
skin ((a) and (b)) and acellular dermis seeded with kératinocytes at varying 
seeding densities (1.38X10® per cm  ^(c) and (h); 4X10® per cm  ^(d), (e), (i) and 
(j) and 1.38X10® per cm  ^ (f), (g) (k) and (I)) and cultured with either Green’s 
((h), - (I)) or Opti-MEM®1 (with 1% fetal calf serum and O.SmM CaCI) ((c) - (g)) 
for 10 days. .
Images (a), (b), and (f) were photographed at X I00, (c), (d), (e), (g), (i), (h) 
and (k) at X200 and (j) and (I) at X400 magnification.
Composites were cultured in duplicate (in terms of culture medium and 
seeding density).
As with K-14 and collagen VII there was no discernible difference in 
consistency of K-6 expression at any seeding density or with any medium.
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8.2.4 Survival of keratinocyte-dermal composite grafts in the
Large White pig
The composite graft was developed (Figure 8.5) in order to evolve a model 
that was robust, easier to handle than Dispase released sheet grafts (see 
Figure 8.10), incorporated a basement membrane and did not encourage an 
inflammatory reaction. In vitro the best quality of epithelial cover was achieved 
with a seeding density of 1.38X10® per cm^ (see 8.2.3).
Six pigs were grafted with composites (see Table 8.1a and Figure 8.11). Only 
13% of wounds at time of harvesting were found to have surviving epithelium 
(Table 8.1b). None of the autologous composites survived to 28 days. One 
allogeneic composite survived to 21 days with nuclear localised blue staining 
on incubation with X-Gal confirming that the epithelium originated with the 
graft (Figure 8.12). One chimeric composite graft was seen at 14 days (Figure 
8.13) and two at 21 days
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Figure 8.10: Cultured keratinocyte sheet graft
Photomicrograph showing cultured sheets following dispase treatment, 
stained with H&E (a); and anti cytokeratin 14 (b). Note that the epidermal 
sheets are only 1 - 2  cells deep. In addition in separate sections collagen VII 
was sought but was not detected (not shown as there was no fluorescence 
and therefore could not be seen or photographed). All images were 
photographed at X400 magnification.
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Figure 8.11: Time line showing progression from split skin harvest to 
composite grafting
Day 8 Day 11 Day 14
)kin harvest PI P2
Dermis processing ------
Day 22+
P3 Composite grafting
Keratinocyte seeding
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Figure 8.12: Allogeneic composite graft
Photomicrograph ((a) X 100, (b) X 400) of an H&E and X-Gal stained section 
from a wound grafted with an allogeneic composite graft 21 days previously. 
The dermis is autologous although rendered acellular. The blue stain confirms 
the origin of the kératinocytes. There is a characteristic fall off in the 
proportion of p-gal expressing kératinocytes.
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Table 8.1: Table (a) illustrâtes the types of wounds harvested at particular
time points. Table (b) illustrates the fraction of wound types 
harvested that were shown to have epithelial cover.
( a ) Wound Harvest Time Points (Days) 14 21 28
Types of 
Graft Applied 
to wounds (#)
Autologous Composite 4 6
Allogeneic Composite 3 4 3
Chimeric Composite 3 5 2
Control 2 3 1
(b)
Wound Harvest Time Points (Days) 14 21 28
Fraction of wounds that 
showed epithelium as 
identified histologically 
with H&E staining at 
time of harvest
Autologous
Composite
0/4 0/6 —
Allogeneic
Composite
0/3 1/4 0/3
Chimeric
Composite
1/3 2/5 0/2
Control 0/2 0/3 0/1
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8.2.5 Lac Z marking of cultured kératinocytes within
composite grafts in the Large White pig
As with keratinocyte sheet grafts (grafted onto Integra™) the kératinocytes 
had undergone 3 passages on feeder cells comprising the retroviral producer 
cells PT67 clone 8 and 3T3 fibroblasts in a 2:1 ratio. This was followed by a 
further passage on feeder cells consisting of 3T3 fibroblasts alone.
At 14 days the pattern of positive lacZ staining within epithelium on wounds 
grafted with chimeric composite delineated groups of proliferative 
kératinocytes that were p-gal expressing, and therefore clearly of allogeneic 
origin, and those that were not and may therefore have been of autologous 
origin (see Figure 8.13).
At day 21 lacZ-positive staining, evenly distributed within epithelium, covering 
a wound grafted with allogeneic composite (see Figure 8.12) clearly 
demonstrates the contribution of allogeneic keratinocyte to that epithelium.
The day 21 surviving allogeneic and chimeric composite grafts appeared 
healthy. By day 28 (1 pig with 2 wounds grafted with chimeric composite and 
3 with allogeneic composite) however, epithelium was not detected.
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Figure 8.13: Chimeric composite graft
Photomicrograph ((a) X 100; (b) X 200; (c) X 400) of an H&E and X-Gal 
stained section from a wound grafted with a chimeric composite graft 14 days 
previously. The dermis is autologous and rendered acellular. The chimeric 
graft is constructed with equal proportions of kératinocytes from allogeneic 
and autologous origins seeded onto the dermis. The allogeneic component 
was transduced and the blue stain confirms their origin. The division between 
blue and non blue staining epidermal cells may reflect the mixed origin of cells 
seeded (although the proportion of p-gal expressing kératinocytes in vivo 
appears to fall with time). Note the multilayered hyperproliferative epithelium.
343
8.2.6 Immunophenotyping results
As with the previous study (see Chapter 7) poor graft survival precludes the 
drawing of significant conclusions. Sufficient material was retrieved at days 14 
and 21 however, to allow for useful analysis of graft bed infiltrates.
A panel of 12 porcine-specific monoclonal antibodies was used (see Chapter 
6 Table 6.1, for brief description and Chapter 5 for a more in depth discussion 
of the markers) in the immunohistochemical analysis of graft bed infiltrates.
As with the previous study, two to five sections per wound were stained using 
the nickel-enhanced ABC method and additionally incubated for twenty 
minutes in X-Gal (apart from CD4 and lgX,LC which were detected using Cy3 
-  an immunofluorescent dye). Using an optical grid, counts were taken from 
five random fields (0.04mm^) per section at X200 magnification to a depth of 
0.5mm below the epidermis (apart from CD4 and IgA, LC which were counted 
at X4Q0 magnification and there each field was 0.01 mm^) (see Table 8.2 and 
Figures 8.14-8.15).
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Table 8.2: Log of animal and wound processing (composite grafts applied
to deep fascia) (a)
Monoclonal
Antibody
Specificity
Microscopemagnification
Field
Surface
Areau^
Day 14 
Chimeric Composite
Day 21 
Chimeric 
Composite
Day 21 
Allogeneic 
Composite
CD1 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
CD2 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
CD3 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
CDS 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 2 1 1
Fields 10 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
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Table 8.2: Log of animal and wound processing (composite grafts applied
to deep fascia) (b)
Monoclonal
Antibody
Specificity
Microscope
magnification
Field
Surface
Areaiii^
Day 14 
Chimeric 
Composite
Day 21 
Chimeric 
Composite
Day 21 
Allogeneic 
Composite
CD4 400X 10,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 2 1 1
Fields 10 6 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
CD8 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
SLADR 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fie ids/section 5 5 5
SWC3 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
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Table 8.2: Log of animal and wound processing (composite grafts applied
to deep fascia) (c)
Monoclonal
AntibodySpecificity
Microscopemagnification FieldSurface
Areaju^
Day 14 
Chimeric 
Composite
Day 21 Chimeric 
Composite
Day 21 Allogeneic 
Composite
CD45 200X 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
IgXLC 400X 10,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 2 1
Fields 5 10 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
CD25 X200 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
SWC6 X200 40,000 Animals 1 1 1
Wounds 1 1 1
Blocks 1 1 1
Sections 1 1 1
Fields 5 5 5
Non littermate 
donors
1 1 1
Fields/section 5 5 5
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Figure 8.14: Bar charts illustrating manual counts within the infiltrate of 
wounds grafted with chimeric or allogeneic cultured porcine keratinocyte- 
dermai composite grafts onto deep fascia and harvested at days 14 and 21 
(see 8.2.6). Sections were examined with each monoclonal antibody. Blocks 
from ail chimeric or allogeneic cultured composite grafted wounds were 
examined and sections (see Table 8.2(a)-(c)) from wounds with surviving 
epithelium were stained with monoclonal antibody with antigen-specificities 
delineated in chapter 6 table 1 and then secondarily stained using the avidin 
biotin complex (ABC) immunoperoxidase technique (CD4 and igXLC 
secondarily labelled with Cy3). Included on the right hand side of each graph 
are the results for normal porcine skin and autologous and allogeneic split 
skin graft 10 days post grafting (adapted from chapter 6 Figures 6.4 and 6.5).
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Figure 8.15: Bar charts illustrating manual counts within the infiltrate of 
wounds grafted with chimeric or allogeneic cultured porcine keratinocyte- 
dermal composite grafts onto deep fascia and harvested at days 14 and 21 
(see 8.2.6). Sections were examined with each monoclonal antibody. Blocks 
from all chimeric or allogeneic cultured composite grafted wounds were 
examined and sections (see Table 8.2(a)-(c)) from wounds with surviving 
epithelium were stained with monoclonal antibody with antigen-specificities 
delineated in chapter 6 table 1 and then secondarily stained using the avidin 
biotin complex (ABC) immunoperoxidase technique (CD4 and lg>.LC 
secondarily labelled with Cy3). Included on the right hand side of each graph 
are the results for normal porcine skin and autologous and allogeneic split 
skin graft 10 days post grafting (adapted from chapter 6 Figures 6.4 and 6.5).
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8.2.6.1 Immunophenotyping of cultured chimeric and allogeneic
keratinocyte-dermal composites grafted onto deep fascia in 
the Large White pig
The density of the pan leucocyte (CD45) infiltrate is similar below allogeneic 
and chimeric grafts at both time points (Figure 8.14). It is similar or only 
slightly increased than that seen with normal porcine skin and autologous split 
skin graft (at day 10). This infiltrate (unlike that seen with allogeneic 
keratinocyte sheet graft - see Chapter 7 Section 7.2.3) consisted of SWC3- 
positive cells (macrophages/granulocytes) and T-cells (CD2, 3,and 5-positive 
cells), with SWC3 cells predominating. Additionally, the T-cell population 
contained both GD4 and CD8-positive cells (with CD4 numbers apparently 
predominant within day 21 allogeneic graft infiltrate) but it is not possible to 
come to any conclusion concerning the proportion of single vs. dual 
expression.
The density of infiltrating SLA DR-positive cells was similar to that seen with 
normal porcine skin and autologous split skin graft (at day 10). The density of 
infiltrating dendritic cells (GDI) is similarly comparable with infiltrate densities 
within normal porcine skin and following grafting of autologous split skin (at 
day 10) (see Figure 8.15).
As with earlier studies the densities of GD25 (IL-2)-positive cells, null cells 
(SWG6) and B cells (Ig l LG-positive) within graft bed infiltrates remained very 
low (see Figure 8.15).
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8.3 Discussion
Many of the reasons for poor take of sheet grafts given in the previous 
chapter are equally applicable here. They include the predisposition to 
infection and chamber extrusion and laboratory manipulation of kératinocytes. 
An advantage with grafting onto Integra™ is that the wound bed is well 
vascularised, consisting effectively of controlled granulation with a degree of 
collagen support. In the present study, the composites were grafted onto 
freshly excised muscle fascia rather than biointegrated Integra™. The model 
may therefore have performed disappointingly due to poor early 
vascularisation of the dermal component. The model may therefore be 
criticised in an over reliance on the reasonable take results reported by others 
(Medalie et al., 1996a; Medalie et al., 1996b) and not performing smaller pilot 
studies to evaluate the system in vivo. Incorporation of cultured fibroblasts 
into the processed dermis as described in other skin equivalent systems 
(Ghosh et al., 1997) may have improved keratinocyte attachment, proliferation 
(Maruguchi et al., 1994; Boyce et al., 1993; Boyce et al., 1995) and 
differentiation (Krejci et al., 1991; Démarchez et al., 1992; MacNeil, 1994).
In conclusion, although the take of these composites was not any better than 
cultured sheet grafts, they were considerably easier to handle and the 
resulting epithelium looked more robust.
(3-galactosidase expression by both chimeric and allogeneic composites at 21 
days following grafting suggests that the hypothesis stating that LC depleted 
allogeneic kératinocytes within composites are rejected after a more
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prolonged period of take than allogeneic skin grafts (see Chapter 6) may be 
valid.
Host APCs were seen to have infiltrated the graft at day 14. Hence, the 
hypothesis that 'host APCs are seen to infiltrate the graft bed prior to rejection 
and therefore could be involved in (indirect) antigen presentation’ may be 
valid.
Beneath a graft bed undergoing classical acute rejection an infiltrate dense 
with activated cytotoxic T-cells and macrophages are expected (Rosenberg 
and Singer, 1992). The character of the infiltrate beneath all composites 
examined, judging by the numbers of SLA DR, SWC3, CD8 and CD25- 
positive cells within the infiltrate (Figure 8.14 and 8.15), is not suggestive of 
an acute rejection effector response. A rejection response was not overtly 
evident. Many other factors may have contributed to composite graft loss. 
This experiment can not therefore address the hypothesis that 'rejection is 
primarily effected through alio specific cytotoxic T lymphocytes’.
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Chapter 9
Discussion
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This series of experiments explored, within a Large White pig model, the 
rejection of transplanted cultured allogeneic kératinocytes from which LCs had 
been actively eliminated. The study evolved from being principally concerned 
with immunological events surrounding transplantation of allogeneic 
kératinocytes to one additionally involved with the bioengineering of skin 
equivalents in the search for a suitable model.
Initial experiments were concerned with gene transduction studies the aim 
being keratinocyte labelling that would allow tracking following transplantation. 
Experiments were concerned with attaining 100% keratinocyte transduction 
and for this to remain constant following multiple cell replication. The process 
of transduction was examined for its effect on keratinocyte clonogenic 
potential.
Following cloning and transduction studies with several different packaging 
and producer cell lines, a high titre producer cell line was formed which 
proved capable of almost 100% transduction of porcine kératinocytes. The 
process resulted unfortunately, in an in-vitro reduction in both size and 
numbers of colonies formed when compared with non-transduced 
kératinocytes that had undergone an equivalent numbers of passages. 
Keratinocyte replication potential also appeared markedly diminished after 7- 
10 passages.
The effect of the transduction process on kératinocytes in vivo following 
grafting remains unclear. In the first set of grafting experiments in which 
cultured keratinocyte sheets were grafted onto Integra™, both autologous and 
allogeneic kératinocytes were transduced with the MFG lacZnIs construct. 
Neither was seen by 21 days following grafting. In the next set of experiments
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involving the grafting of epidermal-dermal composites directly onto deep 
fascia, transduced cells were evident 21 days after grafting. The majority of 
kératinocytes had by that stage lost the nuclear localised p-galactosidase 
gene. Further study of the transduction method would be useful to understand 
which aspects of the transduction protocol are harmful to kératinocytes. These 
may be modified so as to evolve a method that is stable and does not damage 
keratinocyte clonogenic potential.
LC are considered key to the initiation of an acute rejection response to 
allotransplanted skin (Rosenberg and Singer, 1992). In an attempt to prolong 
survival of allotransplanted cultured epithelium, this study sought to actively 
eliminate LCs. It is widely asserted that LCs are not detected following plating 
and passage within a keratinocyte culture system (Morhenn et al., 1982; 
Hefton et al., 1984; Thivolet et al., 1986). The presence of LCs within a 
keratinocyte culture system has however been demonstrated, even following 
several weeks of culture (Demidem et al., 1986), although morphological and 
functional antigens appear to be progressively lost. As the keratinocyte culture 
system developed in our Centre is designed to prevent kératinocytes 
differentiating (Bevan et al., 1997), in this environment LCs might also de­
differentiate making their detection difficult. Additionally, the phenotypic 
behaviour of LCs in our porcine keratinocyte culture system has not as yet 
been characterised and it is possible that a significant number of LCs survive 
the culture process all be it in a de-differentiated state. To therefore produce a 
LC-free culture, a step involving LC elimination was incorporated into the 
keratinocyte culture protocol. This was found to be most efficient if following
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enzymatic disaggregation of epidermal cells the cells are incubated overnight 
in culture medium. The method used was similar to that used by researchers 
involved in the elimination of dendritic cells prior to the transplantation of other 
cell types (Faustman, 1995). It involved incubation with SLA DR-specific 
monoclonal antibody followed by incubation with complement. The moAB 
bound to the SLA DR-expressing LC to which complement was then bound 
inducing lysis. Following treatment there were no detectable LCs. There was 
little apparent difference between complement types from four different 
sources in the effectiveness of LC elimination or levels of non-specific cell 
death. Antibody - complement pre-treatment was however shown to affect, in 
a detrimental manner, colony-forming efficiency (both size and numbers of 
colonies formed).
Since the first international workshop to define swine cluster of differentiation 
(CD) antigens in the late 80’s, porcine-specific moABs have become 
increasingly available. Immunohistochemical techniques have not been 
evaluated with regard to many of these and very few indeed have been used 
in relation to normal porcine skin. Indeed there are no published reports 
describing immunohistochemical staining of normal porcine skin. It was 
important therefore to establish a baseline in terms of the density of the white 
cell population within normal porcine skin.
The infiltrate within normal porcine skin was therefore examined using a panel 
of (mostly) recently available monoclonal antibodies. Two positive controls 
were incorporated. These were peripheral blood white cells and jejunal villi 
both from Large White pigs. LCs were found to account for approximately
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4.7% of epidermal cells and stained positively with a variety of moAB 
including SWC3 (stains cells of myeloid origin), CD1, CD45 (pan-leucocyte 
stain) and moABs specific for SLADP, SLADQ and SLADR (MHC class II 
antigens). The papillary dermis was most densely populated with white cells. 
A variety of moABs detecting different 'pan T-cell’ determinants (present on 
majority of T-cells) were used with apparently similar rates of T-cell detection. 
Approximately 20% of the dermal leucocytes were shown to be CD1-positive. 
Within the T-cell population a greater number of T-cells expressed the CD4 
than the CD8 antigen. In immunological terms this implies more T-cells with 
helper phenotype than suppressor or cytotoxic (or dual helper/suppressor) 
phenotypes.
The density of MHC II expression is consistent with levels of CD1 (dendritic 
cell) and SWC3 (cells of myeloid origin) staining. IgX LC (B cell), null cell 
determinant and IL-2R antigen were all detected in low numbers mostly found 
in the papillary dermis although null cells were also seen clustered around 
hair follicles deep in the reticular dermis.
Porcine skin was found to differ in terms of its immune cell population in 
certain respects from porcine jejunum. Within porcine jejunum CD8-positive T- 
cells were almost entirely located within or adjacent to the intraepithélial 
compartment reflecting the relatively precise localisation and 
compartmentalisation of white cells. Leucocyte distribution within the dermis 
however, appears less rigorously organised and may reflect very different 
environmental conditions and functions.
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The study was next concerned with the immune cell infiltrate in acute 
allorejection of split skin graft in the Large White pig. This helped establish a 
baseline-positive control. It also confirmed that a true allorejection response 
was possible in this Large White pig population. By day 10 grafts were seen to 
have been rejected. Immunohistology at this time demonstrated the classical 
pattern of increased numbers of both T-cells and macrophages within the 
infiltrate. CD 1-positive cell numbers were not raised above baseline 
expression in normal porcine skin although numbers of MHC II and SWC3- 
positlve cells as well as T-cells and IglLC expressing cells were increased.
The study next proceeded to examine allotransplantation (through grafting) of 
cultured keratinocyte sheets onto Integra™ (a non-regenerative dermal 
template). Kératinocytes had undergone antibody complement pre-treatment 
to eliminate LCs and gene transduction with the MFG lacZnIs construct in 
order to facilitate identification of keratinocyte origin. Keratinocyte sheets were 
grafted onto biointegrated Integra™ that had been grafted onto deep fascia 10 
days previously.
Wounds were harvested up to four weeks following grafting. In only 37% of all 
wounds was epithelium detected. Wounds harvested after 18 days failed to 
demonstrate any epithelium at all. 52% of wounds harvested up to 18 days 
demonstrated epithelium. As discussed at length in Chapter 7, the 
disappointing epithelium detection rate may be related to problems with both 
the pig chamber model and method of keratinocyte culture, which require 
further investigation.
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p-galactosidase staining confirmed the presence of allogeneic epithelium 18 
days following grafting. At days 21 and 28 no allogeneic epithelium could be 
detected (in 6 wounds -  2 animals).
Infiltration by GDI-positive cells was seen to occur as early as day 7 with 
numbers of infiltrating GDI-positive cells close to that of normal porcine skin. 
There was little change in infiltrate density beneath allografted wounds with 
regard to the remaining antigenic determinants until day 18 where a rise was 
apparent. Staining for the SWC3 determinant suggests that 
macrophages/granulocytes do not form a significant proportion of the increase 
in the day 18 infiltrate. A three to fourfold increase in CD5-positive infiltrate 
density (pan T-cell determinant) in allografted wounds was seen at the day 18 
time point. This increase in infiltrate density was further reflected with CD4 
and CD8 labelling. SLA DR staining approximated that for SWC3 until day 18 
when there is a 50% increase in infiltrate density in wounds grafted with 
allogeneic cultured keratinocyte sheet graft.
B cells (Ig l LG) and null cells (SWG6) were sparsely detected at all time 
points. There was an increase in detected GD25 expression at day 18 
consistent with infiltration by activated T-cells.
Results from this experiment suggest acute rejection occurring between 14 
and 18 days effected principally by activated T-cells which is preceded by 
dendritic cell infiltration approximately 10 days previously.
Keratinocyte-dermal composite grafts were devised in an effort to improve the 
mechanical robustness of the model. These composite grafts consisted of 
autologous dermis upon which was cultured allogeneic, chimeric or
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autologous epithelium. The kératinocytes making up the epithelium underwent 
active LC elimination and had then been passaged 4 times (allowing MFG 
lacZnIs transduction) in an identical manner to the kératinocytes used with 
Integra™.
Epithelium was seen on fewer wounds (13% at day 28, 16% at day 21) than 
with cultured keratinocyte sheet graft onto Integra™. However the surviving 
epithelium looked healthier and mechanically more robust, p-galactosidase 
staining of allogeneic epithelium was demonstrated at 21 days following 
grafting.
Analysis of the immune infiltrate at 21 days revealed similarities to skin and 
the wound bed beneath an autologous split skin graft. This result and the 
robust healthy appearance of the grafts suggest that rejection had not 
occurred and was not happening at that stage. Lack of epithelium seen at 28 
days may be related to flaws inherent in the model, with graft loss due to 
causes other than rejection.
The aim when resurfacing a massive burn is to achieve a permanent stable 
durable skin as rapidly as possible. A prerequisite for skin stability and 
durability is the presence of a basement membrane. Permanence is 
engendered by a lack of rejection, rapidity, by not having to spend weeks 
building up keratinocyte numbers.
There are two ways currently to achieve numbers of cultured kératinocytes 
sufficient to graft large body surface areas. One way is to harvest sufficient 
split skin to enable rapid culture of large numbers of keratinocyte. The other is
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to have a banked store of allogeneic kératinocytes for use in transplantation 
either on there own or mixed with autologous kératinocytes as chimeric grafts. 
Use of cultured allogeneic kératinocytes initially met with enthusiasm, lost 
favour and has only recently been revived as a method for resurfacing chronic 
venous ulcers (Eaglstein et al., 1999). Research into skin equivalents can be 
seen as having gone through a series of developments. Keratinocyte culture 
techniques advanced significantly in the 1970’s (Rheinwald and Green, 1975; 
Green et al., 1979). This was followed (mid 1980s) by studies looking at 
allogeneic cultured keratinocyte transplantation (Aubock et al., 1988; 
Hammond et al., 1987; Leigh et al., 1987; Gielen et al., 1987; Thivolet et al., 
1986). Phase three (late eighties early nineties) was characterised by the 
development of dermal substitutes or ‘neo-dermal’ equivalents (Yannas et al., 
1989). The latest phase although pioneered in the early eighties (Bell et al., 
1981) marries the previous three phases in attempts to produce allogeneic 
skin equivalents (Falanga et al., 1998). Apligraf^ is the only skin equivalent 
commercially available to date and is licensed for and has been used clinically 
in the treatment of chronic venous ulcers (Falanga et al., 1998). Apligraf^^ is a 
bilayered construct with the dermal element manufactured from bovine type I 
collagen impregnated with human neonatal foreskin fibroblasts and the 
epidermal layer manufactured from human neonatal foreskin kératinocytes. 
To date although trials involving their use suggest benefit in terms of faster 
wound healing over controls, there is as yet no evidence of the persistence of 
grafted kératinocytes. In humanised SCID mice Apligraf^^ was seen to persist 
for a week longer than human foreskin (Briscoe et al., 1999).
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The studies reported in this thesis are the first to provide unequivocal proof of 
the persistence of a skin equivalent system for more than twice as long as an 
allogeneic skin graft in a fully immune competent model.
Cloning out holoclonal or stem cells as described by others (Barrandon and 
Green, 1987; Mathor et al., 1996) may greatly improve functional survival of 
the skin equivalent. Incorporation of fibroblasts within the neodermis would 
allow for lower numbers of seeding kératinocytes. More fastidious preparation 
of and attention to the graft bed might also improve take. From a purely 
immunological standpoint we have succeeded in demonstrating early 
infiltration by dermal dendritic cells -  and this was not previously reported. 
Additionally we have shown that allogeneic kératinocytes are not rejected for 
at least twice the time taken for rejection of allogeneic split skin grafts. We 
have not shown that this is due to LC elimination; our model however sought 
to actively eliminate LCs and the lack of early rejection is consistent with the 
work of others with regard to other cell types (Faustman, 1995). It remains to 
be clarified with regard to our keratinocyte culture system whether or not LCs 
need to be actively eliminated. On explant LCs are seen to further differentiate 
and to upgrade MHC II expression (Witmer-Pack et al., 1988). These findings 
may not however pertain to the conditions in which we culture porcine 
kératinocytes.
Future work would concentrate on several key areas. The techniques 
whereby wound infiltrates are analysed require further study. As outlined 
earlier (Chapter 5), immunohistochemistry is limited in several respects. In 
order to appreciate cell phenotypes (for example activated cytotoxic T-cells)
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more completely, staining of dual or triple antigenic determinants is 
necessary. This may provide additional information about intercellular 
relationships. The use of flow cytometry would additionally provide relative 
quantitative information abouT-cell types, the qualitative content of which can 
be enhanced with the use of dual or triple staining techniques.
Keratinocyte gene transduction technology is improving and there have been 
recent reports of increasingly stable and persistent gene transduction (Mathor 
et al., 1996). Gene transduction for the purposes of labelling or otherwise 
needs to be rigorously tested to ensure that the process is not detrimental to 
the keratinocyte population (De Luca and Pellegrini, 1997; Mathor et al., 
1996). In our work it became clear that fewer irradiated 3T3 cells producing 
fewer growth factors, or harmful growth factors produced by the irradiated 
producer cell line, resulted in loss of stem cells or possibly clonal conversion’ 
from holoclones and meroclones to paraclones with fewer, smaller and less 
regular colonies.
The phenotypic behaviour of LCs in the particular keratinocyte culture 
environment used needs further study. If LCs are truly shown to die rather 
than merely de-differentiate then their active elimination may be superfluous. 
Were active elimination thought to be necessary further work is required to 
demonstrate a process by which LCs are eliminated which is not detrimental 
to co-cultured kératinocytes.
For cultured kératinocytes to take effectively a wound bed that provides 
stability and firm adherence is necessary. With regard to keratinocyte delivery 
there are those who favour a pre-confluent delivery system. In this system, 
pre-confluent kératinocytes are dispersed in a less differentiated state and
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therefore a greater proportion may still have proliferative potential than those 
in sheet grafts. The numbers of keratinocyte therefore required to achieve 
epithelial cover may be reduced (Stark and Kaiser, 1994; Harris et al., 1998). 
Others favour the production of a neo-epidermis with the final few days of 
culture at an air liquid interface so as to produce a differentiated multi layered 
stratified epidermis with the uppermost layers cornified (Medalie et al., 1997; 
Ghosh et al., 1997). Regardless of the delivery system or substrate chosen, it 
is important to determine the clonogenic nature of the resultant kératinocytes.
Thus we are lead to several conclusions. First, it is important to ensure that 
the model chosen will support and not confound hypothesis through inherent 
flaws in design. The model used in this study was designed by my 
predecessors working in the field for shorter term use in the early 90’s 
(Kangesu et al., 1993). Its flaws include the fact that it is not a closed system 
and as such is easily contaminated. The chamber used is vigorously expelled 
three to four weeks after implantation by a mixture of wound contraction and 
creep of skin flaps beneath chamber walls. PTFE chambers are used to 
isolate grafts and prevent inadvertent in growth by surrounding kératinocytes. 
Highly efficient labelling of keratinocyte with retroviral transduction may render 
the chambers unnecessary. Chamberless wounds would be flat and could be 
dressed with semiocclusive dressings thus reducing the likelihood of external 
contamination and wound infection. They also simulate the clinical situation 
more closely.
The future of research into skin equivalents needs to address the quality of 
dermis, epidermis and the basement membrane interface.
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Epidermal elements need testing in vitro to ensure a stable population of 
holoclonal and meroclonal cells that does not substantially alter with 
processing.
Rigorous assessment of the immunogenicity of allogeneic kératinocytes 
needs to be addressed. If they are found not to be rejected as some claim 
(Falanga et al., 1998) laboratory engineering of allogeneic neo equivalents 
could take place on an industrial scale with rapid generation and immediate 
benefit to the massively burnt. Were allogeneic kératinocytes to be rejected in 
a delayed fashion, permanent cover might still be achieved with a composite 
graft in which the epidermal element results from co-culture of allogeneic with 
autologous kératinocytes in predetermined proportions. The resulting neo skin 
equivalent might then survive long enough to allow the autologous elements 
to replicate and so fill the void vacated by lysed allogenic cells rejected in a 
highly targeted fashion with minimal damage to surrounding non allogenic 
elements.
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